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FYOCINBS AND THE TREATMENT Qg
PSEUDOMONAS AERUGINOSA INFECTIONS
The aim of this investigation was to study the
interaction of different kinds of pyocine with a single
sensitive indicator strain of Pseudomonas aeruginosa, and
to examine the possible therapeutic applications of these
pyocines to infections caused by the indicator strain.
After surveying the literature concerning Is. aeruginosa.
with particular emphasis on the pathogenicity of the
organism, the past and present therapy of Ps. aeruginosa
infections was discussed.
The literature on the pyooines was reviewed and it wa3
clear that two train groups of pyocines were distinguishable;
the high and low molecular weight groups, and within the
high molecular weight pyooines, two structural types were
defined; contraotile and filamentous. Members of the low
molecular weight group were referred to as small pyocines.
Ninety-four strains of Ps. aeruginosa were examined
for pyocine production against two selected indicator strains,
Ps. aeruginosa 6a and P14. Thirteen strains which produced
pyocines with properties characteristic of each of the
three types of pyocine were selected and examined in greater
detail.
2
5. The inducibility of the strains was examined and the
effects of heat, trypsin and ultracentrifugation on the
extraoted pyocinea were investigated. Eleotronmicroscopy
was used to oonfirm the classifioation of the pyocines.
6. Three pyocinogenic strains were selected for further
investigation! one (5893) which produced contractile
pyocines, another (5882) which produced filamentous
pyocines, and a third (H108) whioh produced small pyocines.
These pyocinogenic strains were defined with respect to their
pyocine activity against indioator strain P14 only and
this indicator strain alone was used throughout the remainder
of the study. The pyooines were numbered according to
their producer strain, e.g. pyocine 5893 was the pyocine
produced by strain 5893 and inhibitory to indicator strain
P14.
7. Various methods for purifying and concentrating the
pyocine preparations were examined and precipitation of the
proteins with ammonium sulphate proved the most satisfactory.
8. Mouse toxicity testing of pyocine preparations at various
degrees of purity revealed that in some forma, certain
pyocine preparations caused adverse effects. Uninduced,
low activity preparations of the pyocine were more lethal,
suggesting that factors other than pyocine were responsible
for toxicity, but examination of fractions of an induced
preparation in vivo favoured the pyocine itself as the
toxic agent.
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9. In view of the toxicity problems, another pyocinogenic
strain (1577)# which produced contractile pyocines
inhibitory to indicator strain HL4, replaced the tacie
pyocine (5893).
10, An extended pyocine purification scheme was devised
that included ion-exchange chromatography. The method
gave satisfactory results with the high molecular weight
pyocines but the small pyocine proved more problematic.
11, The interactions between the pyooines and cultures of
strain P14 were examined in vitro and the effects of dosage
and incubation time on the survival of P14 cells were studied.
12, The pyocines were examined in mic^ alone, and in the
presence of infections caused by strain P14. When the
pyocines were injected into mice by various routes,
inhibitory activity against strain P14 could be identified
in tie serum for several hours.
13, High molecular weight pyooines given intraperitoneally
in the presence of a lethal dose of strain P14 administered
by the same route, were unable to prevent the fatal outcone
of the infection unless they were given before or
simultaneously with the bacteria. The 3mall pyocine
preparation had no protective effect.
14, Infection of experimentally-induced burns with strain
P14 was examined; although colonisation of the burn was
easily established, lethal infections were more difficult
to achieve. The effects of topical application of the
high moleoular weight pyocines on infected burns were
examined and it was eonoluded that the pyocines did not
improve the ohanoes of survival of burned, infected aioe,
15. Despite the problems of pyocine resistance of strain
P14 recognised in vitro, this did not appear to be the
cause of failure of pyocine therapy in vivo#
16* A single, intraperitoneal dose of pyocine was sufficient
to cause the production of pyocine-neutralising antibody,
but topically-applied pyooine did not elicit an antibody
response*
17* The future of pyocine therapy was discussed.
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A bacterium responsible for the bluish discolouration of
pus was isolated by Gessard in 1882 and named by him Bacillus
pyocyaneus. In 1889, Charrin (cited by Forkner, i960) clearly
demonstrated the pathogenicity of this organism in rabbits and
around the turn of the century there were several reports of the
isolation of Bacillus pyocyaneus from various human infections.
Hiere has been a lengthy controversy over the correct nomenclature
for this organism, which has been variously called Bacillus
pyooyaneus. Pseudomonas pyoovanea and Paeudomonas aeruginosa.
Hugh and Lessel (1967) discussed the various forms and concluded
that the name Pseudomonas aeruginosa was the most acceptable.
Despite its recognised pathogenicity, Ps. aeruginosa was not
prominent as a cause of human infections in the first part of this
century when Gram-positive cocoi and tubercle bacilli were
providing more serious menaces to human life (Finland, Jones and
Barnes, 1959)« Although Groves (1909) said of Ps. aeruginosa
"now this is a germ we are too apt to treat lightly", it was some
forty years later following the introduction cf antibiotios,
particularly the broad-spectrum antibiotics, that a marked increase
in infections caused by the Gram-negative bacilli was seen
(Rogers, 1959} Asay and Koch, I960; Barber, 1961). Ps. aeruginosa
has played a leading role in this increase, probably because it
is a ubiquitous saprophyte which is naturally resistant to many
antibacterial agents and it has a great capacity for survival in
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environments such as disinfectants, ointments and humidifiers.
It is an excellent example of an opportunist pathogen that
attacks patients who are already debilitated and whose natural
defences are deficient.
General characteristics of Pseudomonas aeruginosa
Ps, aeruginosa is a G-ram-negative baoillus belonging to the
family Pseudomonadaceae, The genus Pseudomonas consists of many
species which are predominantly free-living in soil or water, but
several are plant pathogens and a few including Ps, aeruginosa, are
pathogenic to animals. Ps. aeruginosa is the type species of the
genus and is an aerobic or facultatively anaerobic organism whose
optimum growth temperature is 37°C. The cells measure about 0.5
by 1.5n and are motile by means of one to three polar flagella
(Bergey's Manual, 1957).
Ps. aeruginosa can be isolated in several distinct colonial
forms (Phillips, 1969) an& a single culture may alter its colonial
type; a phenomenon known as dissociation (Gaby, 1946J Zierdt and
Schmidt, 1964). Lysogeny is common in Ps. aeruginosa and may also
result in phenotypic colony changes. Some workers have suggested
that the different colonial forms differ in their sensitivity to
various agents such as antibiotics and bacteriophage (Zierdt and
Schmidt, 1964; Homma, 1971)• Although Ps. aeruginosa is frequently
recognisable by its colonial appearance, other identifying features
include the production of a greenish-blue pigment, pyocyanin;
the ability of the organism to grow at 42°C, to produce cytochrome
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oxidase, and to produce slime in a defined liquid medium
containing 2-ketogluconate. The analysis of the slime has
produced contradictory results but it appears that the main
constituent is a polysaccharide composed chiefly of glucose.
Deoxyribonucleic acid (DNA), ribonucleic aoid (RNA) and
hyaluronic acid are also present together with small amounts of
protein, rhamnose and glucosamine (Brown, Scott. Poster and
Clamp, 1969)» The slime layer is antigenic and has tcocio
properties that will be discussed later.
The mucoid form of Ps, aeruginosa is one of the less common
colonial types but shows a particular association with pulmonary
infections in children with cystic fibrosis, (Zierdt and Schmidt,
19^4} Doggett et al,« 1965). Some reports propose that the
mucoid cells are encapsulated while others suggest that the
mucous material is less fiiraly bound to the cell. The mucoid
strains of Ps, aeruginosa do not simply produce larger amounts of
the characteristic slime described above, but elaborate a completely
different substance composed of uronic acids and resembling
alginic acid (Carlson and Matthews, 1966),
The cell walls of Ps. aeruginosa resemble those of other
Cram-negative bacteria. Adjacent to the cytoplasmic membrane
is a layer of murein surrounded by a complex membranous structure
of lipoprotein and lipopolysacoharide (LPS). The lipids of the
cell wall consist of two types} those that are fimly attached
to the protein or polysaccharide and those that are loosely bound.
The latter are composed mostly of free fatty acids and phospholipids
and are associated with magnesium and calcium ions (Bobo and
Eagon, 1968). These divalent cations are also thought to play a
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role in stabilising the surface structure of Ps. aeruginosa both
by linking polysaccharide subunits and by stiffening the lipoprotein
component (?imelis and Jackson, 1973)# The LPS constitutes the
somatic antigen and provides receptor sites for some bacteriophages
and pyocines,
Ps. aeruginosa is well equipped for its role as an opportunist
pathogen. It is highly versatile and can adapt to a variety of
situations. Being primarily a saprophyte, the organism has simple
nutritional requirements and a broad spectrum of enzymes enabling
it to obtain carbon and energy by the oxidation of a wide variety
of organic compounds; for example, from the hydrocarbons of jet
fuel (Bushnell and Hans, 1941) and from poor quality distilled
water (Pavero et al.. 1971)* Benzalkonium ohloride is a quaternary
ammonium compound commonly used as a preservative in pharmaceuticals
and Ps. aeruginosa is capable of growing in such preparations,
where it is thought to utilise the benzalkonium ohloride molecule
as a carbon and energy source and destroy its antimicrobial activity
(Adair, &eftic and G-elzer, 1969)# Such contaminated preparations
provide dangerous sources of infection. Ps. aeruginosa can
survive in a range of environments although it has a preference for
the moist over the dry and it rapidly colonises environments that
are contaminated with small amounts of organic materials. It is
the adaptability of Ps. aeruginosa that is the keynote to its
success as an opportunist pathogen.
Pathogenicity of Paeudomonas aeruginosa
Ps. aeruginosa elaborates a large variety of extracellular
products some of which, the pyocirBS, are antagonistic to members
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of the same genus, some have antibiotic activity against other
genera, and some have been implicated in the pathogenicity of the
organism. The last group includes the pigments, slime, endotoxin,
extracellular enzymes and exotoxins, and the parts they may play
in the pathogenicity of Ps. aeruginosa are reviewed here.
Pigments
The blue-green pigment of Pa. aeruginosa was observed before
the organism was even isolated (Fordos, I860). In 1953# Cruickshank
and Lowbury studied the effect of pyocyanin on tissue cultures of
human skin cells and leucocytes and found it to be toxio to the
former at levels greater than 0.002i|. mg/ml and to the latter at
0.08 mg/ml. These authors calculated the amount of pyocyanin
that might be present in the infected burn exudate and suggested
that the pigment would be capable of causing toxic effects in vivo.
Leucocytes were less sensitive and are probably not affected in vivo.
Thus it was postulated that pyocyanin might have a role in the
local toxicity in surface infections.
More reoent work (Armstrong, Stewart-Tull and Roberrts, 1971)
has shown that it is a breakdown product of pyocyanin, 1-hydroxy-
phenazine, that is the active principle and this compound inhibits
mouse liver mitochondrial respiration in vitro. These workers
postulate that in a surface infection with Ps. aeruginosa.
1-hydroxyphenazine would be produced and impair or kill the
macrophages, thereby removing one of the body's front-line defences.
This might be followed by destruction of the tissue cells and the
permeation into the bloodstream of the l-hydroxvphenazine which
would reach the liver cells and inhibit their mitochondria,
eventually causing oytolysis, and death of the animal. However
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Armstrong and her colleagues acoept that this is probably not the
only factor involved in pathogenicity.
Slime
The slime material commonly produced by strains of
Ps. aeruginosa in fluid oultures has been implicated in pathogenicity
(Liu, Abe and Bate3, 1961)j it contains highly polymerised DNA and
Callahan, 3eyerlein and Mull (1964) showed that as the DNA was
depolymerised, the material became increasingly toxic to mice.
These workers suggested that there were enzymes present in the
mouse that were capable of hydrolysing polymerised DNA. Thus the
slime may play a toxic role in the pathogenicity of Ps. aeruginosa.
It has been suggested that the hyaluronic acid component of the
slime, which adheres firmly to the oell surface, nay function as a
microcapsule in a manner analogous to the hyaluronic acid capsules
of Gran-positive organisms (Brown et al.. 1969).
Mucoid strains of Pseudomonas aeruginosa
The mucus material produced by mucoid strains of Ps. aeruginosa
has quite a different chemioal composition from the more common
slime and it has been reported as being toxic to chick embryos
(Cundy and Mattson, I969) and to mice (Doggett and Harrison, 1969),
when administered in a purified form. The material also
possesses antiphagocytic activity (Sohwarzmann and Boring, 1971)•
Endotoxin
Early workers expected that the endotoxin of Ps. aeruginosa
would cause similar effects on the host to those caused by the
endotoxins of the Enterobacteriaceae. However Michaels and
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Eagon (1969) found significant differences between the LPS
isolated from Pa. aeruginosa ana from the Salmonella-Esoheriohia
group. The backbone of the LPS appears to be the same in the
two groups but the side-chains of the Ps. aeruginosa LPS are
much less complex and involve a smaller variety of carbohydrates,
Liu et al. (1961) showed that cells of Ps. aeruginosa were
relatively non-toxic when injected into mice and Hall et al,
(1968) agreed that the cells did not stimulate an endotoxic
reaction. However if the protein portion of the endotoxin is
extracted and tested in vivo it is capable of eliciting a
Shwartzman reaction and a pyrogenic response (Johnston, Morris
and Berk, 1967; Homma, 1971)* But G-orrill (1965) and later
Klynn and G-orrill (1967) suggested that endotoxaemia was the
cause of death in mice that were injected with large doses of
Ps. aeruginosa intravenously. Cunay and Mattson (1969) reported
the toxicity to mioe of endotoxin extraoted from a mucoid strain
of Ps. aeruginosa.
Extracellular enzymes
Ps. aeruginosa produces a battery of extracellular enzymes
including protease, gelatinase, elastase, lecithinase, lipase,
acid and alkaline phosphatase and ooagulase.
In 1953# Yow and Townsend reported the problems of applying
skin grafts to burns infected with Pa, aeruginosa. They isolated
strains of the organism that had potent proteolytic activity and
could lyse blood clots, plasma clots, coagulated serum and
coagulated human skin and muscle. In experiments with rabbits,
Fisher and Allen (1958a) showed that intracorneai inoculation of a
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virulent culture of ?s. aeruginosa caused, corneal ulceration.
But the same effect could be demonstrated by inoculating a cell-free
culture filtrate from the virulent strain. These workers
correlated the corneal damage with protease elaborated by the
organism, particularly collagenase activity (Fisher and Allen,
1958b). They suggested that the enzyme was adaptive and was
induced by the presence of suitable protein substrates in the eye.
Liu et al. (1961) fractionated oulture3 of Ps. aeruginosa
and tested each fraction in mice for its ability to produce
pathological effects. They found that the extracellular enzyme
fraction, particularly protease and iecithinase played an important
role in surface lesions and also contributed to the lethality of
a generalised infection. But later Liu and Mercer (19&3) found
that a strain must be able to grow in the serum of the test animal
as well as to produce extracellular enzymes in order to be virulent
to that animal.
Carney and Jonas (1968) compared the production of extracellular
enzymes by strains of ps. aeruginosa that caused septicaemia and
death in burned raioe (virulent strains) with the production by
strains that did not cause septioaemia and death (avirulent).
In vitro, the virulent strains produced more of each enzyme tested
than did the avirulent strains. The maximum enzyme production was
around the fifth day of culture and this is comparable with the time
at which experimentally burned and infected mice die of septicaemia.
Klynn and Gorrill (1967) and later Muszynski (1973) defined
the virulence of a strain as its ability to kill mi.ce after
intraperitoneal administration. They found that stx'ains of
Ps. aeruginosa oould be classified into high, medium and low virulence
1U
groups. The high virulence strains exhibited the greatest overall
extracellular enzyme activity (when tested in vitro) and the best
correlation was between protease production and virulence.
Exotoxins
It has been difficult to show that extracellular enzymes are
actually produced in vivo and thus their importance in the
pathogenicity of Ps. aeruginosa infections has not been confirmed.
Liu (1966) found that when a virulent strain of Ps. aeruginosa
was grown in rabbit serum, leoithinaae was not produced and the
protease production was very low. He isolated a "lethal toxin"
from the excised 3kin of a rabbit that had been injected
intracutaneously with a strain of Ps. aeruginosa, and showed it
was lethal to mice when administered intraperitoneally. The toxin
could not be identified with any in-vitro enzymatic activity that
had been described. A similar toxin could be produoed in vitro
by suitable manipulations of the growth conditions. This toxin
appears to be a protein with a molecular weight in the range of
serum globulin and without enzymatic activity, In-vivo experiments
showed that the toxic factor could kill mice within a few hours but
no significant histopathological changes were seen at necropsy.
In later studies, Liu (1973) found that a strain could produce
several types of exotoxins, one of which, exotoxin A, was relatively
stable and therefore more easily purified. When tested in mice,
a purified preparation of exotoxin A contained 8,000 LD^C per mg
protein, which is of the same order as the exotoxins of other
bacteria (Liu, Yoshii and Hsieh, 1973)* Antitoxio sera produced
against exotoxin A could prevent the lethal effects of infection
15
caused by strains of Pa, aeruginosa whose somatic antigens were
unrelated to the toxin-producing strain, provided the exotoxin of
the lethal strain was serologically identical to exotoxin A
(Liu and Hsieh, 1973)» The latter finding suggests that the
LPS somatic antigen is not an important factor in the pathogenesis
of Ps. aeruginosa.
Injection of the exotoxin into dogs (Atik et al.. 1968) resulted
in two types of reaction} an immediate anaphylactoid reaotion,
and a late hypotensive reaction. The dogs usually recovered from
the first, only to die of the second. In some ways these
reactions resemble those following Injection of endotoxin but
differ in that invasion of the bloodstream by the organisms
was not necessary. Y/hen the toxin is added to African green
monkey-kidney cell cultures, it binds immediately to the cells
but there is then a lag of about five hours before Irreversible
damage occurs (Pavlovskis and G-ordon, 1972). The toxin was found
to damage the electron-transport chain in mitochondria and whole
cells from mouse liver, and induced mitochondrial swelling,
suggesting changes in membrane permeability (Pavlovskis, 1972).
Damage to mouse liver mitochondria was also induced by the pigment
breakdown product 1-hydroxyphenazine as already noted.
In summary, of the factors that have been implicated in the
pathogenicity of Ps. aeruginosa, endotoxin seems to play a very
3mall role. The pigments may contribute to the deleterious effects
but the extraoeXLular enzymes and the exotoxins seem to be the
main contenders. The slime may also be toxic and may play a role
in protecting the onanisms from the hosts' defences.
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Experimental Pseudomonas aeruginosa lnfeotlona in animals
One of the problems encountered in the study of the pathogenicity
of an organism is that the virulenoe factors may be produced only
in vivo. In reoent years evidence has accumulated that many
bacterial species grown in infected animals are chemically and
biologically different from their counterparts grown in vitro
(Smith, 1972), The exotoxin and extracellular enzymes of
Ps. aeruginosa described by various workers (Liu et al., 1961;
Liu, 1966; Carney and Jones, 1968; Bavlovskis, 1972) may play
a role in damaging the host but the mere presence of large
bacterial populations may also harm the host by producing emboli
or depleting the host tissue of its essential nutrients.
Bartell, Orr and G-aroia (1968) described an in-vivo experimental
system which allowed quantitation of the bacterial population during
the oourse of an infection. Mioe were inoculated intraperitoneally
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with a dose of Pa. aeruginosa (2.5 x 10 organisms) which resulted
in 80-100^ mortality within 48 hours. Smaller doses of organisms
had no adverse effeoi on the animals. The mioe were killed at
intervals after inoculation and the numbers of organisms in
peritoneal washings, blood, lung, liver, kidney and spleen were
determined. Bartell et al. (1968) suggested that their results
showed three distinct events during the course of the infection.
.Firstly the lethal factors were expressed. Secondly there was
a significant increase in the numbers of bacteria present and lastly
the mioe died. The rapid oourse of the fatal infection (death
usually occurred within 8-12 hours of inoculation) suggested a
toxic death, but preformed toxin oould not be demonstrated in the
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inoculum and it was implied that the toxin was elaborated in the
animal after the injection of the baoteria. Bartell et al.
(1968) U3ed specific bacteriophage to control the numbers of
bacteria at various times during the course of infection. They
found that unless the phage were administered within 30 min.
of inoculation of the bacteria, the mortality of the mice was
unaffected. Thus the authors suggested that the increase
in bacterial numbers did not contribute to the lethality of the
infection but that some toxic substance was implicated. These
results sipport the finding (Liu, 1966; Bavlovskis, 1972;
liu, 1973) that exotoxins are the chief virulence faotors of
Fa, aeruginosa. However the experimental model used by Bartell
et al. (1968) where a massive dose of organisms is introduced
directly into the peritoneal cavity, is not typical of naturally
occurring Pa, aeruginosa infections in humans. Smaller numbers
of Ps. aeruginosa injected intraperitoneal^ can produce lethal
Infections in mice if the animals are pretreated with cortisone
(Rosenthal, Killican and Rust, 1957) or 6-mercaptopurine
(V/hittaker, 1971)» or if the infected dose is suspended in mucin
(Olitzki, 1948; Stephens, 1959).
In an effort to examine an experimental infection that more
olosely resembled a human infection, Klynn and G-orrill (1967)
studied the development of Ps. aeruginosa pyelonephritis in mioe.
They attempted to establish infection by intravenous inoculation
of the organisms but found that in healthy mice the abscess-forming
dose wa3 very close to the lethal dose. However where death was
avoided, the mice did develop typical pyelonephritis which imitated
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the human infection, but conclusions on the possible virulence
factors of Ps. aeruginosa involved were not reached.
The animal studies described above are based on intraperitoneal
or intravenous administration of large doses of P3, aeruginosa
frequently resulting in rapid death of the animal. But sueh
approaches are not satisfactory for the study of the pathogenic
mechanisms involved in surface infections such as those of burns,
Ps, aeruginosa infections of experimentally-produced burns in
animals have been studied by several workers. Mice and rats
are usually used and the burns are produced either by immersing
part of the anaesthetised animal in boiling water or steam
(MoRlpley and Garrison, 1964-} Teplitz et al,. 1964; Skornik and
Dressier, 1970) or by applying a heated brass block to the back
of the animal (Jones, Jackson and Lowbury, 1966), The size of
the burn is so designed that the animals survive unless they are
deliberately infected with Ps, aeruginosa,
Teplitz and his colleagues (1964) recognised the importance
of pseudomonas septicaemia as a common cause of death following
infection of burns and they devised an experimental model to try
and elucidate the pathogenesis of pseudomonas burn wound sepsis.
Rats were burned over 20fo of their body surface area by soalding
the skin in boiling water for 10 s. This resulted in a full-skin
thickness burn whose natural course was characterised by sloughing
of the eschar and formation of soar tissue. The burns ware seeded
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with 1 ml of a culture of Ps, aeruginosa containing 4 x 10 bacteria
and the rats were killed at intervals after infeotion. The course
of the bacteria during the infection was followed by estimating the
number of organisms in the excised burned tissue and in the blood
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and organs. Up until 2k hours after infection, the Pa, aeruginosa
remained on the surface of the eschar but after this time, intra-
eschar counts began to ri3e and by the fourth day the bacteria
had invaded damaged muscle tissue beneath the burn. By the eighth
day the bacteria had invaded the viable tissue surrounding the burn
and splenio and blood cultures were also positive for Pa, aeruginosa.
None of the rats developed visceral lesions before the seventh
day, but thereafter these increased in frequency and were found
most commonly in the lungs, Teplits et al, (19&*) suggested
that their findings bore a close resemblance to the human
infection. The rats frequently became ill before positive blood
cultures were observed and the authors suggested that this was due
to the production and liberation of toxic factors by the
Ps, aeruginosa in the burn wound before septicaemia developed.
Stone (1966) fractionated a culture of Ps„ aeruginosa into
two extracts; the slime layer and the somatic layer, V.hen these
fractions were administered to mice by the intraperitoneal route,
the somatic layer was not lethal, but the slime layer contained
three groups of lethal toxins. One was a, haemolysin that
produced marked haeoolytic anaemia when injected into rats. The
second group of exotoxins consisted of cytctoxins which produced
areas of necrosis when injected subcutaneously into rats, and the
third group of toxins inhibited certain functions of the host's
reticulo-enaothelial system. The latter group may be those of
the type described in in-vitro studies by Liu (1973)♦ Stone (1966)
postulated that the inhibition of host defence mechanisms by the
13. aeruginosa toxins might be sufficient to precipitate toxaemio
death of burned and infected patients or at least to facilitate
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invasion of the organisms into the bloodstream. This could
help to explain the observation of negative blood cultures in
the presence of overt burn wound sepsis.
Skornik and Dressier (1970, 1971) used burned rats to
examine the development of respiratory tract complications
following burn injury. After infection of the burns with
Ps. aeruginosa they found an apparent depression in the reticulo¬
endothelial response, particularly in the lung macrophage
mechanism, thus supporting Stone's observations (1966) on the
inhibition of the host defences. The inability to clear
bacteria from the lungs c correlated with the numbers of organisms
in the sub-eschar tissue. Death from infection did not occur
unless the bacterial count in the fascia and muscle underlying
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the eschar rose to about 10 organisms per g of tissue.
In a series of experiments with mice, Jones and his
colleagues evolved an experimental model for pseudomonas burn
infeotion. The animals were burned by the application of a
standard brass block previously heated in boiling water (Jones
et al.. 1966). Following infection of the burns with a virulent
strain of Ps. aeruginosa, the mortality rate was Jlfo and the mean
time to death of these mice was 6.2 days. Carney, Dyster and
Jones (1973) compared the activities of two strains of
Ps. aeruginosa on mice burned by this method; one strain was
lethal to burned mice, but the other was not. During the first
48 hours after the burns had been seeded with the lethal strain,
considerable bacterial multiplication occurred on the surface of
the skin and in the hair follicles. The bacteria then began
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to invade and multiply deeper in the dermis and in the dorsal
muscles. Death due to septicaemia occurred around the fifth
day after infection. In contrast, the non-lethal strain
remained localised in the outer regions of the burned skin
and did not invade the deeper tissues. The invasive
properties of these two strains of Pa. aeruginosa were thought
to be associated with their ability to produce extracellular
enzymes, particularly proteases (Carney et al». 1973)•
Carney and Jones (1968) had previously shown that protease
production occurs at a maximum from the fifth day of culture
in vitro and it may be significant that invasion of the deeper
tissues of the burned animal, culminating in death, also
occurred around the fifth day.
The burn infection model, in its various forms, has proved
very useful in the study of pseudomonas infections. At first
sight it may appear somewhat artificial but in fact it mimics
the human burn infection very closely. The results suggest
that the pathogenicity of Ps. aeruginosa in burns i3 due partly
to the toxigenic and partly to the invasive properties of the
organisms. In vivo, Ps. aeruginosa appears to produce a number
of exotoxins in conjunction with the slime and one or more of
these impairs the host defence mechanisms. The extracellular
enzymes that were described in vitro (Liu et al.. 1961;
Carney and Jones, 1968) play a role in the invasion of the bacteria
from the surface into deeper tissues.
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Infections caused by Pseud aaonas aeruginosa
Ps. aeruginosa ia primarily a aaprophyte but its pathogenic
properties have already been stressed. The hospital provides
a delightful environment for an opportunist pathogen such as
Ps. aeruginosa; debilitated patients abound, moist niches for
the organism to skulk in, and an abundance of antibiotics and
disinfectants which serve to reduce the numbers of competing
organisms while the resistant Pseudomonas survives triumphant.
Outside the hospital Ps. aeruginosa rarely troubles healthy
humans and carriage rates of the organism in the population
are low (Lowbury and Pox, 1954) and oolonisation of the gastro¬
intestinal tract is difficult to achieve experimentally in
humans (Buok and Cooke, 1969). But a high proportion of
hospital patients oarry pa. aeruginosa in the bowel (Stoodley and
Thorn, 1970) and contaminated food and medioaments have been
considered as possible reservoirs from which a patient may become
colonised (Shooter et al.. 1969)# However, most Ps. aeruginosa
infections in hospitals are thought not to be endogenous in
origin.
In his monograph on pseudomonas infections (i960), Forkner
wrote "Given the proper predisposing circumstances, there is
scarcely a region of the body exempt from infection with
Pseudomonas aeruginosa." The "predisposing circumstances"
are almost always constituted by a primary debility in the patient
and infections are unoommon in other circumstances, except when
the bacteria are directly introduced e.g. by lumbar puncture or
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in eye surgery. In other words, Ps. aeruginosa takes the
opportunity of infecting patients whose defence meohanisms are
already under par.
When considering a list of infections caused by P3. aeruginosa
it is hard to find a part of the body that escapes a mention.
The primary sites of colonisation are the skin and muoous
membranes and the organisms may remain localised or disperse to
invade other organs.
Skin infections with Ps. aeruginosa often occur in patients
with neoplastic disease or those receiving large amounts of
antibiotics. Conditions such as green-nail syndrome and
toe-web infection are localised infections resulting from
colonisation by Ps. aeruginosa under conditions of increased
moisture, and are not serious. However the skin lesions
constituting ecthyma gangrenosum are viewed much more seriously
and are virtually pathognomonic of pseudoraonas septicaemia.
The lesions evolve in a characteristic manner: Small vesioles
develop, typically isolated from one another, oedema is followed
by erythema and the fluid ocntents of the vesicle become milky
or haemorrhagio and burst spontaneously leaving a necrotic area
surrounded by induration (Hall et al«. 1968; Borff et al.. 1971)*
The entire sequence may be completed within 12 hours. The
bacteria proceed to invade the walls of the veins and later the
arterial walls and septicaemia rapidly develops. Blood cultures
may be positive for Ps. aeruginosa before the ecthyma gangrenosum
is manifest but more often the skin condition is noted first.
Whichever way, the fatal course of a septicaemia is rapid and
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effective therapy is difficult to achieve unless the condition
is diagnosed in its early stages.
Forkner et al. (1958) examined 23 cases of septicaemia of
which 22 were fatal. Twenty-one of the 23 patients had malignant
neoplastic disease. The median duration of life after the first
positive blood culture was four day3. Similarly, Cooper (1967)
reported 34- deaths among 35 children with pseudomonas septicaemia.
He found that the tendency to infection in tho face of a primary
debility was not universal but the ages of his patients may have
contributed to their disadvantage.
Ps. aeruginosa endocarditis is uncommon but when it occurs
it is very difficult to treat. Blood-borne spread, of the organisms
may lead to localisation of bacteria on the heart valves and from
here complications of the central nervous system frequently
develop. Ps. aeruginosa may implant on normal as well as
abnormal heart valves (Carruthers and Kanokvechayant, 1973) and
the infection is often fatal. A diagnosis of endocarditis is
difficult to make in a patient who survives and is usually
assumed on the basis of prolonged bacteraemia without any other
apparent source.
Ps. aeruginosa is a menace in burn infections and frequently
contributes to the fatal outcome. In 1965, Lindberg et al.
reported that 60-70^6 of deaths in burned patients due to
septicaemia were attributable to pseudomonas burn wound sepsis.
The burn provides a large surface area, rich in nourishment and
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susceptible to colonisation by many organisms including
Ps. aeruginosa. Colonisation is a nuisance because it
delays wound healing and provides a dangerous source of
organisms from which other patients may be infected. But the
pseudomonads may not be content with colonisation alone and often
invader deeper into the burned areas and into the adjacent viable
tissue and eventually enter the bloodstream. Septicaemia
develops rapidly and is often fatal. Ironically, the presence
of Ps. aeruginosa in a burn may have some advantage. Stone,
Given and Martin (19&7) observed that homografts survived longer
in patients whose burns were infected with Ps. aeruginosa.
This may be due to the production of toxins by the organisms
which depress the host defence mechanisms (Stone, 1966).
A disturbing number of Pa. aeruginosa infections, whioh
should be preventable, result from the use of contaminated fluids
or equipment. EJye infections with Ps. aeruginosa, caused by
instillation of contaminated eye drops or saline, have been
reported. Ps. aeruginosa is a particularly dangerous pathogen
to the eye, where it rapidly causes corneal ulceration which
often leads to lose of the eye (Ayliffe et al.. 1966).
Contaminated fluids or equipment have also been incriminated in
cases of meningitis following spinal anaesthesia (v/einstein and
Perrin, 19M3). Like endocarditis, infection of the meninges
with ps. aeruginosa is uncommon but important because of the
high mortality rate. Meningitis may also develop as a result
of haematogenous spread of the bacteria (Forkner, I960).
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Contamination of needles and syringes was thought to be
the cause of two oases of osteocyelitis and vertebral disc
infeotion in heroin addicts reported by Selby and Fillay (1972).
In suoh circumstances, heroin is usually diluted in unsterile
conditions before administration and injection is made without
prior cleansing of the skin and often with a syringe and needle
shared by a group of addicts, so it is hardly surprising that
infections occur.
Catheterisation is almost a password for the development
of urinary tract infections. Because of the abundance of
Pa. aeruginosa in the hospital environment and its ability to
survive in disinfectants whioh may be used for storing catheters,
it is often the causative agent of urinary tract infections.
As a result, pyelonephritis may develop and be extremely difficult
to treat. Improvement in catheterisation techniques (Pyrah
et al.. 1955) and the use of disposable catheters has to a large
extent reduced the occurrence of this form of Pa. aeruginosa
infection.
Pseudomonas pulmonary infections frequently result from the
use of contaminated respiratory equipment (Bassett, Thompson and
Page, 19^5; Phillips and Spencer, 1965; Tinne et al.. 1967).
Such equipment often incorporates a water reservoir which provides
an ideal environment for Ps. aeruginosa to lurk in. Prom the
contaminated reservoir, aerosols containing large numbers of
viable bacteria are generated and pass directly into the patient's
respiratory tract. Complex pieces of apparatus, such as
27
respirators, are a hallmark of modern medicine but they are
notoriously difficult to sterilise and. Ps, aeruginosa is adept
at taking advantage of this situation. The patients at greatest
risk are those with chronio lung disease or other debilitating
states (Tillotson and. Lerner, 1968). Ps, aeruginosa may give
rise to an acute infection but it frequently lingers in the
lung in a state of chronic suppuration which is almost impossible
to eradicate with antibiotics (Burns, 1973)»
Cystic fibrosis (CF) is an inherited disease which results
in the production of abnormal body secretions including a highly
tenacious mucus in the lungs. This has the effect of creating
a static condition in the lungs and consequently CF patients
are very vulnerable to pulmonary infections. The staphylococcus
is usually the primaiy pathogen but Pa, aeruginosa is a close
contender and. more diffloult to treat. As a pseudomonas
infection progresses in a CF lung, the organism tends to change
to its mucoid form and this is associated with a concomitant
deoline in the clinical condition of the patient. The infections
are of a chronic nature but despite massive pulmonary involvement,
septicaemia rarely develops (Doggett and Harrison, 1972),
Babies, particularly premature babie3, are susceptible to
Ps, aeruginosa infeotlon and their only predisposing debility
may be their age and low natural resistance, Gastro-enteritis
and diarrhoea caused by Ps, aeruginosa are found more frequently
in children than adults and sometimes occur in epidemics in
nurseries (Florman and Schifrin, 1950; Falcao at al,« 1972).
A maternity hospital was the scene of an outbreak of Ps. aeruginosa
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infection which was unusual in that intestinal symptoms were mild
or absent but four infants developed acute otitis media, four
others conjunctivitis, and two mothers suffered from mastitis
(Kwantes, I960). Otitis media in babies, caused by Ps, aeruginosa.
has also been reported by Carithers (1950) but in neither this nor
Kwantes* report were any fatalities recorded. Otitis externa
may develop from colonisation of the outer ear by Ps. aeruginosa.
particularly in moist environments (Hall et al.. 1968). Ear
infections usually remain localised but occasionally Ps. aeruginosa
invades deeper regions of the skull.
From this survey of Ps. aeruginosa infections, it is clear
that the organism's versatility is not confined to its
biochemical capabilities but embraces its ability to cause a wide
variety of infections in compromised hosts.
Treatment of Pseudomonaa aeruginosa infections
The problems of treating Ps. aeruginosa infections were
realised soon after the pathogenic nature of the bacterium was
recognised. Early forms of treatment were of two main types;
directed either against surface infections or administered
systemioally. Prior to 1938 the agent used in the systeraio
treatment of Pa. aeruginosa infections was autogenous vaocine
made from a culture of the organisms isolated from the lesion.
Groves (1909) was probably on® cxf the first to treat a patient
with a Ps. aeruginosa infection with vaccine; following two
injections of the vaccine the boy's pseudomonas pyaemia recovered.
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Vaooine therapy was continued with variable results until the
introduction of the sulphonamides(Freeman, 1916; Garretson and
Cosgrove, 1927)•
Taylor (1916) considered that Ps. aeruginosa was never a
source of acute danger to a patient but caused delay in wound
healing; an observation which has been frequently reported to
the present day, Taylor noted that Ps. aeruginosa was less
often present when discharges from wounds were acid, suggesting
that treatment with an acid antiseptio might be efficacious.
He found that of the acids he tested, 1% acetic acid in physiological
saline was the most inhibitory to Ps, aeruginosa. Since this
report, acetic acid has regularly been advocated for treat rent
of Ps, aeruginosa surface infections. Rank (1940) recommended
the use of 2% acetic acid or household vinegar to prevent
pseudomonas infection prior to skin-grafting, and more recent
studies have confirmed the antipseudomonas aotivity of this acid
(Hedberg and Miller, 1969; Rhoades and Short, 1970),
Vaooine therapy for Ps. aeruginosa infections fell into
disuse with the advent of the sulphonand.des in 1938 and later
the antibiotics, Stanley (1947) reviewed some of the methods
in use at the time and concluded that sulphonamides and streptomycin
could be useful in treating Ps. aeruginosa infections but trie
sensitivity of the oiganism to these antibacterial agents
in Vitro was variable and strains that were initially sensitive
to streptomycin sometimes became resistant during the course of
treatment.
The innate resistance of P3, aeruginosa to many antibiotios
was coming to light and it was not until the introduction of
30
antibiotics directed specifically against the Gram-negative
baoilli that much progress was made. The polymyxin
group of antibiotics, particularly polymyxin B and E (coli3tin)
emerged as one of the few groups of antibiotics that were aotive
against systemic Pa, aeruginosa infections. The use of
polymyxins has been reported more frequently from the U.S.A.
where carbenicillin was not released for general use until
recently. The problem with the polymyxins lies in their
toxicity even at normal therapeutic doses. They are potentially
nephrotoxic (Beirne et al.. 1967) and can cause acute neuromuscular
blockage leading to respiratory muscle paralysis in patients with
poor renal function (Lindesmith et al.. 1968).
Carbenicillin is a semi-synthetic penicillin with considerable
potential for treating Ps. aeruginosa infections. It is also
inhibitory to Proteus species and some strains of Escherichia coli
but tends to encourage superinfection with resistant Klebsiella
and Serratia organisms (Bodey, Rodriguez and Luce, 1969)#
Carbenicillin is inactive when administered orally but serum
levels of 100 pg/ml can be achieved by giving large doses
intravenously. There have not been any reports of serious
toxicity even at the necessarily high doses. About 85/S of
Ps. aeruginosa strains from clinical isolates are sensitive to
100 fig/ml carbenicillin but much higher levels of the drug are
required to inhibit the remaining 15/o of strains (''feshington,
1972). Bodey et al. (1969) reported the use of carbenicillin
in 23 episodes of Ps. aeruginosa infection in cancer patients
with a success rate of 91%• But even in ih e presence of high
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serum levels of the antibiotic, bronchial and surface infections
are often not eliminated, Carbenicillin treatment of
Ps. aeruginosa pulmonary infections in children with cystic
fibrosis sometimes results in clinical improvement but the
organism is rarely eradicated from the sputum (Boxerbaura, Doeshuk
and Pitman, 1968; Phair et al,. 1968).
Gentamicin belongs to the amino-glycoside group of antibiotics
and i3 active in vitro against a wide range of Gram-negative
bacteria including Ps, aeruginosa, and some Gram-positive
bacteria including neomycin-resistant staphylococci (Darrell and
Waterworth, 1967)# However, the antibiotic has been reported
as nephrotoxic and causes injury to the vestibular division of
the auditory nerve (Stone et al«. 1965), Gentamicin has proved
a useful addition to our armoury for attacking ps. aeruginosa
infections particularHy in the topical treatment of burns, but patients
with impaired defence mechanisms and granulocytopenia respond
poorly to gentauicin therapy while carbenicillin treatment seems
to be unaffected by these conditions (Rodriguez, Whitecar and
Bodey, 1969)#
Synergy has been demonstrated between carbenicillin and
gentamicin in vitro at concentrations of each drug which are
easily aohievea in the blood. The mechanism of synergy may be
due to carbenieillin inducing the formation of 3pheroplasts which
are muoh more susceptible to gentamicin than are normal cells
(Phair, Watanakunakorn and Bannister, 1969). This synergy may
be useful in vlvc but individual sensitivity testing of strains
is necessary because a single combination of the two antibiotics
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which is generally synergistic against a range of Ps. aeruginosa
strains has not yet been found. Kon±ckov£ and Pr£t (1971)
found synergy between oarbenicillin and gentamicin when the
drugs were used in combination in the treatment of experimental
ps. aeruginosa pyelonephritis in rats, but these workers
reported that the infection was only occasionally completely
eliminated. Polymyxin B has also been reported as having
some synergistic action vdth cartenicillin against Pa. aeruginosa
(Phair et al.« 1968).
However, it has recently been reported that carbenicillin
is capable of inactivating gentamicin in vitro, and the half-life
of gentamicin in the sera of eight end-stage renal patients was
greatly reduced when carbericillin was given concomitantly
(Davies, Morgan and Anand, 1974).
Topical therapy
Surface infections caused by Ps. aeruginosa, especially
those of burns, do not respond well to antibiotics administered
parenterally and topical treatment is found to be better for
reducing stqjerficial infections and preventing invasion of the
bacteria into the underlying tissues. As described earlier,
antibacterial agents such as acetic acid were used in early
years for topical treatment. In 19.51, Jackson, Lo?bury and
Topley reported the value of local polymyxin treatment of
Ps. aeruginosa in burns. Application of a 0,1;' polynyxin-E
cream greatly reduced the incidence of colonisation of burns by
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Ps« aeruginosa. Polymyxin is safe for prolonged topical
treatment because very little of the antibiotic is absorbed
from wounds or mucous membranes.
The use of topically-applied gentamicin cream to reduce
Ps« aeruginosa colonisation of burn wounds has proved very
effective. In a water-miscible solution the antibiotic
penetrates well and can reduce the numbers of Ps. aeruginosa
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to less than 10 per g of infected tissue (Stone, 1969).
Uninterrupted treatment is necessary to prevent the emergence of
resistant mutants but there is a tendency for Klebsiella and
other resistant organisms to oause superinfections. The toxicity
associated with the systemic use of gentamicin is much less
serious when the drug is administered topically, but some
workers feel that because of its effectiveness when given
systeraically, it should be witheld from topical use to disefourage
the development of resistance (Shuck, 1972).
Silver nitrate solution plays a prominent role in the local
treatment of burns. Itoyer et al. (1965) found that silver
nitrate compresses were successful in reducing fluid loss from
the surface of large b urns and in preventing bacterial colonisation.
Cason and Lowbury (1968) presented results which showed a
sigoificant reduction in the isolation of Ps. aeruginosa from
burns and blood cultures after the introduction of local treatment
with 0,5> silver nitrate compresses, Analysis of the data from
one hospital showed that mortality due to burns had hardly
changed over the period 1949-1964 but following the introduction
of routine prophylaxis against P3, aeruginosa with silver nitrate
3k
compresses, there was a significant improvement in survival
(Bull, 1971). However, silver nitrate can cause severe
electrolyte depletion in a burned patient and occasionally
methaemoglobinaemia develops.
Lindberg and his colleagues (1965) showed that the use
of Sulfamylon (Mafenide) cream reduoed the frequency with which
Ps. aeruginosa was recovered from burns but there were some
adverse side-effects. Lcwbury and his co-workers (1971)
carried out a controlled trial of the alternative forms of local
treatment of burns, comparing compresses of silver nitrate with
Sulfamylon Cream and with exposure to warm dry air. They found
that silver nitrate was generally more effective than Sulfamylon
in maintaining the burns free from bacterial colonisation although
there was little difference in the two forms of treatment against
Ps. aeruginosa specifically. Both treatments were preferable
to the exposure method. However Sulfamylon is very painful on
application (Lowbuxy et al«. 1971) and has sensitizing properties
which may lead to long-lasting cross-sensitization to other
sulphonamidea (Bleumink and Klokke, 1971)• It is also a potent
inhibitor of carbonic anhydrase and onuses respiratory and
metabolic ocmplications. Thus both silver nitrate and Sulfamylon
have disadvantages as agents for topioal therapy.
Silver aulphadiazine is a compound designed to combine the
antibacterial activities of silver and sulphadiazine. It is
active against Ps. aeruginosa and some strains of Proteus and
Staphylococcus aureus (Pox, Rappole and Stanford, 1969),
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Disadvantages in its use have not been reported to date and it may
have an important role to play in the treatment of burn infections.
Resistance of pseudoaonaa aeruginosa to antimicrobial agents
P3, aeruginosa has a diversity of enzyme systems which
allow it to grow on many different substrates. Therefore it is
difficult to interfere with an essential enzyme pathway and this
may partly account for the oiganisin*s natural resistance to
many antimicrobial agents. Treatment of Ps. aeruginosa
infections is further complicated by the acquisition of
resistance by sensitive strains.
Some forms of resistance in Ps. aeruginosa are thought to
be associated with changes in the cell wall structure. for
example, cells which are resistant to polymyxin have much less
phospholipid in their cell walls than sensitive cells. Phospholipid
is thought to be involved in the passage of polyn^yxin to its active
site at the cytoplasmic membrane where it destroys the osmotio
barrier activity (hindesmith et al.. 1968), and if the phospholipid
is reduced, much higher levels of antibiotic are required in order
that some should reach its target (Brcwn and WatkLns, 1970)•
Resistant mutants of Ps. aeruginosa can be isolated from
cultures grown in the presence of sub-inhibitory concentrations
of carbenicillin. These carbenioillii>»resistant cells are
thought to have changes in the type or amount of cell wall
lipc-polysaocharide (Barrett and 4ascher, 1972). The margin
between the concentration of carbenicillin obtainable in the serum
and the minimal inhibitory dose of many dL inioal isolates of
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Pa. aeruginosa is small but much higher concentrations of the
antibiotic can be obtained in the urine. Thus Pa. aeruginosa
is usually rapidly eradicated from the urinary tract by
earbenicillin therapy but may persist in extraurinary infections.
Holmes and his colleagues (1969) found that persistent
Pa. aeruginosa increased their resistance to carbenicillin
fourfold or more during the course of treatment. Resistance
to oarbenicillin does not only arise from selection of resistant
mutants but also by acquisition of resistance determinants on
*
resistance transfer factors. In the Birmingham Accident Hospital,
Lowbury and his colleagues (1969) reported a gradual increase in
the frequency of isolation of oarbenioillii>-resistant strains of
Ps. aeruginosa over the period 1966-1968, but early I11 1969 highly
resistant strains began to appear and quickly ousted the more
sensitive strains of Ps. aeruginosa. Resistance appeared to be
due to the production of a oarbenicillinase enzyme and a
resistance transfer system was implicated (Lowbury et al». 1969)#
Later an R faotor was isolated from these resistant strains and
was found to confer on the cells resistance to carbenicillin,
neomycin, kanamyoin and tetracycline (Grinsted et al.. 1972).
The R factor was shown to be a plasmid which was freely
transmissible between strains of Ps. aeruginosa. Each, coll and
Proteus mirabilis in vitro and in vivo in experimental infections
of mouse burns (Roe, Jones and Lowbury, 1971)*
Resistance to gentamicin has also been observed to develop
during the course of treatment and may be encouraged by the rapid
fall-off in serum levels of the drug leaving sub-inhibitory
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concentrations (Darrell and Waterworth, 1967).
Thus we are thwarted in our treatment of Ps. aeruginosa
infections both by the innate resistance of the organism to
many antibiotics and by its ability to acquire resistance to
the few effective antibiotics such as oarbenicillin.
With these problems in mind, earlier forms of treatment have
been reconsidered, particularly vaocine therapy.
Immunotherapy
Treatment of Ps. aeruginosa infections by vaccination is
not a new idea and Groves (1909) used a vaocine to treat a
pseudomonas pyaemia. But early vaccine therapy had variable
results and was later superseded by antibiotic treatment. In
recent years the failure of antibiotics to cure Ps. aeruginosa
infections, fox* reasons outlined above, has led to a revival of
interest in vaccines. Work in this field has foeussed
particularly on Ps. aeruginosa infections of burns which often
have fatal consequences. Although burned patients are more
susceptible to Ps. aeruginosa infections than normal people,
their antibody production against chemical ard. particulate
antibodies is normal and thus active immunisation is a feasible
proposition.
Various fraotions of Ps. aeruginosa cells have been shown to
be antigenic in animals, for exanple the slime (Liu et al,« 1961),
the LPS of the cell wall (Young, 1972), and the extracellular
enzyme fraction (Jones, 1968). It is thought that the LPS
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constitutes the principal antigenic component (Young, 1972)•
Vaccines can be prepared using whole cells and these stimulate
good protection in animals against infection by a homologous
strain but the protection is leas good against a heterologous
strain (Liu et al«. 19&L)* Fisher, Devlin and G-nabasik (1969)
established an immunotype scheme based on protective antigens.
They prepared whole-cell killed vaccines from 3^-2 strains of
Pa. aeruginosa, from clinical sources and tested the ability of
eaoh vaccine to protect mice against infection by each of the
other strains. Thus these workers were able to group their
strains on the basis of cross-protection. Seven immunotypes
emerged and from these a heptavalent vaccine was prepared.
In 1971» Alexander, Fisher and MacMillan reported the success
of the olinical trials of this vaccine in burned patients.
When a suitable dosage was given, the vaccine could elicit a
rapid antibody response which was capable of being sustained
and which was associated with protection of the patient against
subsequent infection by Ps, aeruginosa. The results of
Alexander et al. (1971) show a significant reduction in
mortality from pseudomonas sepsis among seriously burned patients
but they recorded the presence of side-effects to the vaccine
in some of their patients probably due to the LPS of the
purified antigens which are used to prepare the vaccine.
However the side-reactions were considered insignificant in
relation to the danger of an infected burn.
Active immunisation involves a time-lag of about 5 days
between administration of the antigen and maximum antibody
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production and during this time the patient remains unprotected
against pa. aeruginosa. However, it has heen shown that the
patient may be protected against infection by passive immunisation
with hyperimmune serum (Jones, 1968; Piers on and Feller, 1970).
The recent success of vaccine therapy suggests that this
form of treatment may be useful in protecting other grovps of
patients who are highly susceptible to Ps. aeruginosa infections
bdt whose antibody production is normal. But Fs, aeruginosa
infections are al3o common sequelae of primary debilitating
diseases in which antibody production is naturally or artificially
depressed and there are still considerable problems associated




Like other forms of life, bacteria are subject to infection
and inhibition by a range of viruses and viruslike particles which
fall naturally into two main categories: bacteriophages and
baoteriocines. The first descriptions of these two types of
inhibitory agent were made within ten years of each other.
In 1915, Twort isolated a virus responsible for the lysis of
staphylococci, and in an independent study in 1917» d*Herelie
described the dysentery bacteriophage, d*Herelle coined the term
"bacteriophage" (literally "eater of bacteria") which is now
commonly abbreviated to phage. A few years later, dratia (1925)
recognised the presence of an inhibitory agent in the culture
filtrate of Escherichia coll V which acted specifically against
E30h, coll This agent showed many similarities to phage but
was unable to reproduce itself in the sensitive cell which it
attaokea and was later defined as a bacteriocine. During the
next 20 years there was little published work on the bacteriocines,
but by 1946, G-ratia and Eredericq had examined a number of strains
of Each, coli and found that the inhibitory phenomenon was fairly
general. They named the agents responsible, colicines. Although
recognising that the activity of colicines was highly specifio,
directed against other strains of the same genus, they found that
some strains of Shigella and Salmonella were also susceptible.
By 1948, Erederioq had recognised 17 colicines that were
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distinguishable by their different speotra of activity, the
morphology of their inhibition zones, the extent of their
diffusion through agar, their ability to pass through cellophane
and their sensitivity to heat and proteolytic enzymes#
Frederieq suggested that cells that were sensitive to attack by
more than one coliclne possessed specific reoeptpr sites for
each colioine. He also found that colicine-resistant mutants
arose spontaneously from the parent culture and were stable.
He used this latter feature in a classification scheme for
colicines based on the specificity of resistant mutants.
As h'soh. coli has played a key role in microbial genetics,
much of the early work on baoteriocines centred on colicines.
However, Pseudcmonaa aeruginosa is one of the oldest known examples
of a bacterium that produces substances that are antagonistic to
other bacteria. Bouchard (1889) was the first to recognise the
antibiotic activity of preparations of Pa, aeruginosa against
Bacillus anthracis and later this agent was marketed as a
commercial product, pyooyanase, and was used in the treatment of
diphtheria, grippe and meningitis; however, it fell into
disrepute because the manufacturers "failed to produce a potent
product" (Hays et al.t 1945)» These early studies did not
examine the antagonistic activity of oulture filtrates of
Ps, aeruginosa against other strains of the same 3peoies and it
was not until 1954 that bacteriocine activity v/as recognised
among Ps. aeruginosa strains and the term pyocine was introduced
(•Jacob, 1954). It is the speoific activity of pyocines against
other strains of Pseudomonas that separates them from other
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antibiotic substances produced by Pa» aeruginosa. Prior to his
description of pyocines in 1954, Jaoob and Wollman (1953) had
proposed the name baoteriocine for
"these particular antibiotics which appear
to be protein-like substances, the synthesis
of which leads to bacterial lysis, and are
adsorbed on speoific bacterial receptors,"
Jacob realised that baoteriocine aotivity was probably not oonfined
to colicines and pyocines and it is now appreciated that
baoteriocine production is a widespread phenomenon, Bactsriocines
have been recognised in the Gram-positive genera Staphylococcus
(Fredericq, 1946), Streptococcus (Kelstrup and Gibbons, 1969),
Lactobacillus (Upreti and Hinsdill, 1972) and Bacillus megaterium
(Holland, 1962), Among the Gram-negative organisms, baoteriocine
activity has been identified in Vibrio cholerae (Lang, McDonald and
Gardner, 1968), Neisseria gonorrhoea (Flynn and MoEntegart, 1972),
Serratla marcespens (Foulds, 1971), Enterobaoter cloacae
(de Graaf et al,. 1968) as well as in Shigella and Proteus species,
and this list is by no means exhaustive.
The nomenclature of baoteriocines is based on the specific
name of the producing organism, e.g. pyocine is derived from
Ps, pyooyanea and although the ozganisra is now more frequently
known as Ps. aeruginosa, the term aeruginocin, which has been
suggested, seems rather unwieldy.
The class of agents referred to as baoteriocines includes a
wide range of substances from simple enzymes (e.g. megacin A is a
phospholipase) to complex particles resembling viruses (e.g. some
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pyocines and a vibriocin). A sub-division of the heterogeneous
collection of substances can usefully be made into two main
groups; the high molecular weight bacteriocines, which appear
to be of viral origin or have viral assocaatdons, and the low
molecular weight agents, which appear to be constituents of the
bacterial cell (e.g. associated with the somatic antigen).
According to Bradley (1967)» these two groups probably have quite
separate origins and occupy different positions on the
evolutionary scale. It is frequently found that each family of
bacteriocines, for example the pyocines or the colieineg, consists
of representatives of the two different groups. Sandoval, ReiUy
I
and Tandler (1965) postulated that if colicine3 were the produots
of defective lysogeny, they may range from relatively simple
proteins to completely formed phage particles. All the
bacteriocine3 that have been studied in sufficient detail have
been shown to include or consist of protein or polypeptide and do
not have any DNA or RNA.
Hamon (1956) extended Jacob's work and examined 15 strains of
Pa. aeruginosa of which ten produced pyocines. He defined some of
the properties of pyocines: inactivated by heating, non-dialysable,
diffusible in agar, sometimes sensitive to proteolytic enzymes,
possess antigenic properties, resistant to DNase aid ultra-violet
irradiation, precipitated by ammonium sulphate and by acetone.
Hamon described the pyocines as "lethal corpuscles of protein
nature."
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Physical and chemical properties of pyocities
Among the bacteriocines produced by Pa, aeruginosa, a
variety of agents are recognisable. There are low molecular
weight pyocines, frequently associated with the cell wall,
especially the lipopolysaccharide (LPS) of the somatic antigen,
A cell wall-associated protein with pyocine activity was
described by Horama and Suzuki (19^4), and Homma, Goto and
Shionoya (19^7) identified pyocine A^ from the cytoplasm and
pyocine A^ from the cell wall of Ps, aeruginosa strain PI-UI,
The molecular weight of A was estimated as 23,000, These low
2
molecular weight pyocines are known as S-type or small, Ito,
Kageyama and Egami (1970) found small-pyocine activity in the
supernates of strains of Ps. aeruginosa I,HI and P28 and estimated
the molecular weight of the agents to be c. 100,000. Recently,
a detailed study of a small pyocine was described (Ohkawa,
Kageyama and Egami, 1973). Pyocine S2 was produced by strain
M47 and appeared to be a simple protein of moleoular weight
4
£• 7*5 x 10 and thus of the same older as some colicines
9
> e3. V v and K)«
The pyocines that have been studied more extensively are
. 6
those that belong to the high molecular weight group (1 x 10 -
1 x 107). The morphological similarity of these pyocines to the
tails of T-even ooliphages has frequently been observed and indeed
some authors believe that these substances should be regarded aa
defective phages and should not be defined as bacteriocines
(Reeves, 1972),
Fyocine R was one of the first pyocines to be visualised in
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the electron microscope and was described by lahli, Kishi and
Egand (1965) as being composed of rod-shaped contractile
structures. The original pyocine, CIO, of Jacob (1954) was
examined by Bradley (1967) and found to be morphologically
identical to pyocine R, In their earlier paper, Higerd,
Baechler and Berk (1967) could only recognise oontracted
particles in electronmior©graphs of pyocine 09 but suggested
that this might have been an artefact of the preparation. Later,
thqy described contracted arxl relaxed forms of the pyocine
(Higerd, Baechler and Berk, 1969) and suggested that the
uncontraeted state was the active form. Higerd and his
colleagues (1969) examined pyocine preparations after various
chemical treatments and found that contraction of the sheath was
promoted by 0.5SMMgCl , Ifc formalin, low pH, sonic treatment, and
freezing and thawing. The contraction brought about by 0.5M-MgCl
2
oould be reversed by reducing the salt concentration to 0.02M-MgCl .
2
Yui (1971) examined pyocine R in detail and suggested that it
was composed of at least four structural components: sheath, core,
baseplate and fibres. It is the sheath which is capable of
contraction. &ovan (1974a) examined several pyocines in the
electron microscope and distinguished the same components.
He found that in the relaxed state, the pyocine particles possess
a helical or horizontally striated substructure of about 20 subunits
and measure c.100 x 15nm. In the contracted particles, a hollow
core can be seen, partially enclosed in the sheath. The amino
acid analysis of the components (Yui, 1971) showed that the sheath,
which occupies 53% of the pyooine partiole, did not vary greatly
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from the other parts and when compared with the amino acid
composition of ooliphage T2, the pyocine and phage had a common
feature in the high amounts of hydrophobic amino acids.
Treatments that dissociate the sheath into its subunits suggest
that it has an extraordinarily rigid quaternary structure.
The activity of pyocine R is inhibited by p-chloromercuri-
benzoate and raercurio chloride (Kageyama and Egami, 1962)
suggesting that free sulphydryl groups exist in the pyocine
which are responsible for its activity. However, the results
are inconclusive beoause other sulphydryl agents did not affect
pyocins activity (Yui, Ishii and Egami, 1969)* The features of
the pyocine structure that are responsible for its activity are
as yet undetermined but contraction of the sheath seems to play
an important role (G-ovan, 1974a), However, pyocines have been
described that are lacking thi3 contractile sheath. In 1967,
Takeya et al. produoea electronmicrographs of pyocine 28, whioh
appear3 a3 a rocUshaped particle of width c»9nm and of variable
length (50 - 400nm). The fibrous shape and the width of the
particle resemble the pseudomonas phage Pf (Takeya et al.. 196$)»
The specific attachment of pyocine 28 to sensitive cells could be
observed in the eleotronmiorograph3. Since the discovery of
thb filamentous form of pyocine particle, a number of others of
the same nature have been described (Brown, 1973} G-ovan, 1974b).
Although both classes of high molecular weight pyocines are
considered to be proteins, their activity is unaffected by
proteolytic enzymes such as trypsin, chymotrypsin and pronase.
The pyocines are also resistant to DNase, and RMase, lo"^ M-cyanide,
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10"3 ^-ethylenediaminetetraacetic acid (3DTA), id"3 M-cysteine
and 0.1 - 0#7M-NaCl. The activity of the ecntractile pyocine
is unaffected by heat below 70°C, but at or above 70°C, the
pyocine la rendered inactive within 10 min. (Higerd et al., 1967).
The filamentous pyocine is more heat-labile, being almost
completely inactivated by heating at 60°C for 10 min, (Takeya
et al.. 1967).
The small (S-type) pyocines appear to constitute a distinct
category of substanoes. Although they were recognised fairly
early in pyocine history, fewer detailed studies have been
published. The small pyocines are sensitive to the action of
proteolytic enzymes and are considerably more heat-labile than
the high molecular weight particles. Homma and Shionoya (1967)
suggested that the small pyocines A2 and A3 might be included in
the structure of high molecular weight particles and it is only
when they remain unprotected that they are sensitive to proteolytic
enzymes. The study of pyooine S2 by Ohkawa et al. (1973)
revealed that it was an apparently simple protein, whose amino
acid composition had characteristics in eommon with certain
colicinesj rich in oharged and polar amino acids and lacking in
cysteine residues. The lack of sulphydryl groups in small
pyocines is in contrast to contractile pyocines where it is
thought that these groups may play a role in the activity of the
particles. The small pyocines are non-sedimentable and have not
been resolved in the electron miorosoope. They would appear to
be similar in nature to colicines.
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Production of pyooines
The production of pyocines by pyocinogenic cells is
dependent on the cultural conditions; Govan (1968) found that
32°C was the optimum temperature for pyocine production,
A few cells in the population will synthesise pyocine spontaneously
but production by the majority of cells can be induced by
treatment of a culture with mutageidc agents such as ultra-violet
irradiation or Mitomycin C, After induction, the turbidity of
the culture rises and then falls sharply as the cells lyse and the
pyocine is released.
The mechanism of induction is not clearly understood.
The lethal effects of ultra-violet irradiation on a cell are
thought to be due to the formation of pyrimidine dimers in the
DNA. In the presenoe of bound acriflavine, bacteria are protected
against the lethal effects of ultre-violet because pyrimidine
dimerisation is inhibited, but acriflavine does not protect
against induction of pyocine production, which suggests that
induction is not caused by pyrimidine dimersation (Alper, Forage
and Ho dgkins, 1972),
Mitomycin C is an antibiotic produced by Streptomvces caesnltoaua
whose primary effect is the inhibition of DNA synthesis. In the
cell, the antibiotic is converted to an activated form which
covalently bonds with the DNA, leading to the formation of cross¬
links between complementary DNA strands (Waring, 1966), The
biological effects of Mitomycin C and ultra-violet irradiation
show distinct similarities,
Experiments using radioactively-labelled sulphur showed that
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the contraotile pyooine £ is synthesised de novo after induction
and there is little or no transfer of host protein to the
pyocine (ikeda, Kageyama and Egami, 1964). Similar experiments
have not been reported for small pyocines, but if these form
part of the cell wall protein or other normal cell components,
then their synthesis might be expected to differ from that of
high molecular weight pyoeines. Following induction of the
pyooine R producer strain by ultra-violet irradiation or
Mitomycin C, the pyocine proteins appear after 10 - 15 min. and
the active pyooine particles after about 25 min. Electronmiorographs
taken 45 min. after induction show large numbers of pyocine
particles in cell extracts (Shinomiya, 1972). The killing
activity of pyocine R appears several minutes after the
emergence of antigenic pyocine protein, suggesting that this
interval is the time required for the assembly of the subunits#
The pyocine particles have no intrinsic antibacterial activity
and must be assembled to produce active particles (Shinomiya, 1972)#
DNA synthesis in the producer cell is greatly reduced after
induction, and treatment of an induced culture with an inhibitor
of DNA synthesis (5-fluorodeoxyuridine) has little effect on
pyocine production (Shinomiya and Egami, 1967). There is little
change in RNA synthesis after induction and pyocine protein
accounts for about 30J& of the total protein synthesis.
Fyocine R production can be inhibited by addition of the
amino acid analogue fluorophenylalanine (FPA) (ikeda, 1967) and by
dihydrostreptcrycin (DHSM) (Shinomiya and Egami, 1967). Both
agents are specific inhibitors of pyocine synthesis and other
protein synthesis continues unaffected. DHSM is thought to aot
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through specific effects on ribosome structure, but ths
mechanism of EPA inhibition is not understood.
The mode of action of pyooines
It is difficult to generalise on the mode of action of
pyocines beoause few of these agents have been examined in
sufficient detail. Analogies have been drawn with the action
of colicines which have been studied in greater depth. The
general picture of the mode of action of bacteriooines suggests
that they are bactericidal rather than bacteristatic and that a
single bacteriocine molecule, adsorbed to a specific receptor site
on the sensitive cell surface, is capable of killing that cell.
The specific biochemical mechanism of the host cell that is
affected varies with the attacking bacteriocine. However, the
inhibitory activity is clearly different from that of classical
antibiotics which enter the cell and inhibit enzyme function or in
some cases bind to DNA.
Jacob (1954) showed that after addition of pyocine G10 to a
sensitive bacterial culture, the cells did not multiply and their
respiration gradually decreased. A similar result has been found
with colicine K. Kageyama, Ikeda and Egami (19^4) studied the
mode of action of the contraotile pyocine R. At 37°G, adsorption
was followed by release of ultra/-violet-absorbing material
(at 260nm) and death of the cell. Under defined conditions, the
amount of ultra-violet-ab3orbing material released i3 proportional
to the dose of pyocine added. If a large excess of pyocine is
added, the cells lyse, possibly due to the presence of a lytic
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enzyme. Kageyama et al. (1964) found that a muramidaae-like
enzyme is synthssised at the time of induction of a pyocinogenic
strain an3 aids in the release of pyocine from the producer cell.
At this stage, a certain portion of the enzyme becomes incorporated
into the pyocine structure. An analogous situation has been
reported in some phages.
Kaziro and Tanaka (1965a) studied the mode of action of
pyocine B. and found that addition of the pyocine to a sensitive
cell culture resulted in immediate and complete inhibition of
DNA, RNA and protein synthesis. They postulated that the cessation
of protein synthesis was due to inaciivation of the cell's
ribosomes (Kaziro and Tanaka, 1965b).
If single-hit kinetics operate, i.e. one pyocine particle
is capable of killing a single cell, then the survival of a
sensitive cell population can be calculated from a Poisson
distribution. The results suggest that a straight line
relationship exists between the logarithm of the survival fraction
and the dose of pyocine, Kageyama et al, (1964) found that this
relationship held true but there were inconsistencies at high
concentrations of pyocine. They suggested that thi3 might be due
to the high frequency of mutation to pyooine resistance. If one
pyocine particle is capable of killing one bacterial cell, from a
killing experiment it is possible to calculate the number of
pyocine particles present and hence the number produced by a
pyocinogenio cell. Thus, Kageyama and his oolleagues (1964)
estimated that one cell was capable of elaborating about 200
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pyocine particles.
Ohkawa et al. (1973) found that the small pyocine S2 also
showed a single-hit killing process. The amount of protein
-11
corresponding to one killing unit was calculated as c.3.7 x 10 pg
or about 300 molecules. A similar result was obtained by
Nomura and Maeda (1965) for colioine E2.
Several theories have been devised to try and explain the
mode of action of colicdLnes and although there has been no
counterpart in pyocine studies, it is interesting to examine the
colicine theories in view of the similarities between these
agents and pyocines. Nomura (1967) proposed a model for the mode
of action of colicines based on the following four points:
(1) attachment of the colicine to a specific receptor site
on the cell surface
(2) reversible change in the cell attachment site
(3) transmission of the change to the "target"
(4) effects on bioohemical and killing target
The important feature of the model was the idea that a mechanism
that conveys the stimulus generated by the colicine at its
receptor site to a biochemical target involves an action transmitted
throu^i the cytoplasmic membrane, Changeux and Thiery (1967)
postulated a method by which such a change might be effected in the
cytoplasmic membrane. They suggested that colidnes are specific
components of the cell mentorane of colicinogenic strains that
possess a high affinity for the cell surface of sensitive strains.
The bacterial cell menfcrane is viewed as a co-operative structure
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composed of repeating units arranged in a two-dimensional lattice.
At least two structural conformations are available to the units
within the lattice and the transition of one unit from one
state to another tends to affect its nearest neighbour to change
in the same manner. The binding of a colicine molecule to the
membrane induces the transition of a small number of membrane
units to a conformational state which is not usually present in
large amounts in the resting cell. The transition tends to
spread among the membrane units until the whole cell membrane
is shifted to this unusual conformation. The biochemical
changes induced in the cell by colicine attack are the results
of changes in the conformation of the proteins that are attached
to the inside of the cell mecbrane. The biological activity of
these proteins is consequently upset and the cell is unable to
function.
This theory of Changeux and Thiery (1967) assumes that the
colicine molecules bind to the cell membrane, but more recent work
has shown that the bulk of oolioine receptor aotivity is located
in the cell wall (Sabet and Schnaitman, 1973)* How the oolioines
penetrate the cell surface is at present one of the most
intriguing aspects of colicine action. The faot that pyocine
receptors also appear to be located in the cell wall suggests
anotiter similarity between the mode of action of these two groups
of bacteriocines.
The complex pattern of production of and sensitivity to
pyocines in Ps. aeruginosa suggests that at least some strains are
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capable of producing more than one pyocine anu that sensitive
cells possess a number of different receptor sites. In general,
bacteriocinogenic cells are insensitive to the action of the
bacteriocines they produce, but Goodwin, Levin and Doggett (1972),
examining mucoid and non-mucoid strains of Ps. aeruginosa, suggested
that some strains were autosensitive. A similar finding has been
reported for oolicines but the results are somewhat dubious since
the immunity of cells to the colicine they produce is a primaiy
definition of oolioine classification (Bowman, Sidik&ro and
Nomura, 1973)#
The specifio adsorption of pyooines to sensitive cells was
described by Haoon and Peron in i960 and later Ikeda and Lgami
(1969) extracted the receptor substanoe for pyocine R, The
latter authors found that receptor activity could not be attributed
to a single homogeneous substance, but was associated largely with
the cell wall LPS, The examination of a similar extract from a
cell that was resistant to pyocine R showed that it behaved veiy
differently. The resistant strain was also resistant to pyocine
R3 and R4 and to phage PS5. More recent work by Ikeda and EgamL
(1973) confirmed that the receptor far pyocine R is composed of LPS
and the size of the site required for receptor activity was
5 6
calculated as 10 - 10 . Stewart and Young (1971) also confirmed
that lipid materials, particularly in a complexed f arm, play an
important role in reoeptor activity for contractile pyocines.
Treatment of cells with EDTA resulted in a considerable reduction
in pyocine-adsorbing power. EDTA has been shown to chelate
divalent cations which are essential to the structural integrity
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of the LPS in the cell wall. Further evidence for the role of
LPS as the receptor material for contractile pyocines was
provided by electronmicrograjjis showing the contractile pyocines
21 and 430 adsorbed to LPS extracted from a sensitive indicator
strain (Govan, 1974a),
The receptor sites for filamentous and small pyocines have
not been described but Govan (1974b) demonstrated in eleetron-
micrographs that filamentous pyocines attached to extracted LPS,
but in neutralisation experiments, the LPS failed to neutralise
the pyocine activity.
The genetics of pyooinogeny
The ability to produce baoteriocines i3 a heritable
characteristic, which may be transferable from one cell to
another. The genetic information for colicine production is
thought to be borne on plasmids known as Col factors. Little
is known about the genetics of pyocinogeny, partly because
experimental genetic systems are less well-established in
Ps. aeruginosa than in Each, ooli,
Kagqyama (1970a) showed that the genetic determinant for
pyocine R2 could be transferred from a donor cell to a reoipient
by conjugation and that it was closely linked to the tryptophan
and other chromosomal markers. This suggests a chromosomal
location for the pyocine determinant. I^yocine R2 is a
contractile pyocine and thus may be likened to a defective phage.
The chromosomal position of its determinant may correspond to the
integration site of certain prophages (Kageyaraa, 1970a). Using
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the general transducing phage J?ll6, Kageyama (197Gb) also
showed that the genetic marker for pyocine R2 could be
transduced into recipient cells and again there was a high
degree of linkage between the pyocine and trytophan markers.
More recently, Kageyama, Shinomiya and Ohoumi (1973) have
reported that the genetic determinants for pyocines R and R3
can also be transferred to a recipient strain by conjugation
and transduction.
As yet, nothing is known about the genetics of filamentous
and small pyocines. If the latter are truly to be likened to
odicines, one might expect their genetic information to be
plasmid-borne.
Relationships between baoteriocines and bacteriophages
Since the earliest descriptions of baeteriocines, their
likeness to bacteriophages has been commented on repeatedly.
The two types of inhibitory agent have in common: similar
action spectra; fixation on to specific receptors; specific
immunity to the agent produced; biosynthesis that is both
inducible and lethal. The major difference between
bacteriocines and phages is that the latter are self-reproducible.
Despite the similarities between the two types of agent, the
actual relationship is somewhat obscure. Bacteriocines resemble
virulent phage in their killing aotion, but bacteriocinogenio
factors resemble lysogenio (temperate) phages, yhich are thought
to be incapable of killing sensitive bacteria.
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The obvious similarity between contractile pyocines and
the tails of the T-even phages sv^gests that one may have
evolved from the other. According to Bradley (I967) it seems
unlikely that a cell would develop the genetic information to
code for a selection ani penetration unit before providing
itself with a suitable receptacle for the transmission of genetic
information, i.e. the phage head. Thus it seems possible that
contractile particles may have developed as a result cf the los3
from a temperate phage genome of the ability to code for a head.
Contractile pyocines have been likened to phage ghosts, whioh
are capable of attaching to and killing sensitive cells, but
differ from their parent phage in being unable to replicate
(herriot and Barlow, 1957)»
The filamentous pyocines, of which pyocine 28 is an example,
are thought to be related to fibrous pseudomonas phages, but
structures resembling pyooine 28 could not be produoed from Pf
phage particles by various physical and chemical treatments
(Takeya et al.« 1969). Fyocine 28 also resembles the core
section of a contractile type of pyooine but the filamentous
pyocine is often curved, whereas the cores are always straight.
Bradley (1967) suggested that the fine structure of pyocine 28
showed close similarities to the long sheathless tails of
pseudomonas phages of group B. Yfaatever the correct comparison
is, it seems reasonable to consider that both the high molecular
weight types of pyocine may have evolved from defective phages.
The low molecular weight baeteriocines appear to be quite
58
different from their phage-like, high molecular wei^it counterparts.
It has been postulated that the small bacteriocines may be
related to fertility (F) factors (Reeves, 1965} Bradley, 19£>7)»
Since the determinants for caLicines (ool factors) are thought
to be plasmid by nature, a possible side-evolution from the F
factor is suggested. Hoover, this is conjecture and the true
origin of these agents and the relationship of the small pyccines
to normal cell wall components is not understood.
The serological activity of pyooines
Fyocines are good antigens and immune sera can easily be
produced in animals. Kageyama et al. (1964) demonstrated a
precipitation reaction between pyocine R and antiserum. A
1 in 100 dilution of serum was sufficient to neutralise pyocine
of 10,000 units activity, A number of workers have examined the
serological relationships between different pyocines and between
some pyocines and phages. Homme, et al. (1967) found that
antisera produoed against each of the contractile pyocines
Al B. end R neutralised the activity of all three.
130 sp me
The activity of pyocine Al could also be neutralised by antisera
mo
raised against five temperate phages produced by the pyocinogenic
strain. Phage PSJ is similar to, but not identical with, the
R-type pyocines and has similar receptor specificity. Antiserum
against pyocine R was capable of neutralising the phage activity
but antiserum produced specifically against the pyocine sheath
protein did not neutralise phage activity. This suggests that
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the pyocine component which is common to the phage resides
elsewhere than in the sheath (ito and Kageyama, 1970).
Homma et al. (1967) found that the activity of pyocine 28 was
neutralised by the same antisera raised against contractile pyocines
Al , R , and R _ and the five temperate phages. Serologically,
mc sp mc
pyooine 28 was the same as pyocine Al , but these workers did
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not confirm that pyooine 28 had a filamentous form (Takeya et al,.
I967), Strain 28 has been reported to produce other types of
pyocine as well as the filamentous variety (ito et al.. 1970)*
G-ovan (1974b) found that in strain 430, which produces both
contractile and filamentous pyocines, no serological relationship
could be demonstrated between the two types of pyocine particle.
The small pyocines A2 and A3 showed a serological similarity
with each other, while being quite distinct from the high molecular
weight pyocines. Antisera produced against the whole bacterial
cell or against the cell wall LPS did not neutralise the pyocines
A2 and A3 despite the close association between pyocine A2 and
the cell wall (Homtna and Shionoya, 1967)*
The uses of bacteriocines
The biological significance of bacteriocines in nature is
probably that of conferring a selective advantage to the
bacteriocinogenio strain, despite the actual synthesis of
baoteriooine being lethal to the produoer cell. Production of
baeteriocine by a few cells in a clone may, by killing the
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surrounding baoteria of the same or related species, improve
the prospects of the clone. The existence of bacteriocines
will tend to lead to selection for loss of receptor sites on
sensitive oells (Reeves, 1965)# Thus baoteriocines in their
natural habitat may influence the evolution of bacteria.
It has been suggested that bacteriocinogenic strains may
have a selective advantage in colonising areas such as the human
gut. Colicine production has been thought by some workers to be
a likely mechanism for the control of the intestinal £L ora, but the
results are variable, Hentges and Freter (1962) examined the
antagonism of intestinal baoteria against Shigella flexneri
in vitro and in vivo and they concluded that colicine-like
substances had no role to play. They also pointed out the
problems of relating in-vitro findings to the in-vivo situation.
Branche and hi3 colleagues (1963) studied Esoh. coll in normal
healthy humans over a period of six months and assayed the strains
isolated for colicine production against a single indicator strain.
These workers concluded that the resident serotypes of Each, coli
in the gut produced colicine in vitro more consistently than did
the transient flora. Thus colicinogeny appeared to be an advantage
to a strain wishing to establish itself in the gut. The argument
for and against colicine production as a selective advantage has
continued over the years. Braude and Siemienski (1968) claimed
that in double urinary infections in rats with a colicinogenic and
a colicine-sensitive strain, the latter was eradicated in about one
quarter of the infeoted animals. But Ikari, Kenton and Young
(1969), examining the interaction between colicinogenic and
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colioine-sensitive strains in gemfree mouse intestine,
concluded that colicine production itself did not contribute
significantly, if at all, in the competition for dominance
in the gut.
All the studies of the selective advantage of bacteriooine
production seem to have been carried out with respect to colicines
and there have been no reports of similar studies with pyocines.
The practical use of bacteriocines a3 tools by man is more
tangible. The prime importance of pyocines particularly, has
been in the development of epidemiological typing systems,
Baeteriocine typing originated with colicine typing, developed
by Abbott and Shannon (1958) and later modified by Gillies
(1964) to type strains of Shigella sonnei. This method relies
on colicine production by the unknown strain as indicated by the
sensitivity of a standard set of indicator strains. Sensitivity
of the unknown strain to a 3tock set of colicines was also
examined by Abbott and Shannon but was found to be unreliable and
was not pursued. During the last fifteen years, bacteriocine
typing has blossomed and has been applied to various genera with
variable results, fyocine typing of strains of Ps, aeruginosa
has probably emerged as the most widely used and the most reliable
of the bacteriooine typing techniques.
In i960, Holloway suggested that since about 30% of
Ps. aeruginosa strains are capable of producing pyocines, typing
by production seemed a feasible proposition. Within four years,
Darrell and Wahba (1964) published a pyocine typing technique
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that allowed the recognition ctf 12 distinct types. They
reported that pyocine production was a stable characteristic;
an important feature of an epidemiological marker, Whereas
Darrell and Wahba relied on pyocine production by the unknown
strain, Osman (1965) desoribed a method of pyocine typing based
on the sensitivity of the unknown isolate to four standard
pyocine preparations. By this method, he was able to differentiate
101 strains into 10 types.
In 1966, Gillies and Govan published their pyocine typing
technique based on production of pyocines by the unknown strain
of Ps, aeruginosa, After examining the effeot of medium,
temperature and time of incubation on pyocine production, they
ooncluded that temperature was critical and the optimum condition
for pyocine production was 32°C, Complex media were not required
and the method was attractive because of its simplicity. Using
eight standard indicator strains, 36 pyocine types were recognisable.
However, as mai^r as 3Q$ of strains belong to pyocine type 1, thus
reducing the usefulness of the method for discriminating between
strains. By introducing a further set of five sub-typing
indicators, Govan and Gillies (1969) were able to subdivide type 1
strains into eight sub-groups. The validity of the technique
was confirmed and the method is now U3«d in many centres.
Other methods of pyooine typing have been described (Parmer
and Herman, 1969) and some of these combine pyooine and serological
typing in an effort to obtain finer subdivision of strains, Siem
(1972) found the differentiation between strains was better when
serological and pyocine typing were combined than with either
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method alone. He also found that there was a distinct
relationship between the pyocine types and the serotypes, whioh
to some extent reduced the differentiation. Pyocine typing
does not enjoy universal acceptance in the same way as
staphylococcal phage typing, partly because phage and serological
typing techniques are also available for Pa. aeruginosa. All
three methods have their disadvantages but pyocines certainly
have a useful role to play.
Another use of pyocines that has been recognised more
reoently is that of a tool in bacterial genetics. Nomura's
model of baoteriocine aotion (1967) proposed that the specdfio
target for the aotion of all bacteriocine3 was at the cell
membrane of the sensitive cell. He predicted that it should be
possible to isolate mutants that could adsorb bacteriocine to the
cell surfaoe but were not killed. Such mutants oan be isolated
from strains of Ps. aeruginosa by mixing the cells with an excess
of a small pyocine (Holloway, 1971)* Two types of resistant
mutant result; those cells that have an altered surface and
are unable to adsorb the pyocins, and those that adsorb pyocine
but are insensitive to its aotion. The latter group are referred
to as tolerant mutants. The genetic ohange in tolerant mutants
involves looi that are involved in cell membrane synthesis, and in
addition to pyocine resistance, tolerant cells also show a range
of pleiotropic effects. These include changes in membrane
permeability and in various DNA functions, an increased sensitivity
to ultra-violet irradiation and a decreased ability to undergo
genetic recombination. Changes may also occur in the functions
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of enzymes associated with the membrane. Thus the small pyocines
have provided a useful mechanism for isolating membrane mutants
from which we hope to learn more about the structure and
function of the bacterial cell membrane.
The use of pyooines as therapeutic agents
The inhibitory activity of bacteriophages and bacteiiocines
lias suggested the possible development of these agents for
therapeutio use. Phages were used for treating cholera for a
number of years with variable success. In 1929, a programme of
phage treatment, oombined with anti-cholera immunisation and
disinfection, was introduced in Assam, and a noticeable reduction
in the mortality rate was observed (reported by Fhndit, 1951),
However it was not clear which of these measures was responsible
for the success. In 1934, Morison showed that cholera phage
had no prophylactic value and was of diiious therapeutic use.
The uncertain efficaoy of phage therapy was prolonged and it was
not until 1971 that a group of workers published an exhaustive
study showing that phages given orally or intramuscularly had no
clinical effect on the course of cholera in patients receiving
standard rehydration therapy (Marcvk et al.. 1971)* The failure
of phage therapy in cholera was largely attributable to reliance
on the natural multiplication of the phages within the vibrios
in the patient*s intestine and it was found that each multiplication
cycle was longer than the average transit time through the
intestine in an aotively purging patient. There were also problems
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associated with predicting the phage sensitivity of vibrio
strains likely to be encountered in an epidemio.
However, the idea of phage therapy has not died and a reoent
report from Poland (Medical Laboratory Technology. 1972) advocated
the use of phages for treating dysentery caused by Sh. sonnei
and Sh. flexneri. Phages have also been used in the treatment
of experimental infections. Dubos, Straus and Pierce (19^3)
found that mice injected with Shigella dysenteriae intracerebrally
could be proteoted from death by intraperitoneal administration
of a suitable phage preparation. More reoently, Bartell, Orr
and G-aroia (1968) found that fatal infection could be averted
if mioe, injected intraperitoneal^ with Ps. aeruginosa, were
given specifio phages simultaneously or soon after receiving the
challenge dose.
In contrast to phage therapy, pyooine therapy has received
very little attention. In 1969. Bird and G-rieble reported that
a single dose of pyocine increased the survival of chick embryos
infeoted with Ps. aeruginosa from to 46/*, but crude pyocine
was toxio to 11/i of embryos that received pyocdne alone. The
nature of the pyooine used is not clear. The pyocinogenio
strain was not induced and thus production was low. The pyooine
activity was sensitive to trypsin but was sedimentable by
ultracentrifugation and the molecular weight was estimated to be
greater than 200,000. Thus the preparation had properties
of both high and low molecular weight types of pyocine.
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Merrikin and Terry (1972) examined the effects of pyocine
on experimental infections in mice. Again, the type of pyooine
used is not clear, but induction of the pyocinogenic strain was
used. It was found that mortality of mice infected intravenously
with Ps. aeruginosa could be reduced in some instances, when
pyocine was administered by the same route. However, these
authors did not reoord the numbers of mice involved nor the degree
of protection achieved, and thus their findings are difficult to
evaluate.
Fyooines have some obvious disadvantages as potential
therapeutic agents, in that they have narrow activity spectra
and there is a danger of sensitivity associated with the
administration of foreign protein. However, in view of the
increase in Ps. aeruginosa infections and the resistance of the
organism to many antibiotics and disinfectants, the examination
of pyooines as therapeutic agents may prove useful.
The aim of this investigation was to examine the possible
therapeutic applications of pyooines to Pa. aeruginosa infections.
Sinoe three different classes of pyooines have been identified,
this study was designed to characterise a representative of each
class and to compare the effects of these selected pyocines on




The materials used in the course of this investigation are
listed below:
All commercial dehydrated media were made up according to
the makers' instructions.
Acrinol (rivanol)
Supplied by Koch-Light laboratories
Azoalbuain
Supplied by Sigma, Norbiton Station Yard, Kingston-unon-Thames,
Blood agar
Oxoid Columbia agar CM331 with 5% human blood
(Oxoid Ltd., Southwark Bridge Road, London, S.E.I., England)
Casein






Proteose peptone no. 3 (Difco) 20 g
Oxoid no. 1 agar 10 g
Glycerol 10 g
Distilled water 1000 ml
pH 7.2 Autoclave at 121°C for 15 rain.
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T© 100 ml amounts of the above medium add:
1 ml 15$ solution of K Hpo (anhydrous)2 4
1 ml 15$ solution of MgSQ ,7H 0
^ 2
1.5 ml 2$ solution of cetrin&de (B.P.)
Chromatography materials
DEAE - Sephadex A-25 and Sepharose 4B supplied by Fharmacia
Pine Chemicals AB, Box 604, S-751 25 Uppsala 1, Sweden.
Deoxyribonuclease




Egg yolk emulsion (concentrated)
Oxoid SR 47
Preund




Supplied in 2 mg amounts by Dales Pharmaceuticals Ltd.,
Steeton, Keighley, Yorkshire, England.
Nutrient agar
Oxoid Columbia agar CM 331
A9 agar plates contained 9 ml nutrient agar in plastic Petri
dishes, 85 mm in diameter.
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Nutrient broth
Oxoid nutrient broth no*2 CM 67
20, i nutrient broth in saline
Nembutal
Sterile solution of pentobarbitone sodium. One ml oantaina
60 mg nembutal. Supplied by Abbott Laboratories Ltd.,
Agro-Vet division, Queenborough, Kent, England.
Polyethylene glycol
Molecular weight 6,000. Pure. Supplied by Koch-Light.
Saline
Sterile physiological saline (0.85^)
SSB
Glutamic acid sodium salt 20 S
Yeast extract 1 8
Na HP0 ,12H 0
2 4 2
5.64 8
MgSC .7H 0 1% solution
4 2
10.0 ml
XH P0 Ifo solution
2 4
25.0 ml
Ca(N0 ) .4H 0 1% solution
5 2 2
1.54 ml
Distilled water pH 7.3 960 ml
Sterile glucose solution (0.5 g per ml) added to broth after
autoclaving to give a final concentration of 1%*
THM buffer







Tryptone soya blood agar
Tryptone soya agar with 5/ human (or horse) blood.
EQUIPMENT
Brass burning blocks
Cross-sectional area of each block was 19 x 19 nun and the
weight cf each block was 119 6*
The block was suspended by a length of string through a loop
in the top of the brass.
Cellulose acetate electrophoresis stripe
Oxoid. 16 x 2.5 em. 12(V thick.
Dialysis tubing
Viaklng seamless cellulose tubing. Size 18/32
Digital display unit
Supplied by Soientifica and Cook Ltd., 37-39 Ramsey Road,
Acton, London, England.
Droppers
Platinum-tipped glass droppers calibrated to deliver 0.02 ml
per drop were supplied by Astell Hearson, 172, Erownhill Road,
Catford, London, England.
Homogenissr
Vertical drive, variable speed.
M.S.E. Manor Royal, Cravdey, Sussex, England.
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Needles and syringes
Disposable plastio syringes and Yale microlance needles
supplied by Becton-Diekinson U.K. Ltd., York House,
Empire Way, Wembley, Middlesex, England,
Orbital incubator
Supplied by Gallenkamp, Technico House, Christopher Street,
London, England.
Photographic plates
Special lantern contrasty. Ilford Ltd., 53/5^ Berwick Street,
London, England,
Rotary film evaporator
Eti-050 Supplied by Gallenkainp.
Spectrophotometers
Unicarn Instruments Ltd., York Street, Cambridge, England,
Spreaders
Spreaders were made from glass capillary tubes. Each tube
was 10 oa long and _o.l mm in diameter and was bent at right
angles o,2 cm from one end. Both ends of the tube were
sealed, The spreaders were stored in metal containers and
sterilised in a hot air oven at l6o°C for 1 hour.
The shorter arm of the spreader was used to distribute the
fluid over the entire surface of the agar plate.
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BACTERIAL STRAINS
Pseudomonaa aeruginosa strains F14 and 6a were kindly supplied
by Dr. R. Jones, Birmingham Accident Hospital, Birmingham, 15.
ps« aeruginosa strains Hi*l and H108 were kindly sent by
Professor B. Holloway, Monash University Melbourne, Australia.
All the other strains of Pa. aeruginosa used in this
investigation were obtained from the strain collection in the
Epidemiology Laboratory, Bacteriology Department, University of"
Edinburgh.
animals
*CEE mice were bred in Baoteriology Animal House, Medical
School, University of Edinburgh.
*CBA mice were either bred in the Animal House or obtained
from the Centre for Laboratory Animals, The Bush, Milton Bridge,
Penicuik, Scotland.
MRC Hr and LAC Hr hairless mice were obtained from The Bush.
Porton rabbits were supplied by The Bush.
* Details of breeds are given in M.R.C. Standardised Laboratory
Animals Manual Series 2 (1971).
SECTION 1
SURVEY OF STRAINS OF PSEUDOMONA3 AERUSINQSA FOR THE




Survey of strains of Pseudomonas aeruginosa far the
production of pyocines inhibitory to the selected
indicator strains
The pyocines of Pseudomonas aeruginosa may be divided into
two major groups, primarily on the basis of their molecular
5
weight. Those of low molecular weight (c. 10 ), by virtue of
their size, diffuse easily through agar and pass through certain
membranes. They are no»-sedimentable in the ultracentrifuge
and have not been resolved in the electron microscope. The
second group consists of particles with a molecular weight in
6 7
the range 10 - 10 , which do not diffuse easily through agar
or membranes, and can be sedimented by ultracentrifugation.
Electronmioroscopic preparations reveal two types of particle
in this group: (a) A complex particle resembling the headless
version of a T-even ooliphage, composed of a contractile sheath
surrounding an inner core, (b) A smaller, filamentous particle
resembling certain filamentous bacteriophages. These two kinds
of particulate pyocines are not easily distinguishable except by
eleotronmicroscopy, although the filamentous types more often
diffuse through membranes while the large, contractile type of
pyocine is held back.
The low molecular weight pyocines are also distinguishable
IK
from those of high molecular weight by their sensitivity to heat
and to proteolytic enzymes.
A survey of strains of Ps. aeruginosa was carried out to
select those with pyocine activity against the chosen indicator
strains, and to classify, by the above criteria, the kinds of
pyocines that were produced.
Two indicator strains were examined initially, Ps. aeruginosa
Plk and 6A, belonging to pyooine types 16 and 1 respectively.
These strains have been studied in detail in Birmingham and are




(1) The diffusion of pyocines in agar and their sensitivity
to trypsin
Strains
Pb. aeruginosa indicator strains P14 and 6A were tested for
pyocine sensitivity.
Ninety-four strains of Ps. aeruginosa from the laboratory
collection were tested for their ability to produce pyocinss
active against the indicator strains. These strains were
designated "pyooine producer strains".
All strains were stored on nutrient agar in soref^-oapped
bijoux bottles at room temperature (o. 22°C) and plated out on to
nutrient agar before use.
Media
Tryptone soya agar (at pH 8.0) and tryptcne soya agar
containing 0.05/4 trypsin (final concentration) were dispensed
in 16 ml volumes into plastic Petri dishes.
Apparatus
A "multiple stab inoculator" was made from a honeypot lid,
by passing nine straight Ni-chrome wires (each 4.5 0& long)
through holes in the lid and fixing them with araldite. .Each
wire was placed 2 cm from its nearest neighbour to give a grid
of 3 x 3 wires.
A tube-holder was made from a block of expanded polystyrene
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to hold nine 3 x i in. tubes in the same pattern as the mires
on the inoculator (fig* !)•
growth of pyooino producer strains
The pyocine producer strains of Ps. aeruginosa were grown
in 4 ml volumes of nutrient broth (NB) in 3 in. x £ in. tubes
for 4 hours at 37°C. The tubes mere placed in the polystyrene
holder and the cultures used to oharge the sterilised wires of
the inoculator. Tryptone soya agar plates (with and without
trypsin) were inoculated by stabbing the charged inoculator into
the agar to the bottom of the plate. The wires were re-charged
with the cultures before inoculating each plate. The plates
were incubated overnight at 32°C and then sterilised by inverting
each plate over a honeypot lid containing filter paper soaked
in chloroform. The depth of the agar in each plate was suoh
that a seal formed between the surface of the agar and the rim
of the honeypot lid. Thus the chloroform did not attack the
plastic Petri dish (fig. 2). The plates were exposed to
chloroform vapour for 15 min. and then left slightly open for
1 hour to allow the chloroform to disperse.
Indicator strain overlay
Molten nutrient agar (0»6% agar solution) was held in a
waterbath at 45° C and distributed into 3 in. x ^ in. tubes in
3 ml aliquots. A 0.5 ml volume of a 4 hour NB oulture of the
indicator strain (P14 or 6a) was added to each tube of agar and
mixed by rolling the tube between the hands. An indicator-seeded
agar was poured over each sterilised plate of the pyocine
produoer strains. When the agar had set, the plates were
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FIGURE 1 The multiple stab inoculator and 1;tie-holder
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wooden base
FIG-URE 2 The sterilisation of bacterial growth on plastio
Petri dishes
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incubated at 37°C overnight.
The radius of the inhibition zone of the indicator strain
was measured from the point of entry of the wire to the circumference
of the zone. This measurement included the width of growth of
the producer strain. The zone sizes in the presence and absence
of trypsin were compared,
(a) The passage of ovocines through cellulose acetate membranes
Y,'ahba (1963) suggested that some pyocines were able to pass
through membrane filters while others were held back. Kohn (1966)
introduced the use of oellulose aoetate membranes to facilitate
the removal of macroscopic growth in the pyoaine typing procedure.
However, this modification proved unsuitable for typing because
some pyocines were incapable of passing through the membrane
(G-ovan, 1968). Thus it wa3 thought that cellulose aoetate
membranes might be useful for grouping pyocines according to their
ability to pass through the membranes. This method has
already been applied to a few pyooinogenie strains of Ps, aeruginosa
(frovan, 1974b).
Cellulose acetate electrophoresis strips, out into 8 cm
lengths, were used. Each strip was laid diametrically aoross
the surface of a tryptone soya blood agar plate, talcing care that
no air bubbles farmed between the strip and the medium.
Fyocine producer strains that had inhibited indicator strains
P14 or 6A in the previous experiment were used. Each strain was
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carefully inoculated on to a oellulose acetate membrane using a
bacteriological loop. Duplicate plates, without membranes,
were also inoculated (fig. 3)« All of the plates were
incubated at 32°C overnight.
After incubation, the oellulose acetate strips were removed
with sterile forceps and discarded. The bacterial growth on the
plates without membranes was removed with a sterilised glass
microscope slide. All the plates were sterilised by exposure to
chloroform vapour for 15 min. and then left slightly open for
1 hour to remove any traces of chloroform.
Indicator strains P14 and 6A were grown in KB for 4 hours
and a loopful of each culture was streaked across each plate at
right angles to the original inooulum. The plates were
incubated overnight at 37°C. The inhibition of the indioator
strains was recorded.
Induction of pyooine producer strains
Fyocines are produced spontaneously by only a few oells in
a population, but the number of cells producing pyocine can often
be increased by inducing the pyooinogenic culture with mutagenio
agents such as Mitomycin C or ultra-violet irradiation.
Prom the survey of strains described previously, 13 strains
of Ps. aeruginosa that produced pyooin®3 active against indicator
strain P34 were examined- for their indueibility. These strains
were 19, 26, 41, 47, 62, 5837, 5866, 5873, 5882, 5893, H108, H41
and Ep672.
A 2 ml volume of an overnight KB culture of each pyocinc
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produoer strain was used to inoculate 100 ml of SOB in a 2 1
flask. The cultures were incubated in the dark in an orbital
incubator at 32°C and 80 r.p.m. After 3 hours inci&ation, a
solution of Mitomycin C was added to each culture to give a final
concentration of 1.5 pg per ml, and incubation was continued for
a further 5 hours; the flasks were then removed from the
incubator ana a. 5 ml volume of chloroform was added to each culture
and mixed well. After 15 min. the sterilised preparation wa3
decanted and stored at 4°C. These preparations are referred
to as stage I pyooine preparations.
Estimation of pyooine activity
A standard method of titrating pyooine preparations was
used throughout this study. Lawns were prepared on A9 agar
plates by flooding the surface of the plates with a 4 hour TIB
culture of strain P14, removing the excess oulture with a pipette
and allowing the lawns to dry. Doubling dilutions of the pyocine
preparation were made in saline in a iSHO plate. A 0.02 ml
drop of each dilution was spotted on to the lawn, using a
calibrated platinum-tipped dropper. When the drops had dried,
the plates were incubated overnight at 37°C. The titre of
pyocine activity, expressed in units per ml, was read as 50 times
the reciprooal of the highest dilution causing complete inhibition
of the indicator strain.
Stage I pyooine preparations of the 13 strains of
Pa. aeruginosa were titrated in this manner and their aotivity
against indicator strain P14 was recorded.
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The effeot of trypsin on stam I pyoeine preparations
Pyooines were prepared to stage I by the method described
previously, oentrifuged at 1850& for 30 u&n. and the supernates
were decanted. A 1% stock solution of trypsin was diluted in
distilled water to give a solution containing 4 eg/ml, 0.5 ml
aliquots of each pyocine preparation were mixed with 0.5 ml
trypsin solution or 0.5 sal saline and incubated at 37°C fcr
1 hour. Equal volumes of trypsin and saline were also mixed
and incubated. After incubation, each pyooine mixture was
titrated on a lawn of indicator strain P14 and the plates
were incubated overnight at 37°C. The activity of the pyocine
preparations in the presence and absence of trypsin was recorded.
The aotivity of the trypsin was confirmed by spotting the trypsin
and saline mixture on to the gelatin emulsion of a photographio
plate. This plate was incubated in a moist chamber at 37°C for
1 hour and then held at 4°C for a few minutes before swabbing with
cold water. Clearing of the emulsion indicated the presenoe of
trypsin activity.
The effect of heat on stage I pyocine preparations
The supernates of tlie stage I pyocine preparations, obtained
in the previous experiment, were used. A 1 ml volume of each
pyocine preparation, in a 3 in. * £ in. tube, was gently agitated
in a waterbath at 60°C for 10 min. After heating, the activity
of the pyooine preparations was compared with that of unheated
controls by titrating both test and control preparations on lawns
of indicator strain P14.
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Ultraeentrifugation of stage I pyocine preparations
Pyooine was prepared to stage I as described previously and the
preparations were centrifhged at 1850g, for 30 min« The supernates
were decanted into cellulose nitrate ultracentrifuge tubes and
centrifuged at 100,000^ for 2 hours under refrigeration, using a
Spinco angle 40 rotor. After ultracentrifugation, the supernates
were removed and each deposit was resuspended in 1 ml of saline.
The pyocine activities of the supernates and the resuspended
deposits were estimated by titration on lawns of indicator strain
P14.
Electronmioroaoooy
Two methods were used for preparing the pyocines for viewing
under the electron microscope. The negative staining technique
of Brenner and Horne (1959) was employed.
(a) Pyooine particles alone
Stage I pyocine preparations were ultracentrifuged as described
previously and the deposits were resuspended in 0.5 ml volumes of
1M - ammonium acetate (pH 7*0). Using a platinum loop, two
loopfuls of this suspension were mixed with two loopfuls of a 2?o
potassium phosphotungstate solution (pH 7»0) on a clean glass
microscope slide. A loopful of the mixture was transferred to the
surfaoe of a copper grid (NEW 200) and held for 30 s before the
exoess fluid was removed with blotting paper. The grids were
allowed to dry in a dessicator.
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(b) Pyooine particles adsorbed to calls of indicator strain £14
Stage I pyocine preparations were ultracentrifuged as
described previously and the deposits were resuspended in 1 ml
volumes of saline. 1 ml of reauspended pyocine was added to 3
of a 4-hour peptone water culture of strain P14 and inoubated
at 37°C for 20 min. The adsorption mixture was fixed by adding
two drops of 20fo formaldehyde and after 20 min. the mixture was
centrifuged at 2600£ for 45 min. The deposit was resuspended in




Survey of strains of Paeudomonas aeruginosa for
production of pyoolnea Inhibiting the indicator
strains plk and 6a
(1) Diffusion of pyocines in agar and their sensitivity to trypsin
Ninety-four strains of Pa, aeruginosa were examined for their
pyooine production against the indicator strains p14 and 6a by a
stab inoculum technique. Thirty strains did not inhibit either
of the indieator strains. Indicator strains p34 and 6a were
inhibited by 56 and 22 of the producer strains respectively.
The sizes of the inhibition zones in the presence and absenoe of
trypsin are recorded in tables la and b.
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TABLE la The influenoe of trypsin on the activity of 56
■pvoolne producer strains of P3» aeruginosa against
indicator strain P14
Activity unaffected by trypsin
Radius of inhibition zone (mm)
Strains
without trypsin with trypsin
30, 47, 57, 5821
5823, 5863, 5866, 2 2
5896, £485, PP430
12, 31, 45, 5837











Activity enhanced by trypsin
53, 5878, 1 2
5825, 5867 2 3
£21 1 3
Activity eliminated by trypsin
5907 1 0
5882, 5883, 5908 2 0
54, 5884, 5893 3 0
H108, H41 4 0
13 3-4 0
41, 58 5 0
EP672 6 0
26 7 0
Activity reduced by trypsin
59 3 1
61 3 2






8, 5864 6 3
TABLE lb The Influence of trypsin cn the activity of 22
pypeine producer strains of Ps. aeruginosa against
indicator strain 6A
Activity unaffected by trypsin
Radius of inhibition zone (mm)
f% A •
u«rs>ui8



























(2) Diffusion through cellulose acetate membranes
The inhibition of the indicator strains p14 and 6a by the
44 pyooine producer strains grown on cellulose acetate membranes
is shown in tables 2a and b, and an example is shown in fig. 3«
Three strains, 5853* 5863 and 5903» did not inhibit either of
the indicator strains in this experiment. Twenty-three strains
produced pyocanes that passed throu^i the cellulose acetate
membranes and inhibited indicator strain p14. Fifteen strains
produced pyooines that were inhibitory to strain p14 but did not
diffuse through the membranes. Similarly, 12 strains produced
pyocines that passed through the membranes and inhibited
indicator strain 6a, whereas the pyocines from eight strains
were held back.
Although the inhibition was clear, some growth of the
indioator strains was often observed in the inhibition zones and
this is recorded in the tables.
From this survey of pyocine producer strains it was found
that fewer strains of Ps. aeruginosa produced pyooines aotive
against indicator strain 6a than against indicator strain p14-.
Therefore strain 6a was exoluded from the subsequent investigations.
Strain p34 has the additional advantage of belonging to an unusual
pyocine type (16) (fig. 4) which will be easily distinguishable
in later in-vivo studies.
FIGUitE 3 (a) Growth of pyocine producer strain on tryptone
soya blood agar
(b) Growth of pyooine producer strain on a cellulose
aoetate membrane on tryptone soya blood agar
(e) Inhibition of indicator strains P14 and 6A by
pyocines from the producer strain grows in the
absence of a cellulose aoetate membrane
(d) Inhibition of indicator strain P14 but not of
strain 6A by pyocines from the producer strain
grown on a cellulose acetate membrane
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TABLE 2a Activity of 36 p.yocine producer strains of
Ps. aeruginosa against indicator strain gLjfc.
Producer strains inoculated on to the medium
or on to a cellulose acetate membrane on the















5820, 5823, R21 + +R
5866 +R +
5837, P«f30 ♦ -





Key; + * inhibition of indicator strain P14
- as no inhibition of indicator strain P14
R s growth of resistant colonies of the
indicator strain in the inhibition zone
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TABLE 2b Activity of 20 pyoeine producer strains of
Ps. aeruginosa against indicator strain 6A.
Producer strains inoculated on to the medium
or on to a cellulose acetate menbrane on the













30, 47, 59, 61,
5849, 5858, 5908 +R .
Key: + * inhibition of indicator strain 6A
- = no inhibition of indicator strain 6A
R = growth of resistant colonies of the
indicator strain in the inhibition
zone
FIGURE 4 A typing plate showing the pyocine type 16
inhibition pattern produced by Pseudo.monaa
aeruginosa strain P14
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Induotion of pyoclne produoer strains
Thirteen selected strains of Pa. aeruginosa were examined
for their ability to produce pyocines after induction with
Mitomycin C. The results are shown in table 3« Strains that
gave pyooine titres greater than 1600 units per ml after induction
were considered to be inducible. By this orlterion, nine strains
were inducible and only one of them (Ep672) also produced
bacteriophage against indicator strain P14 as indicated by plaques
in the indicator lawn. Strain Ep672 together with the non-
inducible strains (26, 41, 5866, 5873) were not investigated
further.
































Key; * = bacteriophage active against strain P34
was also produced
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The effect of trypsin on stage I pyocine preparations
The sensitivity of the induced pyocines to trypsin was
examined. The treatment of stage I pyooine preparations with
trypsin completely removed the inhibitory activity of the pyocines
from strains 19, H41 and HI08. The remaining pyocine preparations
showed little change in activity. The results are given in table
4.
TABLE 4 The effeot of trypsin on stage I pyooine preparations
Pyocine from Activity of pyocine against strain P14
strain (units per ml)









jyocine producer strains 19 and 5837 were not investigated
further because thsy produced low titres of activity.
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The effeot of heat on stage I pyooine preparations
The effect of mild, heat treatment on the activity of the
selected stage I pyocine preparations is shown in table 5»
The activity of pyocine preparations from strains 5882, l£L08
and H41 was markedly reduoed by heating the preparations at
60°C for 10 min. The activity of pyocines from strains 47,
62 and 5893 was unchanged by the heat treatment,
TABLE 5 The effect of heat on the inhibitory activity of
stage I pyooine preparations
Pyocine from
strain
Activity of pyocine against indicator strain P14
(units per ml)









Ultraoentrifugatlon of 3tage I pyocine preparations
The selected stage I pyocine preparations were ultraoentrifuged
and the pyocine titres of the siqperaates and the resuspended
deposits were assayed against indicator strain PlA. The results
of the titrations, given in table 6, show that the pyocines
from strains 47» 62, 5282 and 5893 were sedimentable whereas
those from strains Hi08 and HA1 remained dispersed throughout
the fluid after ultracentrifugation.
TABLE 6 Inhibitory activity of 6 pyooine preparations against
strain PlA after ultraoentrlfltgation
pyoeine from
strain









Eleotronmicrographs of pyooine preparations from strains
HI08 and HA1 did not show ar^y pyocine particles. In an
eleotronmicrograph of the pyocine from strain 5882 adsorbed to F1A
eells, many filamentous particles were seen attached to the cell
surface (fig. 5). Pyocine preparations from strain 47 showed a
few contractile pyocines and some filamentous particles attached
to a oell of P14. Strain 5893 appeared to produce contractile
pyocines that attached to cells of strain P14.
FIOOPJ5 5 An electrontd.orograpfa showing the filamentous
particles of pyocdne 5882 attached to a cell
of indicator strain ?34 (x 1CC-,0CC)
98
DISCUSSION
fyoeine production is recognisable when a suitable indicator
strain is used to detect the inhibitory activity. There are two
major groups of pyocines; the low molecular weight (small)
pyocines and the high molecular weight group. The latter may
be divided into contractile and filamentous types and these
pyocines may be observed by electrons!croscopy. This is the
only definite means of confirming their presence. The existence
of the small pyocines is not so easily verified because they
cannot be resolved in the electron microscope. If a pyooinogenic
strain produces only a small pyocine then the pyocine is
conspicuous by its absence in electronmicrographs and may be
classified as "small". But a single strain of Ps, aeruginosa
may produce more than one type of pyocine simultaneously and these
may or may not attack the same indicator strain. Thus a
contractile particle may be visible in the electron microscope
while the inhibition of the indicator strain is due to a small
(and therefore invisible) pyocine. In this instance, it may be
necessary to remove the high molecular weight pyocine and examine
the remaining material for inhibitory activity, However, such
visual identification is not practicable for screening large numbers
of pyooine producer strains and other properties of pyocines must
be used to obtain a preliminary classification. The small
pyocines are distinguishable from the high molecular weight group
by their diffusibility and their sensitivity to heat and proteolytic
enzymes.
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In this survey, %■ strains of Pa, aeruginosa were examined
for their ability to produce pyooines inhibitory to the seleoted
indicator strains. The types of pyocine responsible for the
inhibition were classified initially according to their
diffusibility and their sensitivity to trypsin. From a point
inoculum of a producer strain in agar, the pyocines diffused
outwards and the extent cf their diffusion was shown by overlaying
the plate with a sensitive indioator strain. Strains that gave
rise to wide inhibition zones, which were completely removed by
trypsin, were tentatively classed as producing small pyocines.
Conversely, producer strains that gave smaller inhibition zones
which were unchanged by trypsin, were thought to be producing
high molecular weight pyocines. It was not possible to distinguish
between zones produced by contractile and. filamentous pyooines.
Some producer strains gave rise to inhibition zones in the
indioator overlay that were reduced in size but not removed by
trypsin. Such strains were thought to be producing a mixture of
small and high molecular weight pyocines inhibitory to the
indicator strain. A small number of producer strains gave rise
to inhibition zones that were slightly enlarged in the presence of
trypsin; a finding still to be elucidated.
From the results with indicator strain P14# the average
radius of the inhibition zone produoed by the postulated seb.11
pyocines wa3 mm, whereas the average for the high molecular
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weight pyocines was 2.6 cm. The average radius of inhibition
zones that were diminished in the presence of trypsin changed
from 4.6 mm to 2.5 mm when the enzyme was incorporated into the
medium. This supports the view that such zones are the result
of a mixture of types of pyocines and the larger average radius
(4.6 mm compared with 3.6 mm for small pyocines alone) could be
an additive effect of more than one pyocine.
In the second part of the survey, the ability of pyocines to
diffuse through cellulose acetate membranes was examined.
Contraotile pyocines have been shown to be retained by such
membranes (dovan, 1968) while small and filamentous pyocines are
able to diffuse through. Forty-four of the original 94 strains
of Ps. aeruginosa were examined, and the results, together with
those from the first part of the survey were used to postulate
what types of pyocines were responsible for the inhibition of the
indicator strains. Thirteen pyocinogenic strains were selected
for further investigation : strains 47* 62, 5837 and 5893 gave
small inhibition zones that were insensitive to trypsin and their
pyocines did not diffuse through cellulose acetate membranes.
These strains were thou^rt to produce contractile pyocines.
Strains 5866, 5873 and 5882 also produced small inhibition zones
that were insensitive to trypsin (except the zone produced by 5882
which was trypsin sensitive) but the pyocines from these strains
did diffuse through the membranes and therefore were thought to be
of the filamentous type. Strains 19# 26, 41, 10.08, H41 and Ep672
were all suspected of producing small pyocines because they gave
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■wide diffusion zones which were sensitive to trypsin and they
diffused through cellulose aoetate meflbranes.
The eventual aim of this study was to examine the therapeutic
uses of pyocines and it was felt that highly active pyocine
preparations would be required. Although pyocines may be
produced spontaneously by a few cells in a population,
production is often increased by induction of the culture with
a mutagenic agent such as Mitomycin C. The 13 pyocinogenie
strains of Ps. aeruginosa selected from the preliminary survey,
were examined for their inducibility and any production of
bacteriophage which also attacked the indicator strain. Nine
strains were found to be inducible but ozie of these also produced
phage against indicator strain P14 and was therefore discarded.
Throughout this investigation, a critical dilution assay
technique was used for estimating the inhibitory activity of
pyocine preparations. This method, in which doubling dilutions
of the pyocine preparation are spotted on to a lawn of the
indicator strain, is technically easy to perform. However,
accurate determination of the end-point, that is the highest
dilution of the pyocine giving complete lysis of the indicator
lawn, it sometimes difficult. For this reason, a single reading
could not always be made and the results of titrations are
occasionally given as ranging between two adjacent dilutions.
More accurate methods for the determination of pyocine activity
have been examined and these are usually based on measurement of
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turbidometric changes that occur when a pyocine preparation is
added to a sensitive cell suspension (Young and Stewart, 1971#
Merrikin and Terry, 1973)* Although providing more accurate
results, this type of assay is more complex, to perform.
Pyocines were prepared from the remaining eight producer
strains, and the trypsin sensitivity of the extraoted pyocine
was examined. The results confirmed that pyocines from strains
19, Hi08 and H41 after induction were also trypsin-sensitive and
thus probably of the small variety. The activity of the pyoeines
from the other strains (5882, 47# 62, 5837 and 5893) was not
inhibited by trypsin at the concentration tested, therefore
confirming the suspicion that these pyocines belonged to the
high molecular weight group. Strains 19 and 5837 gave low titres
of activity throughout and were not investigated further.
Ito, Rageyama and Egami (1970) found that heating at 60°C
destroyed the activity of a small pyocine but a contractile
pyocine was unaffected. Takeya et al. (1967) found that the
activity of the filamentous pyocine 28 was almost completely
destroyed by heating at 60°C for 10 min. The results of this
experiment showed that pyocines from strains H108 and 1:41 were
heat sensitive which supported the view tint these were small
pyocines. The pyocine from strain 5882 was thought to be of the
filamentous type and its activity was also significantly reduced
by heat treatment. Strains 47# 62 and 5893 were thought to
produce contractile pyocines and this was supported by their
13
insensitivlty to heat treatment.
The classification of the selected pyocine producer strains
was endorsed by the results of ultracentrifugation and
electronmicroscopy of the pyocine preparations. Strains H108
and H41 produced pyocines that were non-sedimentable and not
visible in the electron microscope. These results, in
conjunction with the diffusibility of these pyocines and their
sensitivity to heat and trypsin, confirmed that the inhibition
of indioator strain P14 by strains H108 and H41 was due to the
production of small pyocines. I^rocines from strain 5882, that
attacked strain P14, were clearly shown by electronmicroscopy
to be of the filamentous type. Strain 47 was observed in the
electron microscope to produce a mixture of contractile and
filamentous pyocines whereas strain 5893 appeared to produce
contractile particles only, which could be seen attached to cells
of strain P14.
In summary, from the experiments in this section three
pyocinogenie strains of Ps. aeruginosa were selected; each strain
produced one type of pyocine particle inhibitory to the indicator
strain. The strains chosen were : H108, which produced small
pyocinesj 5882, which produced filamentous pyocines, and 5893*
which produced contractile pyocines. All these pyocines showed
inhibitory activity against indicator strain P24.
SECTION 2
A STUDY OF THE PURIFICATION, CONCENTRATION AND
TOXICITY OF SELECTED FYOCINES
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SECTION 2
A study of the purification, concentration and toxicity of
selected pyooines
pseuiomonas aeruginosa strains 5893* 5882 and HI08 produce
contractile, filamentous and amall pyocines respectively which
inhibit indicator strain F14. The induction of these three
pyocinogenic strains and the method of estimation of their
activity against strain P14 has been described, and in this
section, methods for the concentration and purification of the
pyocines were investigated and the toxicity of the preparations
in mice was examined.
In the remainder of this study, pyocine 5893 refers to the
pyocine produced by 3train 5893 and inhibitory to strain P14;
similarly for pyocine 5882 and pyocine H108.
METHODS
Removal of slime from stage I pyopine preparations
Ps. aeruginosa frequently produces large amounts of slime in
broth culture and it was necessary to remove the slime in order to
separate the cells from the pyocine-containing supernate. Three
methods of slime removal were tested on 100 ml aliquot3 of stage I
preparations of pyocines 5893» 5882 and H108.
Method I: Molar solutions of manganoua chloride (MnCl^.ifNgO) and
sodium hydroxide were mixed in the ratio 2:1 and filtered through
Whatman No. 1 filter paper. The filtrate was added to the pyocine
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preparations to give final concentrations of either 2, 6, 8
or 10/>. The pyocine and filtrate were mixed vigorously and
oentrifuged at 1850& for 30 min.
Method 2; Deoxyribonuclease (BNase) was dissolved in distilled
water to give a solution containing 100 pg/ml. One ml of this
solution was added to a 100 ml volume of each pyocine preparation
and inoubated at 37°C for 1 hour. The activity of the DNaae was
confirmed by spotting the enzyme solution on to DNase agar and
allowing the drops to dry. The plate was then flooded with
1M-HC1 and clear zones appeared where drops of the active solution
had been placed.
Method 3: A 2 ml volume of 1% aqueous acrinol was added to 100 ml
volumes of the pyocine preparations.
After each treatment the activities of the pyocines were
estimated by titration against strain F14.
Stage I pyocine preparations from which the slime had been
removed were designated stage II.
fiaBggjtoJAsa eM wilXipattoa pi* staff? II ssa&ias. sxaaaxa&aM
The ultimate aim of this study was to examine the therapeutio
applications of pyooines in Ps. aeruginosa infections and therefore
it was considered necessary to design a method of achieving high
activity pyocine preparations. Since pyocines are thought to be
of a protein nature, methods of concentration and purification
used for proteins were tested. Two simple concentration
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procedures were exanLned; the use of polyethylene glycol
(PEG-), and of a rotary film evaporator, Preoipitation by
ammonium sulphate and the use of ultraeentrifugation as methods
of achieving concentration and some degree of purification were
al3o investigated.
(a) PEC
200 ml volumes of stage II pyooine preparations (slime
removed by manganous chloride) were poured into sacks of dialysis
tubing and the tubing was knotted and laid on a tray sprinkled
with PEG-. The sacks were completely covered with PEG- and held
at 4°C for 4 hours. After this time, the exuded fluid and
excess PEG were discarded and the concentrated pyocine was removed
from the dialysis tubing.
(b) Rotary film evaporation
100 ml volumes of stage II pyocine preparations v<ere reduced
to approximately 10 ml by rotary film evaporation at 37°C»
(o) Ammonium sulphate
50 g of ammonium sulphate were added to 100 ml volumes of
stage II pyooine preparations (bo give 75$ saturation) and mixed
well until all the salt had dissolved. The treated preparations
were held at 4°C for 48 hours when the precipitate was collected
by oentrifugation at lAOOg for 1 hour under refrigeration. The
resulting supernates were discarded and the deposits resuspended
in THM buffer. These suspensions were dialysed against the same
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buffer at 4°C for at least 24 hours to remove any traces of
ammonium sulphate*
(d) bltracentrifugation
Stage II pyocine preparations were ultracentrifuged at
80,000$ for 90 min. under refrigeration using a Spinco angle kO
rotor. The supernates were removed and the deposits were
resuspended in 4 ml of THM buffer.
After each treatment, the aotivities of the pyocine
preparations were estimated by titration against strain P14.
Storage of pyoeines at different temperatures
The stability of the pyocine preparations at different stages
in their purification was examined. Two ml volumes of pyocines
5893# 5882 and Hi08 at stage II and after PEG- and ammonium sulphate
treatment were stored in screw^oapped bijoux bottles at room
temperature (c. 22°C), in the refrigerator (c. 4CC) and in the
deep-freeze (c. -20°C). The activity of the pyocines was checked
initially and after 5 &ad 15 weeks storage.
Examination of the toxicity of pyoclne preparations in mice
Stage II preparations of pyocines 5893, 5882 and HI08 vrare
tested, together with the concentrates of these pyocines
prepared previously by PEG or ammonium sulphate treatment or
ultracentrifugation. The activity and sterility of the
preparations were confirmed prior to injection.
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Pairs of mice were injected intravenously, intraperitoneally
or subcutaneously with the pyocine preparations in their various
forms. The mice received 0.5 ml volumes by the intraperitoneal
or subcutaneous route and 0.3 ml volumes intravenously. The
animals were weighed immediately before injection and at intervals
thereafter until the 13tn day of the experiment when they were
killed by cervical dislocation.
The results of the toxicity testing of pyocine preparations
in mioe suggested that pyooine 5893 had some toxic properties.
Therefore, preparations of this pyocine were examined in greater
detail in the following four experiments to try to elucidate the
toxic factor.
DETAILED STUDY OF PYOCIHB 5893
(1) A comparison of the effects cf induced and uninduced
preparations of pyocine 5893 in mice
A culture of Pa. aeruginosa strain 5893 was grown in SGB
and induced -with Mitomycin C. A second culture was grown under
the same conditions but without induction. Both cultures were
purified to stage II and aliquota of the stage II preparations
were treated with PEG or ammonium sulphate. The activity and
sterility of the preparations were confirmed before use.
Twenty-eight male CBA mice were caged in groups of four and
given food and water ad lib.. One group acted as controls and
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these mere injected subcutaneously vdth 0.5 *al of saline. Of the
other six groups, three received induced preparations of pyocine
5893 at stage H, after PEG, or after ammonium sulphate treatment,
and the other three groups were given the corresponding uninduoed
preparations. All injections were of 0,5 ml volume given by the
subcutaneous route. The mice were weighed immediately before
injection and at intervals thereafter until the 17th day of the
experiment when the survivors were killed by cervical dislocation,
(2) Examination of induced and uninduoed stage II preparations of
pyocine 5893 for haemolvsln and extracellular enzymes
Induced and uninduced stage II preparations of pyocine 5893
were tested for the presence of haemolysin, protease and lecithinase
by the following methods,
(a) Haemolysin
Liu, Abe and Bates (1961) recommeniod human red blood cells
(RBC) for the estimation of haemolysin activity, whereas Carney
and Jones (1968) used horse RBC, In this study, both types of
RBC were tested as indicators cf hae mo lytic aotivity.
The RBC were washed three times in saline and 5% suspensions
of the washed cells were prepared in saline. Doubling dilutions
of induoed and uninduced preparations of pyocine 5893 were
prepared in duplicate in 0.2 ml volumes of THK buffer in WHO plates.
Horse and human RBC were added to a set of dilutions in 0.2 ml
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volumes and the plates were agitated well and incubated at 37°C
for 2 hours. After incubation the haemolytic activity of the
pyocine was read as the highest dilution causing complete lysis
of the BBC.
(b) i^'otease
A 1% suspension of casein in THM buffer was allowed to stand
in boiling water for 15 min. to dissolve the protein (Kunitz, 1947)*
Doubling dilutions of the induced and uninduced preparations of
pyocine 5893 were prepared in 1 ml volumes in THM buffer, 1 ml
of the cooled casein solution was added to each dilution, and
the mixtures were incubated in a waterbath at 37°C for 5 min.
After inoubation 3 ml of 5% trichloracetic aoid were added to eaoh
dilution and allowed to stand for 1 hour at room temperature.
The sanplea were centrifuged at 1100£ for 10 min. and the optical
density of the resulting supernates was read at 280 nm in a Unicam
uP5Q0 spectrophotometer. A substrate control containing casein
and saline and an enzyme control containing pyocine and saline
were treated in the same manner as the test samples,
(o) Leoithinase
A 5$ suspension of egg yolk (Oxoid) in saline was added in
1 ml aliquots to equal volumes of doubling dilutions of induced
and uninduoed preparations of pyocine 5893* After mixing well,
the samples were incubated at 37°C overnight. The presence of
lecithinase activity was detected by a clearing of the cloudy
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suspension and a curdled surface layer after incubation,
(3) Fractionation of induced and uninduced pyocine 5893
preparations by gel filtration
A Pharmacia chromatographic column (dimensions 2.5 x 45 cm)
•was filled with a suspension of Sepharose (Pharmacia) and
washed for several hours with THM buffer at a pressure head of
34 cm,
A stage II preparation cf pyocine 5893 was treated with PIS
to reduce the volume from 100 ml to 5 ml# The concentrated
pyocine was applied to the top of the oolumn and allowed to run
into the gel. The sample was then eluted with THM buffer and
the eluate was collected at 10 min. intervals for 6 hours.
The optical density of the samples at 280 nm was estimated using
a Unicam SP500 spectrophotometer and pyocina activity was
estimated by titration of each fraction against strain °14»
The Sepharose oolumn was washed with buffer for 18 hours
(o. 1000 ml buffer) and the fractionation procedure was repeated
using an uninduced preparation of pyocine 5893, concentrated with
PEG as described above. The optical density of the eluate was
recorded automatically but the pyocine activity was not estimated,
(4) Fractionation of induced pyocine 5893 and assay of eluate
samples for pyoojne. protease and ela3taae aotivity
The gel filtration of an induced preparation of pyocine 5893
wa3 repeated by the method described in experiment 3« The optical
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density of the eluate at 280 no was recorded automatically and
samples were collected at 20 min. intervals using an automatic
fraction collector. Each eluate fraction was assayed for
pyocine, protease and elastase activity, lyocine activity was
estimated by titration of each fraction against indicator
strain P14-,
The protease assay was based on the method of Tomarelli
et al, (1949). A solution of azoalbumin (Sigma) containing
25 mg/ml was made up in HIM buffer anl 0,5 ml aliquots were
added to 0.5 ml of each eluate fraction and. the reaction was
allowed to proceed for 30 iain. in a waterbath at 37°C. A 4 ml
volume of 57° trichloracetic acid was added to each reaction mixture
and the samples were centrifuged at HOOg for 20 min, A 2,5 ml
volume of each supernate was mixed with an equal volume of 0.5M-Na0H
and the optical density of the resulting suspension was read at
440 nm (.Filter 2) in a Unicam 3P1300 colorimeter.
The elastase assay was based on the method of Uaughton and
Sanger (1961). A suspension of ela3tin-Congo Red was prepared
in THM buffer to contain 5 mg of substrate in 3.5 ml of buffer.
One ml of each ©luate fraction was added to 3.5 ml of the elastin-
Congo Red suspension and incubated for 1 hour in a waterbath at
37°C. The reaction mixtures were centrifuged at 1100£ for 20 min,
and the optical density of the supernates was read at 495 nm
(Filter 3) in a Unioam SP1300 colorimeter.
The eluate fractions containing the two peaks of pyocine
activity were ultracentrifuged at 80,000^ for 90 min. under
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refrigeration U3ing a Spinco angle 40 rotor. The supernates
were decanted and the deposits were reauspended in 3 ml of THM
buffer and Doth components were titrated against strain F14.
The resuspended deposit of peak I and the supernate of peak II
were examined for toxicity by animal inoculation. The eluate
fractions containing the maximum elastase and maximum protease
activity were also tested in vivo. The effects of these
selected fractions were compared with those of unfractionated
pyocine 5893*
Twenty-four female CPE mice were caged in groups of four
and given food and water ad lib.. The mice were injected
intraperitoneslly with 0.5 ml volumes of fractions of a pyocine
5893 preparation. (froup 2 received unfractionated pyocine 5893j
group 3, the maximum protease fraction; group 4, the maximum
elastase fraction; group 5, the pyocine peak I; and group 6,
the pyocine peak II. The mice in group 1 acted as controls and
were injected with 0.5 ml of THM buffer. The animals were weighed
immediately before injection and daily thereafter until the 11th
day of the experiment, when they were killed by cervical dislocation.
Extended survey of pyocine producer strains
Preparations of pyocine 5893 were found to have undesirable
effects in vivo and it was difficult to obtain high titre3 of
pyocine activity even after concentration. Therefore, it was
decided to extend the survey of pyocine producer strains outlined
in Section 1 in an effort to find another strain of Ps. aeruginosa
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that produced contractile pyocines that inhibited indicator
strain P14. Seventy-seven strains of Ps. aeruginosa were
tested by the methods described in Section 1 and those strains
that were suspected of producing contractile pyocines were
examined further. Strain 1577 was selected and the properties
of its pyocine preparation were compared with those of pyocine
5893.
Toxicity testing of pyooine 1577
A 400 ml volume of pyocine 1577 was prepared to stage II
and 200 ml of this preparation were reduced to 4 ml by treatment
with PE&. Fifty g of ammonium sulphate were added to a further
100 ml of the stage II pyocine, mixed well, and allowed to stand
at 4°C for 2k hours. The preoipitate was collected by
centrifugation at 1400g for 1 hour under refrigeration and
resuspended in 6 ml of MM buffer. The resuspended material
was dialysed against the same buffer at 4°C overnight.
A 96 ml volume of stage II pyocine 1577 was ultracerrtrifuged
at 80,000|£ for 90 min. under refrigeration, using a Spinco angle
40 rotor. The supernates were discarded and the deposits were
rssuspended in a total volume of 6 ml of THM buffer.
The toxicities of the stage II pyocine 1577 and the concentrates
prepared by PEG- or ammonium sulphate treatment or ultracentrifugation
were tested in mice. The activity and sterility of each
preparation was confirmed before use.
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Male CFS mice were caged in groups of four and injeoted
intraperitoneal!^ (0.5 ral) or subcutaneously (0.3 ml) with one
of the pyocine preparations. Control mice received THM buffer.
After subcutaneous injection, the mice were massaged at the site
of injection. The mice were weighed immediately before
injection and regularly thereafter until the 10th day of the
experiment, when they were killed by cervical dislocation and
examined at necropsy for any obvious pathological changes.
Further purification of pyocine 1577
The results of the toxicity testing of preparations of pyocine
1577 were not entirely satisfactory ard although the original plan
was to design a method of pyocine preparation that only required
a few days to complete, in view of the toxicity problems, further
purification steps were examined. The method is set out below:
Stages in the preparation of purified pyooine
Day 1 Three 200 ml volumes of SG-B culture of Pa. aeruainoia
strain 1577 were induced with Mitomycin C by the standard
method. After incubation, the cultures were stored
at 4°C overnight (stage i).
Day 2 The pyocine-containing supernate was treated with
a filtrate of MnCl + NaOH to give a final concentration
2
of 4/o» After mixing well, the slime precipitate was
deposited by centrifugation at 1600£ for 50 rain, and
the stpernate was decanted (stage II). 250 g of
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ammonium sulphate were dissolved in 500 ml of
pyocine-containing supernate and held at 4°C for
24 hours.
Day 3 The ammonium sulphate-treated pyocine was
centrifuged at 2100£ for 60 min. at 4°C. The
supernate was discarded and the deposit was resuspended
in 25 ail of THM buffer. The resuspended material
was dialysed against two changes of the same buffer
in 72 hours at 4°C (stage III).
Day 6 The dialysed pyocine was centrifuged at 1500£
at 4°C and the supernate was decanted and ultraeentrifuged
at 80,000^ for 90 min. under refrigeration, using a
Spinco aqgle 40 rotor. The resulting supernate was
discarded and the deposits were resuspended in a total
volume of 12 ml of THM buffer (stage IV).
Day 7 Ion-exchange chromatography of stage IV pyooine;
10 g of DEAE-Sephadex A-25 were swollen in 250 ml of
THM buffer for 48 hours at room temperature and used
to pack a chromatographic column (Pharmacia; 30 x 1.5 cm).
The packed column was washed for several hours with
THM buffer and allowed to stand overnight.
A 6 ml sample of a stage IV preparation csf pyocine
1577 was run into the top of the ion-exchange column
and the system was closed for 1 hour to allow the pyocine
to adsorb to the resin. The column was then washed with
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THM buffer for 5 hours (e. 200 ml buffer). The
pyocine was eluted with a sodium ohloride gradient
(0 - l.OM-NaCl in THM buffer) and the eluate fractions
were collected at 15 min. intervals by an automatic
fraction collector. Elution was allowed to proceed
overnight, during which time 68 fractions were
collected with an average fraction volume of 6.5 ml.
Day 8 The protein content of the eluate samples from the
ion-exchange column was estimated by reading the optical
density (O.D.) of the sauries at 280 nm in a Unioam
SP 8000 spectrophotometer. The eluate samples with
high O.D. readings were titrated against strain P14
and the remainder of the samples were spotted on to
lawns of F14.
Day 9 The eluate samples that were found to contain high
activities of pyocine were dialysed against THM buffer
for 5 hours (stage V) and then ultracentrifuged at
80,000^ for 90 min. under refrigeration, using a Spineo
angle 40 rotor. The deposits was resuspended in THM
buffer (stage VI), and the activity of the pyocine was
estimated by titration against strain P14.
Toxicity testing of pyocine 1577 at various stages of purification
Twenty-four male CM mice were caged in groups of four and
given food and water ad lib.. Each group received pyocine 1577
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from one of the stages of the purification procedure (stages II-Vl)
and the mice in the remaining group were injected with THM
buffer. The activity and sterility of the preparations was
oonfirmed before use. All the injections were of 0.5 ml volume,
given intraperitoneaUy. The mice were weighed immediately
before injection and daily thereafter for 13 days.
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RESULTS
The removal of slime from stage I pypeine preparations
Three methods for removing slime from pyocine preparations
were examined and the inhibitory activities of the pyocines after
the different treatments are shown in table 7. Deoxyribonuclease
and acrinol did not markedly reduce the activity of the pyocines
but neither did they remove the slime from the preparations.
Therefore, they were rejected as slime removal agents. The
MnClg + NaOH filtrate removed the 3lime from pyooine preparations
efficiently but at higher concentrations of the filtrate, the
pyooine activity was diminished, probably due to co-precipitation
of the pyocines with the slime. Therefore a final concentration
of filtrate of 4# was adopted as a standard. After oentrifugation
to remove the slime precipitate, some MnCl^ remained in the pyocine-
containing supernate, but this was removed by dialysis against
distilled water. After slime removal, the pyocine preparations
were designated stage II preparations.
TABLE 7 Removal of slime from 3tage I pyooine preparations




at 12,800 200,000 3200
" 4# 6400-12,800 100,000 3200-6400
" 6# "Jt 1600-3200 100,000 3200
" 8% 800-1600 50,000 1600
" 10# 200 50,000 1600
DNase 3200 200,000 6400
Acrinol 800-1600 200,000 12,800
Untreated control 6400 200,000 6400
120
Concentration and purification of stage II pyocine preparations
Polyethylene glycol (PE&) and rotary film evaporation were
examined as methods for concentrating stage II pyocine
preparations. Precipitation with ammonium sulphate and the use
of ultraoentrifligation for concentrating the pyocines and
achieving some degree of purification was also investigated.
The activities of the pyocinea after the different treatments
are shown in table 8, Rotary film evaporation was found to be
unsuitable for concentrating pyocine preparations because the
pyocine activity was considerably reduced or completely removed
after the treatment.
TABLE 8 The activities of pyooines 5893. 5882 and H108 at

































Key: t activity of resuspended deposit
* activity of supernate
Storage of pyocine preparations at different temperatures
Samples of pyocine preparations at various stages of
concentration and purification were stored at different temperatures
121
and their activities examined 5 and 15 weeks later. The results
are shown in table 9,
In general, the purified preparations showed a greater loss
of activity than the stage II preparations and all the samples
lost their activity during storage at room temperature.
Preparations of pyocine H108 were tiie least stable and only
retained their activity after 15 weeks if stored in a deep-freeze
(-20°C), However the high molecular weight pyocines retained
their activity better at 4°C,
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TABLE 9 The activities of pyocines 5893. 5882 am HI06 against
strain EUfc after storage at 22^0^ 4°8 and -20°C i'or


















5893 stage II 0 12,800 12,300 12,800
5 50,000 50,000 50,000
15 12,800 25,000 50,000
5893 after PEG 0 200,000 200,000 200,000
5 6400 400 6400
15 200 800 1600
5893 after 0 100,000 100,000 100,000
ammonium sulphate 5 6400 50,000 0
15 0 25,000 0
5882 stage H 0 200,000 200,000 200,000
5 50,000 25,000 200,000
15 12,000 100,000 50,000
5882 after PEG 0 1,600,000 1,600,000 1,600,000
5 2,000,000 2,000,000 2,000,000
15 100,000 400,000 1,600,000
5882 after 0 1,600,000 1,600,000 1,600,000
ammonium sulphate 5 100,000 800,000 50,000
15 3200 1,600,000 0
H108 stage II 0 1600 1600 1600
5 0 800 1600
15 0 100 800
Hi08 after PEG 0 6400 6400 6400
5 0 100 6400
15 0 0 100-200
HI08 after 0 6400 64CO 6400
ammonium sulphate 5 0 400 6400-12,800
15 0 0 800
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Toxicity testing of preparations of pyocines 5893. 5882 and
ID.08 in mice
The results of injecting various types of pyocine preparation
intraperitoneally, intravenously anl siibcutaneously into mice
are shown in table 10# The activities of the relevant pyocine
preparations are those shown in table 8.
One of the two mice injected intraperitoneally with
pyocine 5893, concentrated by PEG-, died. One mouse of each
pair injected Intraperitoneally with PEG and ammonium sulphate-
treated pyocine H108 died, Pyocine 5882 caused no visible
adverse effects.
Lesions developed around the neck and forelegs of some of
the mice injected siibcutaneously with pyooine 5893 (fig* 6).
One mouse that received pyocine Hi08 suffered similarly but had
recovered by the end of the experiment. Mice that developed
lesions were not killed at the end of the experiment (13th day)
but left alive so that the progress of the lesions could be
observed. On the 10th day, the lesions were swabbed, but
cultures yielded no bacterial growth and after about 20 days
the lesions were healing naturally.
Lesions were not observed in mice injected with pyocine 5882.
or THM buffer.
12It.
TABLE 10 Toxicity testing of preparations of pyooines 5893.
5882 and H108 by various routes of injection in pairs
of mice
Fyocine Stage of pyocine Route of Number of Number of
preparation injection deaths per lesions per
pair of pair of
mice mice
5893 stage I SC 0 0
ft tt IP 0 0
!» after PEG SC 0 2
M IP 1 0
H after ammonium SC 0 2
sulphate
>t t» IP 0 0
N after ultra- r\ o
centrifugation
DO c.
H tt IP 0 0
M It IV 0 0
5882 all stages all routes 0 0
HI08 stage I SC 0 0
H w IP 0 0
H after PEG SC 0 1
*1 n IP 1 0
f» after ammonium SC 0 0
sulphate
fl fi IP 1 0
Vt after ultra- SC 0 0
oentrifugation
M n IP 0 0
ft it IV 0 0
Controls THM buffer SC 0 0
M n IP 0 0
N n IV 0 0




FIGURE 6 Le3ion on a mouse ten days after subcutaneous
injection of pyooine 5893
DETAILED STUDY OF PYOCHB 5893
(1) The effects of induced arid uninduced preparations of
pvocine 5893 in aloe
The results of the previous expexdment showed that six of
the eight mice that received pyooine 5893 subcutaneously developed
sores and one of the eight mice injected intraperitoneally died.
In this experiment, the effects of induced preparations of pyocine
5893 were compared with those of uninduced preparations} the
latter having low pyooine activity. The activities of the
pyocine preparations administered to the mice are shown in table 11,
TABUS 11 The inhibitory activities of induced and uninduced
preparations of pyooine 5893 administered to mice
stage of activity of pyocine 5893 against strain F14
pyocine (units per ml)
preparation induood uninduced
stage II 6400 (1) 400 (4)
after PES 25,000-50,000 (2) 1600 (5)
after ammonium
sulphate N-/8CO 1600 (6)
figures in brackets indicate mouse group number
The changes in average weights of the groups of mice and the
time of death are shown in fig. 7. The average weight of a group
relative to its initial weight was taken as a measure of the state
of health of the group. There were no deaths among the mice that
received induced preparations of pyocine 5893 hut three of the four
mice died in groups that were injected with uninduced pyocine 5893
at stage II or after PES treatment. The mice were all injected
aubcutaneously but no surface lesions were observed.
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FIGURE 7
Changes in average weights of groups of four mice injected
with induced and uninduced preparations of pyocine 5893
day of experimentgroup
baseline for each group is the initial average weight of the group
figures in brackets indicate the number of surviving mice where this is less than 4
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(2) Extraoellular enzyme and haemolytic activity of induced
and unlnduoed stage II preparations of pyocine 5B93
There was no evidence of any haeraolytic or lecithinase activity
in either the induced or uninduced preparations of pyocine 5893*
The protease assay showed a slight rise in optical density
of the test samples above the controls, indicating that some of
the casein substrate had been digested and thus some proteolytic
activity was present in both induced and uninduced preparations
of pyooine 5893*
(3) Fraotionation of induced and unindueed preparations of
pyooine g8?g
Samples of induced and uninduoed preparations of pyocine 5893
concentrated by PEG- treatment, were fractionated on a Sepharose 4B
gel filtration column and the optical density of the eluate was
recorded. The pyocine activity of the eluate fractions of induced
5893 was also estimated and the results are shown in fig. 8.
(4) Toxicity of fractions of an induced preparation of pyooine
5893 in mice
The fractionation of induced pyooine 5893 was repeated and the
eluate samples were assayed for pyocine, protease and elastase
activity. The results are given in table 12 and fig. 9*
The changes in average weights of the groups of mice injected
with fractions of the pyocine 5893 preparation are shown in fig. 10.
Group 5» which received pyocine peak I, were the only animals
that were visibly unwell and this observation was borne out by
their loss of weight. This group showed the greatest weight loss
but the other groins of mice also lost weight initially. The
samples containing high protease and high elastase activity
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FIGURE 8
Fractionation of induced and uninduced preparations of





appeared, to have less adverse effects than the pyocine-
containing sauries or the unfractionated pyocine 5893#
At necropsy, the organs of all the mice appeared normal
except the spleens, which were often pulpy and sometimes
enlarged.
TABLE 12 Assay of pyocine. protease and elastase activity of
eluate samples from the fractionation of induced
mmm ii i in rnmmmmmmmmmmmm mmmmm————— m mmmmmmmmmmmmmmmmmmmmmmmmmmmmm■ ■ »■ mmmm
pyocine 5093 on Sepharose 4B
Eluate sample pyocine activity
(units per ml)
protease activity
O.D. at 440 nm
elastase activity
O.D. at 495 nm
1 0 0 0.025
2 0 0 0.02
3 0 0 0.03
4 0 0 0.015
5 0 0 0.015
6 100-200 0 0.025
7 6400-12,800 0.005 0
8 3200 0.005 0
9 1600 0.001 0.003
10 800 0.002 0
11 200-400 0.01 0
12 800 0 0
13 3200 0.005 0
34 6400 0.02 0
15 6400 0.005 0
16 400 0.015 0
17 0 0.002 0
Unfraetionated
5893 200, 000 0.022 0.175
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Fractionation of a pyocine 5893 preparation and assay of eluate




Changes in average weights of groups of four mice injected










Baseline for each group is the initial average weight of the
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Extension of the initial survey for another strain producing
oontraotile pyooines
Studies of pyocine 5893 i-Q ®ice suggested that the toxie
effects observed might have been due to the pyocine itself and
not to other contaminating protein. Strain 5893 was therefore
discarded as the representative contractile pyocine produoer.
Prom a further survey of pyocine producer strains, using the
methods described in Section I, Pa. aeruginosa strain 1577 was
seleoted. tyoeine 1577 was prepared to stage II and its
properties were compared with those cf pyocine 5893 and are
tabulated below (table 13).
Electronmicrographs of pyocine 1577 showed clearly many
contractile pyocine particles attaohed to cells of indioator
strain Pit (fig. 11).
TABLE 13 A comparison of the properties of pyocinea 1577 and 5893
Treatment Activity of pyocin
(units
1577
ie against strain Pit-
per ml)
5893






Trypsin (4 mg/ml; 60 min.)
37°C













FIGUEE 11 An electrownicrograph showing the contractile
particles of pyocine 1577 attached to a ceXL of
indicator strain F14 (x 50,000)
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Toxicity testing of pyoolne 1577
The inhibitory activities of the pyocine 1577 preparations
administered to the nice and the average weight changes of the
groups of four animals are shown in fig. 12,
All the group3 lost weight during the first two days after
injection with pyecine. The oontrol animals also showed a
weight loss but this was smaller than that of the test groups,
MLoe injected intraperitoneally lost more weight than those
that reoeived pyocine subcutaneously.
Two mice injected intraperitoneally with PEG-concentrated
pyooine were dead on the 6th day. One death also occurred in
the group of mice inoculated with ammonium sulphate-treated
pyocine, but at necropsy, the gut appeared distended and death
may have been caused by injection into the gut, No deaths
occurred in the groups of mioe injected subcutaneously with
pyocine preparations and no surface lesions were observed.




Changes in average weights of groups of four mice injected
with pyocine 1577 intraperitoneally or subcutaneously











9 day of experiment
mice injected intraperitoneally -—-—mice injected subcutaneously
Baselines represent initial average weights of groups of mice
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The purification of pyooine 1577 and toxiolty testing at
different stages of purity
The elution profile of a stage IV preparation of pyocine 1577
from a DSAE-eellulose ion-exchange column is shown in fig. 13«
The maximum pyocine activity was eluted at a sodium chloride
concentration of c. 0.17M.
Samples of pyocine 1577 from stages II-VI of the purification
procedure were tested for toxicity to mice. The activities of
the pyooine preparations injeoted are given in table 14. The
numbers of surviving mice and the daily average weights of the
groups are shown in table 15 and fig. 14.















Three of the four mioe that received stage IV pyocine died.
whereas only one mouse succumbed in the group that received stage
VI pyocine, of higher activity. There were no deaths in ai^ of
the other groups, but all the mice showed some loss of weight.
This may have been because some of the animals fought badly and
the control mice eventually had to be caged individually.
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FIGURE 13
Fractionation of pyocine 1577 on DEAE-cellulose.-
optical density of eluate fractions and elution profile of pyocine
eluate fraction number
pyocine -- protein
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DISCUSSION
Early studies of bacteriocines were of a descriptive
nature and concentrated mainly on the detection and assay of
these inhibitory agents. More reoently there lias been an
increasing interest in the molecular biology of bacteriocines
and concurrently, descriptions of suitable purification
procedures have been reported. The purification of a
contractile pyooine preparation was described in detail by
Kageyama and Egami (1962) and this method has become the basis
for many of the published purification procedures. The
purification of filamentous pyocines has not been studied
in detail but is similar to the method used for contractile
pyocines (Takeya et al,. 1969). In a recent study of a small
pyocine, Ohkawa, Kageyama and Egami (1973) advocated the method
of Kageyama and Egami (1962) with certain modifications designed
to overoome the instability of small pyocines. The main
qualification was that all the procedures should be carried out
at 0«4oC and that prolonged dialysis should be avoided because
of the instability of the small pyooine at low salt concentrations.
Purification of a pyooine-c curtaining supernate is necessary
because Pa, aeruginosa elaborates a wide variety of extracellular
growth products, including slime and enzymes. Although pyooines
are active in unpurified preparations, it was felt necessary to
obtain purified pyocines for studies of the inhibitoxy activity
of these agents in vitro and in vivo, furthermore, since it
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has been shown that the baoterieldal oapaoity of a pyocine
preparation is proportional to the amount of pyooine present,
(Xagevama, Ikeda and Kgami, 1964) concentrated pyocine
preparations were required. But purification and concentration
procedures are often lengthy and since a fresh batch of pyooine
would be required for each in-vivo experiment, it seemed
desirable to keep the preparation time to a minimum. Thus a
compromise was sought between the degree of purification and
concentration of the pyocine preparations required and the
length of time such procedures entailed.
The methods of purification examined in th±3 study were
based on those of Kageyama and Egaml (1962) and various
modifications reported by other authors were also tested.
The removal of slime is an important initial stage in the
purification of pyocine preparations, not only because the 3lime
contaminates the pyocine, but also because its presence hinders
the separation of bacterial debris, and makes the handling of
pyocine preparations difficult. The slime material has also
been shown to be toxic to animals (Callahan, Beyerlein and Mull,
1964). Various methods for the removal of slime have been
described, Kageyama and Egami (1962) found that treatment of
a pyocine preparation with manganous chloride was effective in
precipitating the viscous material, but it was necessary to add
sodium hydroxide simultaneously to maintain the pH at about 7*4.
The divalent manganese cation speeifioaily precipitates nuoleic
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acids, but the pyocine does tend to be precipitated with the
slime when manganous chloride is used. To avoid this loss
of pyocine activity, Yui, Ishii and Bgami (1969) recommended
the addition of aqueous acrinol to the pyocine preparation.
This method has the disadvantage that traces of aorinol remain
in the treated preparation and can only be removed by passage
through a carboxy-methyl (CM) cellulose ion-exchange resin.
Since the slime of Pa. aeruginosa is composed largely of
deoxyribonucleic acid (DNA), treatment of a pyocine preparation
with DNase was found to be an effeotive method of slime removal
(ito, Kageyama and Egami, 1970).
In tiiis laboratory, a modified method of manganou3 chloride
treatment has been used successfully (Brown, 1973)* Molar
solutions of manganoud chloride and sodium hydroxide are mixed
in the ratio 2:1 and filtered to remove the brown precipitate.
The filtrate is then added to the pyocine preparation. The
slime forms a fluffy, white precipitate that is removed by
centrifugaticn. This method has the advantage over that of
Kagayama and Egami (1962) in that it is technically easier to
perform. The efficacy of Brown's method of manganous chloride
treatment was compared with that of DNase and acrinol and was
found to be superior in slime removal. However, it was
necessary to keep the final concentration of filtrate down to
4% to prevent diminution of pyocine activity.
Since pyocines are proteinaceous in nature, the established
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methods of conoentration and purification of proteins are
applicable to pyocine preparations. Two methods of
conoentration were examined, both involving the removal of
water and consequent reduction in volume of the pyocine
preparation. The use of polyethylene glycol for concentrating
fluids containing protein, reported by Kohn (1959), was fbund
to be effective for concentrating pyocines, while retaining
their activity. The rotary film evaporator allows the
separation of solvents by distillation at a reduced pressure
and controlled temperature. It operates on the principle of
continuously spreading a thin film of solution over a large
area, so providing a large evaporating surface. Since rotary
film evaporation is particularly suitable for concentrating
heat-sensitive solutes, its application to pyooine preparations
wan investigated. However, it was found to be unsatisfactory
because the pyocine activity was destroyed or considerably
reduced.
The disadvantage of both methods was that the impurities
in the preparations were concentrated together with the pyooines;
it might have been better to purify the pyocine preparations
before trying to concentrate them by these methods.
Salting-out by saturation of a preparation with ammonium
sulphate is an established technique for purifying proteins and
can also be used as a method of concentration. The application
of salting-out to pyocine preparations was reported by Hamon (1956)
and has since been advocated by many authors (Kageyama and Egami,
** 5 C'
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1962; Higerd, Baeehler and Berk, 1967} Takuya et al.. 1969)#
The recommended degree of ammonium sulphate saturation varies
from 70 - 80%, In this study, 75> saturation (i.e. addition
of 5C$ w/v ammonium sulphate) was tested and found to be
effective. The fluffy material that collects after ammonium
sulphate treatment usually forms a precipitate which is
sedimentable by centrifugation (Kageyama and Egami, 1962)
but it may remain as a surface layer which is more difficult
to collect (Takeya et al.. 1969). In the three pyocine
preparations tested, the protein formed a precipitate at 4°C
and was oollected by centrifugation in the cold. Concentration
was affected by resuspending the precipitate in a small volume
of buffer. Better results were obtained when the ammonium
sulphate-treated pyocine was held at 4°C for 24-48 hours
rather that the shorter time described by other workers
(Kageyama, 1964; Higerd, Baechler and Berk, 1967).
Ultracentrifugation was found to be a useful method for
concentrating the high molecular weight pyocines and also freed
the preparation of low molecalar weight contaminants. However,
it was less effective than ammonium sulphate in concentrating
the pyooines and was limited by the small volume that could be
centrifuged at one time. When ultracentrifugation was used
in sequence with ammonium sulphate treatment for the purification
qnd concentration of high moleoular weight pyocines, it gave
very good, results. However, ultracentrifugatien is ub ©less in
the concentration of small pyocines, such as pyocine H108,
because they are non-sedimentable.
1:,6
The "shelf-life" of purified pyoeines is relevant to their
use as therapeutic agents because if preparations retained their
activity on storage, large batches of pyooine could be made at
one time and held until required. Kageyama and Egami (1962)
found that the activity of a high molecular weight pyocine was
completely destroyed after lyophilisation. Higerd, Baechler and
Berk (1969) found that a contractile pyocine preparation lost
its activity yhen preparations were frozen and thawed, but
suspension in 12$ dimethylsulphoxide or 5$ glycerol, followed
by storage at -60°C protected the protein and the pyooine
retained its activity. These authors did not record the
duration of storage. Colicines and K have been reported
to retain their activity after several rounds of freezing and
thawing (Fields and Luria, 1969) and it was thought that the same
finding might be true of small pyooines. Indeed, the small
pyocine H108 was more active after storage at -20°C than at
4-°C or 22°C. In contrast, the high molecular weight pyooines,
5893 and 5882, retained their activity better at 4°C. These
pyocine preparations were stored without any protective agent
because an earlier experiment had shown that it was difficult
to separate the pyooines from glycerol after storage. In general,
it was found that purified pyocines suffered a greater loss of
activity after storage than the less pure preparations.
iyooine3 are not generally thought to be toxic although
Homma and Suzuki (1964-) showed that some cell-wall associated
proteins with pyocine activity were capable of eliciting a
ii47
Schwartzman phenomenon and a pyrogenic response. Higerd,
Baeohler and Berk (1967) found that a purified contractile
pyocine preparation was not lethal to mice when injected
intraperitoneally at levels of 28,000 - 1,400,000 units.
Neither did these authors observe dermonecrosis when pyocines
were given to rabbits subcutaneously. G-ovan (1968) found that
the contractile pyocine 3121 was non-toxic to mice in impure or
purified forms (both at 400,000 units per ml), when administered
by various routes. Before pyocines could be proposed as useful
therapeutic agents, it was necessary to show that they were not
toxic or lethal to animals.
The toxicities of preparations of pyocines 5393, 5882 and
K108 at various stages of concentration and purification were
examined. No adverse effects were observed in mice that
received pyocine 5882, but pyooines 5893 ICL08 did appear to
have some toxic properties. The toxicity of the small pyocine
H108 may be related to the observation by Homma and Suzuki (1964)
concerning cell-wall a3300iated pyocines.
Initially, it was thought that the lesions observed in mice
injected subcutaneously with pyocines 5893 and Hi08 were the
manifestation of local reactions to ifce toxic pyooine preparations.
However, later experiments suggested that the fluid injected
subcutaneously did not always disperse, but remained concentrated
around the neck, thereby producing an irritation to which the
14S
mouse reacted by scratching. In the light of these findings,
when pyocine 1577 was tested for toxicity, the volume of the
subcutaneous injections was reduced from 0.5 ml to 0.3 ml and
the neck wa3 massaged after injection. No lesions were
observed in any of the later experiments.
In view of the apparent toxic effects of pyocine 5893,
it was decided to examine preparations of this pyocine in
greater detail. The findings of other workers suggest that
the contractile pyocine itself is not toxic (HLgerd, Baechler
and Berk, 1967; Govan, 1968) ax^d the adverse effects that were
observed may have been caused by other substances present in the
preparations, A comparative examination of the effects of
uninduced and induced preparations of pyocine 5893 supported
the theory that the pyocine was not the cause of the toxicity;
there were no deaths among the mice injected with induced pyocine
preparations, but 50?? mortality among mice that received
uninduced preparations, low in pyocine activity. This result
suggests that extracellular products other than pyocines may be
incriminated in toxicity and that more of these are present in
the uninduced preparations.
Slime and extracellular enzymes as well as a protein exotoxin
have been implicated in the pathogenicity of Ps. aeruginosa
(Liu, Abe and Bates, 1961; Liu, 1966). Slime was removed from
all the pyocine preparations before their toxicity was examined,
but non-pyocine protein present in the pyooine-containing culture
supernate was concentrated with the pyccine by polyethylene glycol
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and ammonium sulphate treatment, and it was in mice that received
such preparations that toxic effects were most frequently seen.
Induced and uninduced stage II preparations of pyocine 5893
were examined for their haemolytic and extracellular enzyme
activity by methods described by Liu et al. (1961). Most
strains of ?s. aeruginosa produce a variety of extracellular
enzymes but maximum production usually occurs after three or
more days incubation of a culture. Govan (1968) found that
preparations of pyocine R21 infrequently contained haemolysins,
lecithinases or lipases, and gelatinase activity, if present,
rarely exceeded a titre of 1 in 64. Preparations of pyocine
5893 tested in this stuiy, were able to digest casein, suggesting
the presence of a protease, but there was no lecithinase or
haemolytic activity detectable. Liu and Mercer (1963) suggested
that protease and lecitliinase were the most important enzymes in
the pathogenesis of pseudomonas infections but the lack of
enzymatic activity in preparat ions of pyo cine 5893 suggests that
the enzymes were not the toxic agents.
In order to examine pyocine 5893 further, a concentrated
preparation was fractionated by gel filtration, using Sepharose
5 7
4B (exclusion limits 10 - 2 x 10' molecular weight). This technique
was applied to Ps. aeruginosa oulture supernates by Carney and Jones
(1968) and was found to separate extracellular enzymes from other
protein material. These authors examined culture supernates
up tc seven days after inoculation, but made no mention of
pyocine activity. Fractionation of an induced preparation of
pyooine 5893 on Sepharose 4B resulted in two closely linked peaks
of pyoeine activity, the second corresponding to the peak of
ultra-violet-absorbing material. The elution of two pyocine
peaks led to the suspicion that there was more than one kind
of pyocine particle present. Elastase and protease activities
of the eluate fractions were estimated by the methods described
by Carney and Jones (1968), Although the level of enzyme
activity was very low, the sample with maximum elastase activity
was found to precede that of maximum protease activity. The
latter corresponded to the peak of ultra-violet-absorbing material.
When an uninduced preparation of pyoeine .5893 was eluted from a
Sepharose 4B column and the optical density of the eluate assayed,
the peak of ultra-violet-absorbing material was found to occur
somewhat later than the peak in the induced preparation. This
may reflect different proteins in the two preparations.
When the toxicities of selected fractions of the induced
pyocine 5893 preparation were tested in mice, the animals that
reoeived a sample of the first pyocine peak were the only ones
that became visibly unwell. All the otter groups of mice
appeared healthy, although they did show slight loss in weight.
This finding suggested that the pyocine itself, or some factor
closely assooiated with it, was causing the toxic effects in mijje.
In view of the undesirable findings associated with pyocine
5893; its toxicity, the possibility of production of more than
one type of pyocine, and the generally low pyocine activity
achieved even after induction and concentration, it was decided
to resume the search for a contractile pyooine inhibitory to
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Pa. aeruginosa strain P14. A further seventy-seven strains
of Ps« aeruginosa were examined for pyocine production and
strain 1577 was selected. Fyocine 1577 had the properties
of a contractile pyocine when attacking indicator strain KL4;
it was poorly diffusible, resistant to the action of heat and
trypsin, and sedimentable by ultracentrifbgation. Electron-
micrographs of pyocine preparations clearly revealed contractile
particles attached to cells of strain F14. Injection of mice
with preparations of pyocine 1577 at various stages of
purification and concentration did not result in any deaths, but
a considerable weight loss was recorded, particularly in animals
that received the preparation with the greatest pyocine activity#
The adverse effects of pyocine preparations on mice were
disturbing and it was decided to sacrifice a short preparative
procedure for a more extended purification technique. This was
based on that of Higerd, Baechler and Berk (1967) and is described
in detail in the methods of this section# The buffer used
throughout was one recommended in a later paper by these workers
(Higerd, Baechler and Berk, 1969) and contained 0.C^M-MgClg whioh
is reported to stabilise the contractile pyocines in the
uncontracted, active state.
The purification procedure was lengthy, requiring at least
ten days to complete. It was also limited by the volumes of
pyooine that could be conveniently handled at any one time#
In the initial stages, the slime was removed and the protein
was collected by salting-out with ammonium sulphate. The high
molecular weight protein was sedimented by ultracentrifugation
and a sample of the resuspended. deposit was applied to a DEAE-
cellulose ion>-exchange column. When the pyocine was injected
into mice before chromatography, it caused a considerable weight
loss, but when eluate fractions, containing high levels of
pyocine activity, were ultracentrifuged and the resuspended
deposit was injected, the mice showed very little loss in
weight. The pyocine activity of the final sample (stage VI)
was higher than that of the intermediate sample (stage IV) which
caused the greater weight loss. This suggests that the adverse
effects are caused not by the pyocine, but by some factor
closely associated with it, which is deposited in the initial
ultracentrifugation but is separated from the pyocine by ion-
exchange chromatography, V£Lth these findings in mind, it wa3
decided that fully-purified pyocine should be used for all future
in-vivo studies.
Chloroform is used routinely for sterilising bacteriocine
preparations and was used in the early stage of this investigation,
but it has been reported (Mayr-Harting, Hedges and Berkeley, 1972)
that the potency of some bacteriocines is reduced by chloroform
treatment. However, it was found to be unnecessary to use
chloroform at later stages in the purification procedure because
the pyocine preparation was free from Ps, aeruginosa contamination.
In order that the therapeutic use of the three selected
pyocines should be comparable, the extended purification procedure
was tested on pyocines 5882 and IH08, Fyocine 5882 behaved
similarly to pyocine 1577 and the peak elution of pyocine from
the iox>-exohange column was at approximately the same sodium
3.. 3
chloride concentration as that of pyocine 1577» When the optical
density (at 280 nm) of the eluate samples of the two pyocines
was compared, it was observed that pyocine 1577 bad a protein
peak which was eluted about 60 ml after the pyocine peak.
This later peak was absent in pyocine 5882 elutions and this
may be related to the complete lack of toxicity of this pyooine
at all stages in its preparation.
The purification and concentration of pyocine Hi08 presented
several problems. Small pyocines are non-sedimentable in the
ultracentrifuge and precipitation with ammonium sulphate is an
important method of concentration. When a sample of pyocine
H108 was applied to a DEAE-cellulose column in the same way as
high molecular weight pyocines, the results confirmed those of
Ito, Kageyama and Egami (1970); i.e. the small pyocine did not
absorb to DEAE-oellulose but passed through the column. These
authors reported that chromatography with CM-cellulose resulted
in a considerable loss of pyocine activity, but Ohkawa et al,
(1973) found that while 955^ of the ultra-violet-absorbing
material passed through a CM-cellulose column, moat of the
small pyocine was absorbed and eluted by increasing the
concentration of sodium chloride. Whan the method of Ohkawa
et al, (1973) was applied to pyooine Hi08, the pyocine did not
absorb to the resin but passed through the column in the
preliminary buffer wash.
Small pyocines have been shown to be unstable at room
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temperature and at low salt concentrations (ohkawa et al..
1973) and are not generally produced in high titres even
after induction of the pyocinogenic strain (Holloway, pers.
comm.), Fyocine H108 also appeared to have some toxic
properties. When the survey for another contractile pyocine
was carried out, the producer strains were also examined for
small pyocine activity. However, no strain was recognised
as producing a small pyocine superior to pyocine KL08.
Therefore, pyocine H108 remained the representative small
pyocine throughout the investigation.
In summary, methods of purification and concentration of
the selected pyooines (5893. 5882 and HI08) were examined and
effects of these pyocines on mice were observed. Fyocine 5893
was found to have undesirable effects in vivo although these
could not definitely be ascribed to the pyocine. Therefore
this strain was replaced by Ps. aeruginosa strain 1577 which
also produced oontraotile pyooines active against strain P1/+.
An extended purification procedure was established which
included ion-exchange chromatography of the pyocine preparations.
This technique gave good results with the high molecular weight
pyooines but the small pyocine proved more difficult to handle.
SECTION 3
A STUDY OF THE INTERACTIONS IN VITRO BETWEEN
FYOCINES 1577. 5882 AND H108 AND CELLS OF
PSEUDOMONAS AERUGINOSA STRAIN Pllf
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SECTION 5
A study of the interactions in vitro between pyodnes 1577.
8382 and K108 and cells of Paeudomonaa aeruginosa strain ?I4
METHODS
general methods used throughout this series of experiments
(1) Preparation of Paeudoaonas aeruginosa strain H.4
The in-vitro experiments in this section were designed as
models for later in-vivo experiments. Therefore, the suspension
of sensitive cells of strain P14 was prepared in the same manner
as an infective dose. A 100 ml volume of NB/jo3 was inoculated
with a single colony of strain F14 from a nutrient agar plate
and incubated overnight in a 2 1 flask in an orbital incubator
at 37°C and 100 r.p.m.. A 20 ml volume of this culture was
cerxtrifuged at 1850^ for 30 min. and the cellular deposit was
resuspended in 40 ml of NBggS. The cell suspension was held
at 4°C (for not longer than 3 hours) and warmed to 37°C
immediately prior to use.
(2) Preparation of the pyoolnes
Pyocines 1577» 5882 and iil08 were prepared to stage II
(see Section 2) and the activity and sterility of the preparations
was confirmed before use. Those that were contaminated with
Ps. aeruginosa were sterilised by the addition of 5?i v/v
chloroform, mixed well and allowed to stand for 10 min.. The
pyocine preparation was then decanted.
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(3) Viable oount technique
Early studies showed that the Miles and Misra technique for
viable counts (Miles and Misra, 1938) was not entirely
satisfactory for Ps« aeruginosa because the organism has a
tendency to form slightly spreading colonies. Therefore a
spread-plate technique was employed throughout these experiments,
A viable count of a culture was made by preparing a series
of tenfold dilutions of the culture in saline in 3 in. x 2
tubes, using 0.1 ml of culture in 0.9 rol of saline, A fresh,
sterile Pasteur pipette was used for each transfer and an
automatic syringe was used throughout. Volumes of 0.1 ml of
suitable dilutions were delivered by pipette on to the surface
of A9 agar plates and the fluid was spread over the entire
surface of the plate using the shorter arm of a glass spreader.
A separate spieader was used far eaoh plate. Dilutions were
plated in triplicate unless otherwise stated. The spread-plates
were allowed to dry, inverted, and incubated at 37°C overnight.
This method of making viable counts gave reproducible results.
Colony counts were made with the aid of a digital display
unit, at a dilution of the culture that gave between e. 100 and
600 colonies per plate.
(4) Mixing of Pik cells and pyooine and, sampling of the mixture
Equal volumes of a P14 cell suspension and a pyocine
preparation were mixed in 100 ml conical flasks and incubated in
a waterbath at 37°C under agitation. A cell control and a
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pyocine control, in which pyocine and cells respectively were
replaced by saline, were also inoubated, At each sampling time,
2 ml were withdrawn from the test flask and 2 ml from the cell
control flask and these seniles were centrifuged in 5 in, x 5/8 in,
tubes at 1600& for 20 ndn,. The supemate from the test
sample was decanted into a tube containing 0,2 ml of chloroform
and was later titrated, together with a sample from the pyocine
control, for pyocine activity against Ps, aeruginosa strain KL4»
The supernate from the cell control sample was disoarded. The
deposits from both test and cell control samples were each
resuspended in 2 ml of saline and viable counts were made by
the method described above.
The details of the sampling times are given individually
for each experiment.
The following experiments were carried out:-
(a) The effect of each pyocine individually on cells of strain P14.
(b) The effect of a mixture of pyocines 1577 (contractile),
5882 (filamentous) and H108 (small) on cells of strain P14.
(e) The long-term survival of strain P14 in the presence of
pyocine,
(d) The effeot of repeatedly dosing a culture of strain P14
with pyocine,
(a) The effect of each pyooine individually on cells of
Ps, aeruginosa strain P14
A 10 ml volume of pyocine 1577 w&s mixed with 10 ml of a
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suspension of Pl4 cells at the start of the experiment. The
cell control contained 10 ml volumes of ?14 cell3 and saline,
and the pyocine control contained 10 ml volumes of pyocine
1577 and saline.
The first sample was taken at the start of the experiment
from the cell control only, to give the initial viable count.
Thereafter, samples were taken from both test and control
flasks at hourly intervals for 3 hours and treated as described
in the general methods.
The experiment was repeated using pyocine 5882 and using
pyocine H108.
(b) The effect of a mixture of pyocines 1577. 3882 and H108
on cells of Ps. aeruginosa 3train P14
A 9 ml volume of a KL4 cell suspension was mixed with a
"pool" containing 3 ml of each pyocine preparation (1577, 5882
and H108). The cell control contained 9 nil of the P14 cell
suspension and 9 ml of saline. The pooled pyocine control
contained 3 ml of each pyocine mixed with 9 ml of saline,
and individual pyooine controls contained 1 ml of each pyocine
preparation and 5 ml of saline.
At the start of the experiment, a viable count was made
on a sample from the cell control, after centrifugation, as
described in the general methods. Simultaneously, the pyooinea
were added to the cell suspension arid incubation commenced, under
agitation, at 37°C in a waterbath.
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Samples were taken at hourly intervals for 3 hours and
used to prepare viable counts. The pyocine activity of the
test and pyocine control samples was estimated by titration
against strain P14.
(°) The long-term survival of cell3 of Pa. aeruginosa strain P14
in the presence of pyocine
A P14 cell suspension in 0.5 ml volumes was mixed with 5 ml
of each pyocine preparation (1577 , 5882 and 11108) in 6 in. x
5/8 in. test tubes. The cell control contained 0.5 ml of the
cell suspension and 5 ml of saline aid the pyocine controls
contained 5 ml of pyocine and 0.5 ml of saline. All the
mixtures were incubated in a 37°C incubator without agitation.
A viable count was made of a sample of the cell control
at the start of the experiment. Sanple3 were taken from the
test and control mixtures at 24, 72 and 144 hours after the
start of the experiment. Viable counts of the test samples
and the cell control sarnies were made directly (omitting the
eentrifugation step described in the general methods) and 0.5 ml
of each test sample was added to 0.1 ml of chloroform prior to
assay of the pyocine aotivity of the sample against strain P14.
The pyocine controls ware also titrated.
Representatives of the survivor colonies, which grew on
the viable count plates, were pyocine typed, and examined for
resistance to the pyocine with which they had been treated, by
a cross-streaking technique. A tryptone soya blood agar (TSBA)
plate was inoculated with the pyocine producer strain (1577, 5882
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or H108) diametrically across the plate in a strip about 1.5 cm
vd.de. The plate was incubated at 32°C overnight and the
macroscopic bacterial growth was removed with a sterilised
glass microscope slide. The plate was exposed to chloroform
vapour for 15 min. and then left slightly open to allow the
vapour to disperse. Loopfuls of four-hour NB cultures of the
survivor colonies were streaked across the plate at right
angles to the original inoculum and the plates were incubated
overnight at 37°C. An inhibition zone was clearly demonstrable
when the survivor oolony culture was still sensitive to the
pyocine.
The results from the cross-streaking technique were
confirmed by spotting a neat and 1 in 10 dilution of the pyocine
preparation on to a lawn of the survivor oolony culture*
(d) The effect of repeatedly dosing a culture of Ps. aeruginosa
strain PlA with pyocine
A 10 ml volume of pyocine 1577 was mixed with 10 ml of a
suspension of P1A cells in a conical flask and incubated under
agitation for 1 hour at 37°C in a waterbath. The cell control
contained 10 ml of saline and 10 ml of the P14 cell suspension
and was incubated under the same cond.itior.3. A viable count of
the cell control was made at the start of the experiment.
After 1 hour of inoubation, 2 ml of test and control samples
were withdrawn, oentrifuged, and used to prepare viable counts.
Simultaneously, the remainder of the mixture of pyocine and cells
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was centrifuged at l850g for 20 min. and the cellular deposit
was resuspended in 18 ml of fresh pyocine 1577. The
re3U3pended mixture wa3 incubated under the same conditions
for a further 30 min, when the sampling and centrifugation
procedure was repeated, and the cellular deposit resuspended
in 16 ml of fresh pyocine 1577. Incubation was continued for
a further 30 min, before another sample was taken. A viable
count was made on a sample of the cell control at each sampling
time.
The flasks containing the remainder of the pyocine and cell
mixture and the cell control were held in the incubator at 37°C
and were sampled 24 hours after the start of the experiment.
The experiment was repeated using pyocine 5882 and using
pyocine H108.
A selection of the survivor colonies were checked for
pyocine resistance by the cross-streaking teohniqua desoribed
previously.
An investigation into the resistance of Ps, aeruginosa strain PlA to
pyocine 5882
In view of the results of the previous experiment, of
testing survivor colonies for resistance to pyocine 5882, a more
detailed study was carried out.
A NB oulture of strain PlA was plated out on to NA to give
single colonies and incubated at 37°C overnight. Thirty-six
colonies were picked and inoculated into 2 ml TOlumes of NB,
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incubated for 4 hours at 37°C and used to cross-streak a
prepared TSBA plate -which had previously been inoculated with
strain 5882 (see page 159). The cross-streaked plates were
incubated at 37°^ overnight. The inhibition of the % cultures
by pyocine 5882 was recorded. A small amount of the growth
from each cros3-streak was used to inoculate a 2 ml volume
of NB that was then incubated at 37°C for 4 hours. From these
oultures, lawns were prepared on A9 agar plates. Volumes of
0.02 ml from a series of doubling dilutions of pyooine 5882 were
spotted on to each lawn and after the drops had dried, the plate3
were incubated at 37°C overnight.
The 36 cultures were also examined for their sensitivity to
pyooines 1577 and HI08 by the cross-streaking technique.
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RESULTS
(a) The effeot of pyooines 1577. 5882 and Hi08 individually
on Ps. aeruginosa strain PlA
A culture of strain PlA was mixed with pyocine 1577# 5882
or H1C8 and viable counts were made on test and control samples
at hourly intervals. The average viable count per ml of sample
was calculated from the counts from three plates and the results
are shown in tables 16a, b and c and fig. 15.
The three pyocine preparations appeared to reduce the
viability of a PlA cell suspension by approximately the same
amount i.e. by one hundred to one thousandfold, but the KLA
population was never sterilised by these pyocine treatments.
During the three-hour incubation period, in the pyocine
controls the activity of pyocines 5882 and H108 diminished,
whereas that of pyocine 1577 was unchanged.
(b) The effect of a mixture of pyocines 1577. 5882 and HI08
on a cell suspension of strain HLA
The survival of a PlA suspension treated with a mixture
of pyocines 1577# 5882 and H108, is shown in table 17. The
activities of the individual pyocines against strain PlA before
the start of the experiment were 100,000; 200,000; and 1600
units per ml respectively. The pool of three pyooines was
titrated during the experiment and the results are included in
table 17. Individual pyocine controls were also incubated and
1&
muRS 15
Percentage survival of strain P14 (on a log. scale) after




titrated against strain P14 at hourly intervals. The activity
of the pyocine 1577 control remained constant at 6400 units per
ml throughout the experiment. The activity of the pyocine
5882 control dropped from 12,800 units per ml after 1 hour,
to 6400 units per ml after 2 hours and to 32C0 units per ml
after 3 hours incubation. The pyocine H108 control shoved no
activity at all after 1, 2 or 3 hours incifcation.

















C 0 • # •
8
1.77 * 10 100
P 0 12,800 * * •
c 1 • • •
7
9.4 x 10
T 1 25,000 2.2 x 10 2.3
C 2 • • • 1.67 x 108
T 2 25,000 1.43 x 106 0.86
P 2 12,800 • • •
C 3 • • • 2.38 x 108
T 3 25,000 5.33 x 105 0.23
P 3 12,800 • * •
Key; C = cell control sample containing F14 cells and
saline
P » pyocine control sample containing pyooine and
saline
T = test sair^le containing P14 cells and pyocine
. . , - not performed
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Key for both tables;
C » oell control sample containing P14 cells and saline
P = pyocine control sanple containing pyocine and saline
T = test sample containing P14 cells and pyooine
• « not performed
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TABLE 17 The survival of a P14 oell suspension treated
with a pool of ovccines 1577. 5682 and I;lc6


















C 0 • • • 5.96 x 107
P 0 50,000 • • • 100
T 0 • • • • • •











C 2 • • • 8.03 x 107
P 2 25,000 • • • 5.0
T 2 12,800 4.04 x 106










Key: C « oell control containing P14 cells and saline
P a pooled pyocine control containing pyocines 1577*
5882 and III08, and saline
T » P14 oell suspension + pooled pyocine
• • . a test not performed
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(o) The long-term survival of pells of strain P14 in the
presence of pyooine
Viable oount3 of P14 suspensions mixed with pyooines
1577# 5882 or HL08 and incubated for 144 hours are shown in
table 18, and the changes in the activities of the pyocines
in table 19,
The sensitivity of the survivor colonies to the pyocine
with which they were treated was examined by a cross-streaking
technique and by spotting preparations of the pyocines on to
lawns of the survivor colony cultures, After 24-hours
incubation, a culture from the one surviving oolony from the
F14 suspension treated with pyocine 1577 was resistant to that
pyocine when tested by cross-streaking. Cultures from six
of the survivor colonies from a P14 cell suspension treated
with pyocine 5882 were resistant to that pyocine, whereas six
survivor colonies from pyocine Hl08 treatment remained sensitive
to pyocine HI08, After 72 hours incubation, a further selection
of survivor colonies was tested by cross-streaking and again the
survivors of pyocine 1577 and 5882 treatment were resistant to
their respective pyocines but the survivors of pyocine H108
treatment were now resistant to pyocine HI08.
The survivor colonies that were picked after 72 hours
incubation were used to make lawns on to which drops of neat
and 1 in 10 dilutions of the pyocine preparations were spotted.
The results are shown in table 20,
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TABLE 18 The long-term survival of cells of Pa, aeruginosa
strain P14 after treatment v/lth pyooines 1577.
56S2 and hlOS
Sampling Average viable count of sample (cells per ml)
time
(hours from P14 cell 1577 5882 HI08
start) control + P14 cells + P14 cells ♦ P14 cells
0 2.2 x 107 • 9 • • • • • • •
24 3.8 x 107 * 6.5 x 104 1.8 x 10
72 6.6 x 107 5.7 x 107 9.3 x 1C7 8.8 x 107
1A4 3.8 x 107 2.9 x 107 4.6 x 107 4.3 x 107
Key: 1577 * pyooine 1577
5882 = pyocine 5882
H108 * pyocine Hi08
* m 1 colony was recorded on one plate from an
undiluted sanple
. . . a not tested
TABLE 19 The inhibitory activity of pyocines 1577. 5882 and
H108 against Ps. aeruginosa strain P14 after 24.









































Key: C = pyocine control containing pyocine and saline
T » pyocine ♦ P14 Qell suspension
• • • s not tested
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TABLE 20 The pyocine resistance of survivors of strain P1A-.
















1577 15 - - + + + +
5882 9 + + - m + +
H108 15 + + + + -
• • • P14 controls
15 + + + + +
Key: ♦ = Inhibition of lawn culture by pyocine
- a no inhibition of lawn culture by pyocine
N = undiluted pyocine preparation
l/lO = one in ten dilution of pyocine preparation
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(d) The effect of repea-teddy dosing a culture of strain P14
with pyocine
Over a three-hour incubation period, a cell suspension of
strain P14 was treated three times with a pyocine preparation
and the results of the viable counts are shown in table 21,
and represented graphically in fig. 16.
The activities of the pyocine preparations 1577, 5882 and
KLC8 were 800,000; 200,000; and 5200 units per ml respectively
when they were assayed against strain £14,
A selection of the survivor colonies were tested by cross-
strea.ld.ng, for resistance to the pyocine with which they had
been treated. The survivors of pyocine 1577 and pyoaLne H108
treatment retained their sensitivity to those pyocines, whereas
50^ of the survivors of pyocine 5882 treatment were no longer
sensitive to pyocine 5882, This result was confirmed by
titrating pyocine 5882 against lawns of cultures of these
survivor colonies.
An investigation into the resistance of strain P14 to pyoclne 5882
\
Thirty-six colonies of strain P14 that had. never encountered
pyocine 5882 were inoculated into KB and the sensitivity of the
resulting cultures to pyocine 5882 was tested by cross-streaking.
The type of colonial growth was also recorded.
Twenty of the % cultures were inhibited by pyocine 5882,
whereas 16 cultures were resistant to the pyocine. All the
cultures that were inhibited by pyocine 5882 had a smooth
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TABLE 21 Survival of a culture of fltrain P14 after repeated
treatment with pvocines 1577. 5882 or H108
Fyocine Sample
Time of Addition of Average viable
sampling pyocine dose count of sample
(hours from (hours from (cells per ml)
start) start)






It T 1 7.4 x icr
1.5 8





N C 3 1.9 x 10°
If T 3 0 8
N C 2k 3.8 x 10
N T 2k 0









it C 2 1.4 x 10
H X 2 0
2.5
10sit c 3 2.7 x
« T 3 *










II C 2 1.8 x 102N T 2 3.3 x 102
2.5
II C 3 1.8 x 108
II T 3 2.3 x 1C8108II C 24 2.2 x
II T 2k 0
* 3 colonies were isolated on one plate
Key: C » oell control containing P14 cells and saline
T at P14 cell suspension and pyocine
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FIGURE 16
Survival of strain P14 after repeated treatment with
pyocines 1577, 5882 and H108
1*
colonial morphology whereas 12 of the resistant cultures had
a rough colonial morphology and the remaining four resistant
cultures had a smooth colony type.
The results of the cross-streaking were confirmed by using
the cultures to make lawns on which pyocine 5882 was titrated.
It was found that either the culture was completely resistant
to pyocine 5882 or else it res sensitive to 25,000 units per
ml of the pyocine.
When the cross-streaking pro oedure was repeated and the
36 cultures were examined for their sensitivity to pyocinea 1577
and H108 as well as 5882, they were all still inhibited by
pyocine H108. Of the 16 cultures that were resistant to pyooine
5882, six were also resistant to pyocine 1577, while the other
10 remained sensitive to pyocine 1577. Those cultures that
were resistant to both pyocines 1577 and 5882 had a rough
colonial form, but of those cultures that were resistant only
to pyocine 5882, 50^2 were rough and 5Q?fc were smooth colony types.
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DISCU^SIOM
Studies on the mode of action of bacteriooines have been
confined mainly to oolicines but it is thought that at least
some pyocine3 act in the same general manner. The evidence
suggests that a single bacteriocine molecuLe is oapable of
killing a cell by a two-stage process. First, the bacteriocine
adsorbs to a specific receptor site on the bacterial cell surface;
this stage is reversible and the bacteriocine may dissociate or it
may proceed to the second stage and kill the cell. Some
contractile pyocines (Kageyama, Ikeda and FgarrrL, 1964) and. a small
pyocine S2 (Ohkawa, Kageyama and Egami, 1975) have been shown to
act by this single-hit killing process. The mode of action of
filamentous pyocines has not been described. It is thought that
killing begins as soon as the pyocine ia added to a sensitive
bacterial culture (Reeves, 1965) and the survival of the bacteria
is related to the do3e of pyocine administered (Kageyaaa et al..
1964).
The method of assay of pyocine activity used throughout this
study has been the critical dilution method i.e. the estimation
of the dilution at which a pyocine preparation i3 still capable
of inhibiting the growth of a sensitive indicator lawn. This
method is limited by the difficulty in accurately determining the
end-point, but because of its extreme simplicity it has proved
very useful. The results are expressed in arbitrary units per ml
of a pyocine preparation (units per ml = 50 x reciprocal titre of
activity) but this does not measure the lethality of the pyocine
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preparation, A survivor count method of estimating pyoeine
activity can lead to the expression of activity in lethal units
per ml (Mayr-Harting, Hedges and Berkeley, 1972)•
Important features of the survivor count method include the
rapid and thorough mixing of pyocine preparation and sensitive
cells and continued agitation throughout the reaction period.
Although incubation was carried out under agitation in all but one
of the experiments described in this section, a comparative study
suggested tint the lethal effect of pyocine 5882 was just as great
under static incubation conditions as it was under continuous
agitation.
It is also important (MayivHarting et al». 1972) that a sample
of the reaotion mixture is diluted immediately after it is taken,
to prevent further adsorption of the pyocine particles to the cells.
In preliminary studies, it was found that a 1 in 10, or 1 in 100
dilution of the cells and pyocine mixture did not prevent the
transfer of active pyocine on to the agar plates and killing of
survivors during the incubation of the plate. Thus the results
appeared to be anomalous, with higher viable counts at higher
dilutions. To circumvent this problem, samples of the reaotion
mixture were centrifuged to deposit the surviving cells and the
pyocina-containing 3upernate was decanted. The cellular deposit
was resuspended in saline and a viable ccunt was made. By this
method, only the pyocine particles already attached to the cells
were sedimented. It was felt that the introduction of a
centrif ugation step may have reduced the survivor count slightly.
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due to loss of cells that were inadvertantly discarded with the
supernate. But a comparative study showed that there was very
little difference between the viable counts of centrifuged and
uncentrifuged control samples. An alternative method would have
been the addition of specific anti-pyocine antiserum to the sample
to inactivate the pyocine. This method was not used because it
would have necessitated large volumes of antisera and as3ay of
the neutralising power of the antisera before each experiment.
The technique for making viable counts was studied in 3ome
detail to ensure that the method gave reproducible results.
Automatic syringes tend to be somewhat inaccurate but they were
used throughout, which helped to keep the inaccuracy constant and
they made viable counts considerably easier to prepare than Mien
using calibrated glass pipettes. A comparison of Miles and Misra
and spread-plate tecjmique3 for viable counts revealed that the
former resulted in lover counts, probably because the bacterial
colonies tended to merge and become difficult to count accurately.
Therefore the spread-plate technique was used throughout.
Further investigations showed that it was essential to use a
different Pasteur pipette for each transfer of fluid in making
the dilutions, to prevent carry-over of excess culture from one
dilution to the next.
The viable count of the P14 cultures used in these experiments
was approximately the same as that of an infective dose for mice
in order that these results could be related to later in-vivo
studies.
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In this section, the survival of cells of strain HA- was
examined after treatment with the three different kinds of
pyocinesj 1577 (contractile), 5882 (filamentous), and H108 (small),
"When each pyocine preparation was mixed. Individually with a
culture of strain HL4 and survival examined over a three-hour
period, pyocine 5882 was found to kill a greater percentage of the
F14 cells than either of the pyocines 1577 or H108, There was
a 0.055* survival rate after pyocine 5382 treatment, compared with
0,25- and 0.4/5 after pyocine 1577 and pyocine H108 treatments
respectively. Thus, although pyocines 5382 and 1577 had the same
initial activity (expressed in arbitrary units), the killing
potential of the latter was lower or there was a greater number of
the P14 population resistant to pyocine 1577 than to pyocine 5882.
Although the initial activity of pyocine H08 (in arbitrary units)
was only one sixteenth of that of the high molecular weight pyooines,
its killing capacity was half that of pyocine 1577» The reason
for this has still to be eluoidated.
The rate of reduction in the viability of the P14 culture
after pyocine treatment was slower than that reported by other
workers, Kageyatna et al. (1964) found that the killing activity
of a oontractile pyocine preparation was completed within about
20 min. whereas in these experiments the killing continued for at
least 3 hours.
The P14 oultures were not sterilised by pyooine treatment even
though there was active pyocine remaining in the mixture after
3 hours. Although it is thought that only one pycoine particle
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is required to kill a oell, the pyocine must first collide with
and adsorb to the cell surface, Ihen there are relatively few
cells and pyocins particles, the chances of collision are
considerably reduced and this may explain how some cells escape
death, When a preparation of pyocine 1577 of much higher
aotivity (6,400,000 units per ml) was mixed with a culture of
-5
strain P14, the survival rate was reduced to c. 3 x 10
J^yooine resistance also has a role to play in the survival of P14
cells and thi3 is discussed later.
The effect of treating a F14 culture with a mixture of
pyocines 1577, 5882 and UL08 was disappointing in that there was
a higher percentage survival of F14 than resulted from the individual
pyocine treatments. This may have been due to inactivation of
one of the pyocines by anotter in the pyocine pool but was
difficult to ascertain since the individual activities of the
component pyocines of the pool could not be assessed. The pool of
pyooines could have been titrated against three different
indicator strains, each of which was only sensitive to one of the
pyooines, but it would have been unwarranted to assume that this
activity was the same as the activity of the pyccine against
strain P14.
The receptors for some contractile pyocines are known to
reside in the lipopolysaccharide (LPS) of the cell walls of
sensitive cells (Ikeda and JSgami, 1969} Stewart and Young, 1971),
whereas the receptor sites for filamentous and small pyocines have
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not been described. It was hoped that by treating a population
of Pl4 cells with a mixture of the different kinds of pyocines,
those cells that escaped attack by one kind, might succumb to
another. Also, the cells are less likely to develop resistance
to all three types of pyocine simultaneously.
pyocine resistance, or tolerance, appeared to play an important
role in the long-term survival of F14 cultures in the presence of
pyocine. Within 24 hours of treatment of such a culture with
pyocine 1577, there was a dramatic reduction in the viability of
strain ?14, but a culture from the one surviving colony wa3 found
to be resistant to pyocine 1577» From a small number of pyooine-
resistant cells at 24 hours, the P14 population had returned
to its initial level within 144 hours of the start of the experiment
and all the survivors tested were resistant to the pyocine.
Treatment of a culture of strain P14 with pyocine 5882 was
apparently less effective than pyocine 1577 within 24 hours, or
alternatively, the population of pyocine 5882-resistant variants
had started to increase within the 24 hour period. Yhereas the
activity of pyocine 1577 only dropped 3lightly during 144 hours
incubation at 37°C, the activity of pyocine 5882 was reduced in
the pyocine control and absent in the 114 and pyooine mixture
by the end of the experiment. This may be related to the heat
lability of pyooine 5882 described in section 1.
The pattern of survival of strain P14 in the presence of
pyocine H108 was very similar to that of pyocine 5882, but
pyocine-resistant variants of P14 were not observed until 72 hours
lai
after commencement. By this time, there was no pyocine H108
activity remaining in the mixture and the combination of this
and the resistant variants probably ccntributed to the
subsequent rise in the survivor oounts.
The most effective way of reducing the viability of a
population of P34 cells was by repeatedly treating the culture
with pyocine over a 3-hour incubation period. Three treatments
with pyooines 1577 or H108 eliminated the population of P14 cells
within 21+ hours. No P14 survivors were observed after three
treatments with pyocine 5882 in 3 hours, but when the mixture
was sampled after 24 hours, a significant number of P14 cells
were recovered, A selection of the survivors were tested for
their resistance to pyocine 5882, Most of those isolated within
the first 3 hours incubation were sensiUve to the pyocine, but
all of those isolated after 2k hours were found to be resistant
to pyocine 5882,
In view of the rapid emergence of resistance to pyocine 5882
among P14 cell3, a population of strain P14 that had not previously
encountered pyochne 5882 was examined. Sixteen of the 36
cultures grown from single colonies of strain P14 were found to
be completely resistant to pyocine 5882 and six of these were
also resistant to pyocine#1577« Those cultures that were
resistant to both pyooines had a rough colonial morphology.
Dissociation is a common phenomenon in Ps, aeruginosa and Homma
(1971) reported differences in pyocine sensitivity between different
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colony types of Ps. aeruginosa. In salmonellae, rough mutants
are deficient in the side-chains that constitute part of the cell
wall LPS. The rough variants of strain P14 may have been
naturally-occurring mutants that had an altered cell wall LPS
and therefore altered pyocine receptor sites. Although it is
not known whether filamentous pyocines bind to the LPS, a change
in the conformation of the LPS could affect the ability of the
pyocines to bind to their receptor sites.
In summary, it was possible to reduoe, but not to eliminate,
the organisms in a P14 culture by treatment with pyocines 1577*
5882 or Hl08. Results were improved when highly active pyocine
preparations were used. Resistance or tolerance to pyocine
attack emerged rapidly and it was found that a proportion of a
P14 culture was naturally resistant to pyooines 1577 and 5882.
The development of resistance may hinder the successful use of
pyocines as therapeutic agents.
AN INVESTIGATION INTO THE POSSIBLE THERAPEUTIC




An investigation into the possible therapeutic uae of pyocinea
in Paeudomonaa aeruginosa infections
METHODS
Preparation of the infective dose of Pseudomonas aeruginosa
Pseudomonaa aeruginosa P14 is a mouse-virulent strain which
is lethal to the animals when administered in adequate doses.
Previous workers have shown that even with virulent strains of
Ps, aeruginosa, a large dose of organisms is required to produce
mortality following intraperitoneal administration (Eartell, Orr
and Garcia, 1968). In the present work, a number of pilot
experiments showed that a suitable infective dose of strain P14
could be prepared in the following manner:-
100 ml of 20% nutrient broth in saline (Nl^gS) were inoculated
with a single colony of P14 from a nutrient agar (NA) plate and
incubated in a 2 1 flask in an orbital incubator at 37°C and
100 r.p.m. overnignt, A 20 ml volume of this culture was then
oentrifuged at 1850 ^ for 30 min. and the cellular deposit
resuspended in 50 ml of NB^S, Viable counts of cell suspensions
8
prepared in this way were in the range 1,0 - 3*0 x 10 organisms
per ml, A 0,5 ml volume of such a suspension injected
intraperitoneally into mice caused 100% mortality in 6-48 hours,
Thi3 standard method was used for the preparation of the
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infective dose of strain P14 in subsequent experiments unless
otherwise stated.
Activity of pyooines in vivo
In-vitro experiments have shown that treatment of a P14
oultuie with pyocine preparations 1577» 5882 or iil08 insulted in
a significant reduction in the viability of the culture, Frior
to examining similar treatments in vivo it was necessary to show
that the pyocine preparations were not inactivated by the body
fluids of the animal, Braude and Siemienski (1965) showed that
following subcutaneous injection of colicine into mice, inhibitory
activity against a colicine-sensitive strain could be found in the
sera. Mouse serum is not noimally bacterioidal thus the inhibitory
activity was thought to be due to eolicine activity. The aim of
the following experiment was to examine the inhibitory activity of
pyocines in the sera of mice that had been injected by different
routes.
Stage II preparations of pyocines 1577, (8,C x 10^ units per
ml), 5882 (4,0 x iCr' units per ml), and 1H08 (3.2 x 10^ units per
ml) were used. Groups of five mice (CJTE, (J) ) ware inoculated
with 0,3 ml volumes of pyocine intravenously, intraperitoneally
or subcutaneously. Control mice received sterile SGB by tie
same routes. One mouse from each group wxs killed by ether at
0.5» 1# 3, 5 and 24 hours after inoculation and bled from the
posterior vena cava. The blood was allowed to clot, the serum
was removed and tested for inhibitory activity against Pa, aeruginosa
strain P14, Lawns of P14 were prepared on A9 agar plates and
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0.02 ml drops of doubling dilutions of each serum in saline
were applied to the lawns. The drops were allowed to dry and
the plates were incubated at 37°C overnight. The inhibitory
activity of each serum was recorded.
The effect of pyoclnes on Pa. aeruginosa in vivo
(1) By the intraperitoneal route
(A) Using pyocine 1577
Pyocine 1577 was prepared and purified to stage VI and
suspended in THM buffer.
The infective dose of Ps, aeruginosa strain P14 was prepared
by the standard method. Viable counts of the cell suspension
were made before the first and after the last injection and the
infective dose was calculated from the average of these oounts.
The cell suspension and the pyocine were held at 4°C between
injection times and allowed to warm to room temperature (c. 22°C)
immediately prior to injection.
Female CBA mice were distributed at random into groups of six
and caged in these groups. The animals were given food and water
ad lib.. Each mouse received two 0.5 ml intraperitoneal injections
on day 1. The injection schedule is given in table 22.
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TABLE 22 Injection schedule for experiment (A)
Time of injection (hours)
Group number 0 3 6
1 P14 1577* m m
2 P14 1577 -
3 P14 - 1577
4 P14 THM buffer m
5 1577 P14 -
6 1577 - P14
7 1577 THM buffer
8 nb20s N320S m
Key:
♦ Mice in Group 1 were all injected with strain P14 into one
side of the peritoneal cavity and then vd.th pyocine 1577
into the other side.




» 2($ nutrient broth in saline
= Ps, aeruginosa strain P14; cells suspended
in NB2QS
= P^ocine 1577; suspended in THM buffer
= No injection
The mice were weighed before injection and daily thereafter
for 13 days. The spleens were removed from the mice that died
during the course of the experiment and were examined for
Pa. aeruginosa by homogenising in 2 ml of saline. The homogenate
was inoculated on to blood agar and eetrimide agar and any
is. aeruginosa isolated were pyocine typed. At the end of the
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experiment the surviving mice were killed by ether and bled
from the posterior vena cava. The blood from mice in the same
group was pooled, allowed to clot, and the serum was removed
and stored at 0°C prior to serological investigations. The
spleens were also removed from these mice and treated a3
described above.
(B) Using pyocine 5382
The above experiment was repeated with pyocine 5382.
jfyocine 5&82 and the infective dose of Ps. aeruginosa 3train Hit.
were prepared by the methods used in experiment (a). In addition,
the effect of pyocine on infection caused by a pyocine 5882-
resistant variant of strain P14 was examined. P14/A was a mutant
of strain P14 that was not inhibited by pyocine 5882 in vitro.
The infective dose of strain Pll|/R was prepared by the same method
as that for P14.
CBA mice of both sexes were used (adequate numbers of mice
of one sex were not available at the time). The mice were caged
in groups of six; each group being composed of mice of the same
sex. On the first day of the experiment each mouse received two
0,5 ml injections intraperitoneally. The injection schedule is
given in table 25. The mice were weighed and observed as
described in experiment (A),
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TABLE 23 Injection schedule for experiment (b)
Time of injection (hours)
Group number 0 3 6
1 P14 5882* m
2 P14 5882 -
3 F14 - 5882
4 5882 P34 -
5 5882 mm P14
6 P14/R 5882* m -
7 P14/R 5882 -
8 P14/R - 5882
9 5882 P14/R -
10 5882 - p14/r
11 P14 THM buffer -
12 P14/R THM buffer -
13 5882 THM buffer -
14 nb2Qs nb20s
Jfe£!
* Mice in groups 1 and 6 were all injected with strain P14
or P14/R into one side of the peritoneal cavity and then
with pyocine 5882 into the other side
THM buffer = 0.02M-Tris HC1 + 0.02M-MgCl2 buffer pH 7.6
NBggS = 20^ nutrient broth in saline
P14 « Pa, aeruginosa strain P14 suspended in NB^qS
P14/R ■ Pa. aeruginosa strain p14/R (pyocine 5882-
resistant) suspended in NB2qS
5882 = Pyocine 5882 suspended in tb4 buffer
= No injection
(C) Using pyocine H108
It was not possible to obtain a highly active suspension of
pyocine H108 because of the problems that have been discussed
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previously. The effect of pyocine H108 on infections caused
by ?s. aeruginosa strain P14 in mice was studied.
fyocine HI08 was prepared and purified and applied to a
DEAE-ceUulose column as described in section 2. The pyocine
did not adsorb to the column but was washed through with buffer.
This wash was oollected and used for the experiment.
The infective dose of Pa. aeruginosa strain P14 was prepared
by the standard method.
Three groups of four CPE mice were used. Group 1 was injected
with 0.5 ml of P14 cell suspension; group 2 received 0.5 ml of
pyocine H108 and group 3 received 0.5 ml of P14- foilowed by
0.5 ml of pyocine IH08. All injections were intraperitoneal.
The effect of pyocines on Pseudorconas aeruginosa in vivo
(2) Infection of burns with Ps. aeruginosa
The methods used for burning and infecting mice were based
on those described by Jones. Jaokson and Lovtoury (1966). Male
hairless mice were used throughout. Each mouse was kept in an
individual cage which had been sterilised before the start of the
experiment. The sawdust bedding wa3 replaced by sterile paper
towels which were changed daily. The mice received food and
water ad lib..
Burnjng:-> The mice were anaesthetised by intraperitoneal
injection of Nembutal solution (1 part concentrated Nembutal to
9 parts saline given at 0.1 ml per g body weight). A burn was
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made on the 'back of each mouse by the application for 10 s
of a standard brass block heated to 100°C in boiling water.
This resulted in a full skin thickness burn of an estimated
of the body surface (Jones et al.. I966).
Infection;- The infective doee of Ps, aeruginosa strain F14
was prepared by the standard method described previously. Three
hours after burning, the burn on each mouse was inoculated with
0.1 ml of a P14 cell suspension delivered by means of a Pasteur
pipette. The bacteria were spread over the burned area with a
sterile bacteriological loop. Uninfected control animals were
inoculated with on"'7*
Treatment:- This is described in the details of each experinent.
-Experiment 1 Infection of burns with Ps. aeruginosa strain P14
Eight mice were burned. Pour of the burned animals were
infected with 3train P14 and the remainder of the mice were not
infected. The animals were observed for 18 day3 and swabs of
the burns were taken on the third and seventh day.
Experiment 2 Treatment of infected burns with stage VI pyocine 1577
Twenty-four mice were arranged in groups of four (although
each mouse was caged individually). The mice were burned and
infected as described. A schedule of infection and treatment is
given in table 24. Stage VI pyocine 157/ was used for treating
the burn infections. Topical pyocine treatment was effected in
the first instance by pipetting 0.4 ml of pyocine 1577 onto the
191
burn and spreading it with a wire loop. But it was found that
most of the fluid ran off the burn, so the method was altered and
a sterile cotton-wool swab soaked in pyooine was rubbed over the
whole of the burned area. A fresh swab was used for eaoh mouse.
This method was found to be more satisfactoxy and was used
hereafter. Topical treatment was given 3 times daily at 2 hour
intervals on days 2, 3 and 4 of the experiment.
Systemic pyocine treatment was given by intravenous
inoculation of a 0.3 ml volume of pyocine 1577 into the tail vsin,
once daily on days 2, 3 and 4 of the experiment,
TABLE 24 Sohedule of infection and treatment of mice in experiment 2
Treat me lit with pyocine 1577
Group number Infection with
strain P14 Topical Systemic
1 + +
2 + - +
3 + mm •
4 - m -
5 mm + -
6 - - ♦
Rex:
♦ a regime followed
- « regime not followed
The mice were weighed and observed daily for 14 days. Th®
bacterial flora of the burns was monitored before and after
infeotion by frequent swabbing with cotton-wool swabs moistened
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in sterile saline. The swabs were cultured on ''aeConkey agar
and any Ps. aeruginosa isolated were pyocine typed. The spleens
were removed from any mice that died during the experiment.
Each spleen was homogenised in 2 ml saline and the homogenat©
plated on MacConkey agar.
At the end of the experiment the state of each burn was
recorded, the mice were killed by ether and bled from the
posterior vena cava. The blood was allowed to clot and serum
removed and stored at 0°C prior to serological investigations.
Experiment 3 Treatment of burn infections with stage IV and
stage VI preparations of pyooine 1577
Purified (stage VI) pyocine preparations were obtainable in
small volumes only and had to be diluted with buffer to provide
an adequate volume far treatment purposes. This had the effect
of lowering the activity per ml of the preparation. Stage IV
pyocine preparations were more easily obtained in large volumes
and had a higher activity per ml than the purified pyocine
preparations but contained other protein material as well as
pyocine. In this experiment, treatment with stage IV and stage
VI pyocine preparations was compared.
Five groups of four hairless mice were used and were burned,
infected and treated as shown in table 25. The pyocine was
applied topically by means of swabs, as described in experiment 2.
The infective dose of Ps. aeruginosa strain P14 was prepared
in the following manner: Six NA. plates were inoculated with
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strain P14 over their entire surface and incubated at 37°C
overnight. The growth was scraped off the plates with a
bacteriological loop into 10 ml NBg^S and centrifuged at 1850 £
for 30 rain. The supernatant was discarded and the cells were
resuspended in 10 ml NBg^S. This method resulted in an infective
Q
dose with a higher viable count (i.e. 3x 10 cells per ml) than
that prepared by the standard method (p. 183).
TABLE 25 Schedule of infection and treatment of pice in experiment 3
Treated* with pyocine 1577s
Group number Burned Infected Stage VT Stage IV
1 + + _
2 •f + • ♦
3 + + ♦ -
4 + - - +
5 ♦ - - "
Key:
+ = regime followed
• ss regime not followed
* Treatment was given 4 times at 2 hour intervals on day 2
and 3 times at 2 hour intervals on day 3* kioe that were
not treated with pyocine were treated with TIM buffer
The mice were weighed on day 1 before burning and daily
thereafter for 8 days. The burns were swabbed before treatment
and 1 hour after the last treatment on days 2 and 3 and once on
days 4 and 7*
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Experiment 4 Treatment of burn infections with stage TV and
stage VI preparations of pyooine 5082 and with
silver altrate
Five groups of four hairless mice were burned, infected and
treated by the methods described previously, as shown in table 26,
Treatment was given 3 times at 2 hour intervals on days 2 and 3«
TABLE 26 Schedule of Infection and treatment of rise in experiment 4
Treated withj
Group Stage VI Stage TV
number Burned Infected pyoclne pyocine c.5p TKM
5882 5882 AgN03 buffer
1 + + m ♦
2 + + - + - -
3 + -f- + - - em
4 + + - - + m
5 + - • - ♦
El-
+ a regime followed
- = regime not followed
Impression plates
Small Petri dishes (48 mm diameter) were filled to the brim
with nutrient agar. One hour after the last treatment on day 2,
two impression plates were t&iten of the burn on each mouse. One
plate was incubated at 37°C overnight to give an indication of the
bacterial flora of the burn. The other plate was exposed to
chloroform vapour for 5 ®in. and left open, away from the chloroform.
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for a further 10 min. before flooding the surface of the plate
with a 4-hour NB culture of strain P14. Excess culture was
removed and the lawns were allowed to dry and incubated
overnight at 37°C.
Quantitative estimation of Ps» aeruginosa in the burned skin
(Based on Lawrence and Lilly, 1972).
On day 8 a surviving mouse in each group was killed by
ether and the burned area of skin was excised and shredded into
a weighed sterile universal container. The container and skin
were weighed together and 10 ml sterile saline per g of tissue
were added. The burned 3kin was homogenised for 10 min. with
the container surrounded by ice and water. Tenfold dilutions
of the homogenate were made in saline and 0.1 ml of each dilution
was spread onto duplicate A9 agar plates. The plates were
incubated overnight at 37°C. The viable count of Ps. aeruginosa
in the burned skin was estimated from colony counts.
Experiment 5 Treatment of burn infections with a stage VI
preparation of pyocine 5882
Three groups of ten hairless mice were burned and two of
the groups were infected with Ps. aeruginosa strain P14 by the
methods described previously. The uninfected group received
sterile NB20S. One group of infected mice and the uninfected
group were treated with a stage VI preparation of pyocine 5882,
4 times daily, at 2 hour intervals, on the 2nd and 3rd days of
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the experiment. The remaining infected group of animals were
treated at the same times with sterile THM buffer.
The mice were weighed on day 1 immediately before burning,
and daily thereafter for 11 days. The bacterial flora of the
burns was monitored by swabbing before the first and 1 hour after
the last treatment on days 2 and 3 and once on days 4 and 7.
The swabs were cultured on MaoConkey agar and representative
colonies of Ps. aeruginosa isolated were pyocine typed and checked
for resistance to pyocine 5882 by a cross-streaking technique
(see p. 159).
Serological investigations
fyocine neutralisation tests were performed on the sera
obtained from mice in the above experiments. The sera were
stored at 0°C until they were required, when thqy were allowed
to thaw. Stage II preparations of pyocines 1577 and 5882 were
diluted to give activities of 200 units per ml (four times that
required to cause confluent lysis of the indioator strain P14).
The sera were tested for their ability to neutralise the activity
of the pyocine that had been used in the treatment of the mice
from which the sera came. Cross-neutralisation tests were not
performed.
In each test, doubling dilutions of the serum were prepared
in 0.2 ml volumes of saline in a YEO plate. To each dilution
was added 0.2 ml of the appropriate pyocine. Serum and pyocine
controls were also set up, in which the pyocine and serum
respectively were replaced by saline. The contents of the wells
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were mixed by carefully agitating the MO plate and were
incubated at 37°C for 1 hour. The 3erum dilutions were then
assayed for pyooine activity by spotting on to lawns of strain
P14 on A9 agar plates. The plates were incubated at 37°C
overnight and the highest dilution of serum that was capable of
neutralising the pyocine activity was recorded. Positive control
sera were also included in the tests. These were obtained from
rabbits that had been injected with pyocine 1577 or 5882 with
Freund*s complete adjuvant and bled after five weeks.
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RESULTS
Activity of p.vooines in vivo
Normal mouse serum did not show any inhibitory activity
against Ps. aeruginosa strain P14, but sera from mice that had
been injected with pyooine inhibited the growth of strain P14*
The results are given in table 27 • Control mice were injected
with sterile SCB intravenously, intraperitoneally or subcutaneously
and bled after 0,5 or 3 hours. On no occasion did the sera from
these mice show any inhibitory effeot on P3. aeruginosa strain P24.




















































































The effect of pyooinea on Pb. aeruginosa strain P34 in vivo
(1) fty the intraperitoneal route
(A) Uainfi pyooine I577
From the viable counts of the P14 suspension the infective
8
dose was calculated as 1.4 x 10 organisms. The activity of
pyooine 1577 was 1.6 x 10^ units per ml.
The weights and deaths of the mice are recorded in table
28. The infective dose of P14 caused 100?o mortality of the
controls (group 4). The pyocine preparation had no deleterious
effects neither did the suspending agent for the cells (NB^S).
These results also confirm that the trauma of two injections
alone was harmless. The mice in groups 2 and which received
the bacteria before the pyooine, all died. Mice that received
pyocine prior to, or together with, bacteria had a considerably
lower mortality.
Examination of the changes in average weights of the
surviving groups of mice showed that groups 1, 5 and 6 lost
weight initially but regained this over the course of the
experiment, whereas groups 7 and 8 showed no weight loss.
Ps. aeruginosa of pyocine type 16 was found in spleen
homogenates of all the mice that died during the course of the
experiment. No organisms were isolated from the spleens of the
animals that survived to the end of the experiment.
(B) Using pyocine 5882
The infective doses of Ps« aeruginosa strain P14 and P14/R






















































































































































































































































were calculated from the viable counts of the cell suspensions
and were found to be 6,0 x 10^ cells and 5.5 x 10^ cells
k-
respectively. The aotivity of pyooine 5882 was 5.0 x 10
units per nil.
The numbers of surviving nice and the daily average weights
of the groups of mice are recorded in table 29. In table 30
a comparison is drawn between the results of this experiment
and those of experiment (A).
The survival cf mice infected with strain P14 and treated
with pyocine 5882 followed a very similar pattern to that shown
when mice were treated with pyooine 1577 (see table 30). But
a different pattern of results emerged when pyocine 5882 was
used to treat infections caused by strain P14/R: when the
pyooine was injected immediately after the P14/R cells all
the mice died, but if pyocine treatment preeeeded injection by
3 or 6 hours, 3 out of 6 and 2 out of 6 mice survived respectively.
Daily average weights of the survivors in these groups (groups 9
and 10) showed that the animals remained unwell and did not




TABLE 29 The numbers of surviving mice and the average weights of the groups of mice injected with Pa. aeruginosa strain P14 or PI4/R intraperitoneally in experiment l(B)
Day Mouse group number:
number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
a b a b a b a b a b a b a b a b a b a b a b a b a b a b a b
1 6 20.9 6 20.1 6 20.8 6 20.9 6 28.8 6 27.7 6 27.6 6 26.9 6 28.1 6 25A 6 29.4 6 28.6 6 27.2 6 27.4 6 26.5
2 5 19.1 0 0 6 18.9 5 26.6 0 - 0 - 0 - 5 26.3 5 23.7 0 - 0 - 6 26.9 6 27.9 6 25.3
3 5 20.2 0 0 6 19,2 4 25.8 0 - 0 - 0 - 3 25.8 3 21.3 0 - 0 - 6 26.9 6 27.7 6 26.7
4 5 21.1 0 0 6 20.6 4 26.7 0 - 0 - 0 - 3 25.6 3 21.1 0 - 0 - 6 27.4 6 28.1 6 26.8
5 5 21.1 0 0 6 21.3 4 26.9 0 - 0 - 0 - 3 25.6 2 23.4 0 - 0 - 6 26.9 6 28.2 6 26.7
6 5 20.6 0 0 6 20.8 4 26.9 0 - 0 - 0 - 3 24.9 2 22.6 0 - 0 - 6 27.1 6 28.3 6 26.9
7 5 21.2 0 0 6 21.4 4 27.3 0 - 0 — 0 - 3 24.5 2 22.6 0 - 0 - 6 27.5 6 28.6 6 27.1
8 5 21.3 0 0 6 21A 4 27.1 0 - 0 - 0 - 3 23.5 2 22.0 0 - 0 - 6 27.3 6 28.3 6 26.6
9 5 21.7 0 0 6 21.7 4 27.4 0 - 0 - 0 - 3 23.3 2 22.3 0 - 0 - 6 27.8 6 29.1 6 27.5
10 5 21.2 0 0 6 21.2 4 27.5 0 - 0 - 0 - 3 22.9 2 22.2 0 - 0 - 6 27.8 6 29.0 6 27.6
11 5 21.6 0 0 6 21.9 4 27.6 0 - 0 - 0 - 3 22.6 2 22.4 0 - 0 - 6 27.6 6 29.3 6 27.9
12 5 21.8 0 0 6 22.3 4 28.0 0 - 0 - 0 - 3 23.2 2 23.0 0 - 0 - 6 28.2 6 29.5 6 28.1
13 5 22.3 0 0 6 22.7 4 28.2 0 - 0 • 0 - 3 23.6 2 23.8 0 - 0 - 6 28.4 6 29.8 6 28.5
14 5 21.8 0 0 6 21.9 4 28.3 0 - 0 - 0 - 3 23.9 2 24.4 0 - 0 - 6 28.6 6 30.2 6 28.5
Key: a * number of' surviving mice
b a average weight of group of mice (g)
2C4
SABLE 30 A comparison of the results obtained after infecting
Ej.ce with ?s, aeruginosa strain P14 and treating
with jaoolne 1577 or pyocine 5882
Time of injection Time of injection Survivors per group of
of organisms of pyocine 6 mice after treatment
(hours) (hours) with pyocine:
1577 5882
0 0 5 5
0 3 0 0
0 6 0 0
3 0 5 6
6 0 4 4
0 NI 0 0
NI 0 6 6
0* 0 NT 0
0* 3 NT 0
0* 6 NT 0
3* 0 NT 3
6* 0 NT 2
Key:
NT a not tested
NI a not injected
* a mice injected with Pa, aeruginosa strain PlA-A
(C) Using pyocine H108
The infective dose of Pa, aeruginosa strain P14 was calculated
7 5
as 2,8 x 10' organisms. The activity of pyocine KXQ8 was 6,4 x 10
units per ml.
All the mice that were injected with P14 cells died within
8-2If hours of injection whether or not they had also received
pyocine 11108, The mice receiving pyocine EL08 alone all survived.
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(2) Infection of burns with Paeudomona3 aeruginosa
Experiment 1 The establishment of burn infections
The four infected mice began to lose weight within 48 hours
of the start of the experiment; two mice died on day 5 and one
mouse died on day 7# The 4th mouse survived. The average
weight of the uninfected group did not change greatly over the
course of the experiment.
The viable count of the suspension of P8, aeruginosa
strain P14 was 2,1 x 10® organisms per ml and thus the infective
dose per burn wa3 approximately 2,1 x 10^ bacteria. Bums that
had been inoculated with Pa. aeruginosa strain P14 began to show
signs of infection after about 48 hours (fig, 1?)« The burn
became red and. inflamed and also had a greenish tinge. Burns
on the uninfected mice reddened slightly but were not inflamed
and soon began to contract and dry up. The eschars on the
uninfected burns began to lift after four days whereas the eschar
on the surviving infeoted mouse did not begin to lift until 15 days
after the start of the experiment.
Cultures from swabs of the burns taken on day 5 and day 7
showed that all the burns of the infected mice were colonised by
r's, aeruginosa and two of the mice were also contaminated with
Proteus species. None of the uninfected mice had any Ps, aeruginosa
on their burns but 3 out of 4 were colonised by staphylococci
and 3 out of 4 by Proteus species; such colonisation of the
"uninfected" group did not appear to affect the mice and all the
burns healed about 15 days after burning.
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FISURS 1? The appearance of burned aloe infected with
Peeu&gaonaa aeruginosa strain ?14
(a) One day after burning and infecting
(b) Two days after burning and infecting
(c) Four days after burning and infecting
<*> At death, five days after burning and infecting
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Experiment 2 Treatment of infected burns with stage VI pyocine 1577
The viable count of the Ps. aeruginosa strain P14 suspension
used in this experiment was 9*0 x 10^ organisms per ml. Each
mouse received approximate^ 0,1 ml of this suspension, thus the
£
infective dose was 9*0 x 10 organisms per burn.
Stage VI pyocine 1577 suspended in THM buffer was used
for treatment. The average activity of the suspension over the
three treatment days was 4«2 x 104 units per ml.
The average weights of the groups of mice are given in
table 31, The positive controls i.e. mice that were infected but
not treated, showed the greatest loss in weight and one mouse
died three days after infection. Post-mortem cultures of the
spleen homogenate and of swabs taken of the peritoneal and
thoracic cavities revealed abundant growth of Pa, aeruginosa
(pyocine type 16), Animals in group 1, which were infected and
treated topically with pyocine, 3howed a slight loss in weight
initially but recovered later in the experiment.
The bacterial flora of the burns was monitored by daily
swabbing. Before infection with Ps. aeruginosa most of the
burns produced a scanty growth of Gram-positive cocci. The
uninfected burns maintained this flora and one al30 became
colonised by Proteus species. Twenty-four hours after infection
with Ps. aeruginosa strain P14, the burns showed some growth of
this organism on culture and by 48 hours all the infected burns
yielded a heavy growth of Ps. aeruginosa of pyocine type 16.
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Despite topical or intravenous therapy with pyocine 1577,
there was no apparent reduction in the amount of PjjU aeruginosa
colonisation of the bums. The level of Ps. aeruginosa on
the burns began to decrease around the 12th day as healing
progressed.
At the end of the experiment the number of burns that had
lost their eschars was recorded (see table 31). The results
suggested that infection of burns with Ps. aeruginosa did not
prevent healing.
experiment 3 Treatment of buna infections with stage IV and
stage VI preparations of pyooine 1577
The infective dose of Ps. aeruginosa strain ?14 was prepared
from solid culture rather than broth culture because this method
resulted in a higher viable count. In this experiment, the
q
viable count of the cell suspension was 3.6 x 10 organisms per
ml and thus the approximate infective dose per mouse was 3.6 x
8
10 organisms.
Two preparations of pyocine 1577 from different stages of
the purification procedure were used. The stage IV pyocine had
5
an activity of 3.8 x 10 units per ml and the stage VI preparation
4
had an activity of 1.2 x 10 units per ml.
The growth of Ps. aeruginosa on the infected burns was
monitored before and after pyocine treatment on days 2 and 3 of
the experiment and also on days 4 and 7. The infected mice
were all heavily colonised by Pa, aeruginosa (pyocine t;ype 16)
before treatment commenced. Cultures from swabs taken 1 hour
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after the last treatment on days 2 and 3 showed that the amount
of Ps, aeruginosa on the burns had been reduced in both the
stage IV and stage VI pyocine-treated groups. However samples
from the burns taken at the beginning of days 3 and 4 showed that
the Ps, aeruginosa had returned to its pre-treatment level.
In spite of the high infective dose, the positive control
group of mice, which were infected but not treated, had only a
50J2 mortality rate. Similarly in the group treated with
stage VI pyocine 1577, two of the four mice died. Mice that
were treated with stage IV pyocine all survived as did the
uninfected controls,
Experiment 4 Treatment of burn infections with stage IV and
stage VI preparations of pyocine 5882 and with
silver nitrate
The infective dose of Ps, aeruginosa strain P34 used in
8
this experiment was approximately 4.1 x 10 organisms per burn.
The activities of the stage IV and stage VI preparations of
5 4
pyooine 5882 were 1,6 x 10 units per ml and 1,2 x 10 units
per ml respectively.
The mortality of the burned mice is given in table 32,
The mice in group 3, which were treated with stage VI pyocine
5882, showed the best survival, but their burns remained colonised
by Ps. aeruginosa.
Impressions of the burns were made on agar to examine the
bacterial flora after treatment and to try to demonstrate the
TABLE32Mortalityfbu nedmiceafterinfect onw hPa.a rugi osas r^piAandtre tment withsagging5882orilvernitratesolution Group numberInfectedwith Ps.aeruginosa P34TreatmentNumber Diedofmice Survived


































presence of active pyocine on the burn surface. The latter
was shown by the inhibition of growth of strain PlA on a
sterilised impression plate. The results are shown in
table 33.
TABLE 33 The presence of Pa. aeruginosa and of inhibitory
activity on mouse burns treated by various methods
1 hour after final treatment
Burn on day 2
infected Growth of
Group with Ps. aeruginosa Inhibition of
number Ps. aeruginosa Treatment from each bum lawn of PlA
Mouse:
1 2 3 A
1 Yes THM buffer + ■f + NI




3 Yes Stage VI * + t + NI
pyocine
5882
A Yes 0.5$ ♦ + ■f + NI
AgN0?
5 No THM buffer - - - NI
Key:
+ = growth of Pa. aeruginosa
♦ s scanty growth of Pa, aeruginosa
- s no growth of Ps. aeruginosa
NI = lawn of strain PlA not inhibited
I = inhibition of lawn of PlA
On day 8, the burned skin was excised from one mouse in
each group. Viable counts of Ps. aeruginosa were made from
homogenates of the burns and the results are given in table 34.
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SgpyriLflWtrt 5 IggaiaSBS 9? fofeotfons "1th a Stage VI
preparation of pyocine 5882
The infective dose of Ps. aeruginosa strain P14 was prepared
from solid culture rather than broth, and the average viable count
8
per mouse was 2.2 x 10 organisms. The activity of the stage
VI preparation of pyocine 5882 used for treatment was 1,600,000
and 400,000 units per ml on days 2 and 3 respectively.
The numbers of surviving mice in each group are shown in
table 35. No Ps. aeruginosa was isolated from the uninfected
mice and these remained healthy throughout the experiment.
Cultures of swabs taken before and after pyocine treatment of
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infected burns did not reveal any obvious reduction in the
amount of Pa. aeruginosa isolated from the burns after pyooine
treatment. The representative colonies of Ps. aeruginosa that
were picked, were found to belong to pyocine type 16 and had
retained their sensitivity to pyocine 5882, as indicated by
cross-streaking.
At the end of the experiment, 6($ of the mice whose burns
were infected with Ps. aeruginosa strain P14 and treated with
pyocine 5882 were deadj by comparison, fCP/, of the infected
but untreated mice had died. The mean time to death of the
treated mice was 6.3 days compared with 7.3 days for the
untreated group.
TABLE 35 Survival of burned mice infected with Ps. aeruginosa





Number of animals (per
alive on day:
2 3 4 5 6 7
group of 10)





treated 10 10 8 6 6 5 5 5 5 5 4 6.3
Infected &
untreated 10 10 8 8 8 8 8 8 5 4 3 7.3
Uninfected
A
untreated 10 10 10 10 10 10 10 10 10 10 10 • • #
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Serological investjgations
Neutralisation tests were carried out to demonstrate the
presence of specific antibodies in the sera of mice that had
been treated with pyocine. The highest dilution of serum
that was capable of neutralising the pyooine activity was
recorded and the results are given in tables and 37*
(N,B# 1 in 128 was the highest serum dilution tested).
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TABLE 36 Neutralisation titres of sera from groups of mice
injected intraperltonealiy with ns. aerurdnosa




Time of injection on day 1:
036 hours
Neutralisation titre














































* mice in these groups were all injected with strain P14 into
one side of the peritoneal cavity and then with pyocine 1577
or 5882 into the other side
Ps« aeruginosa strain P14} cells suspended in NB^S
Ps« aeruginosa strain P34/B. (pyocine 5882 *
resistant) suspended in NB^S
Pyocine 1577 suspended in THM buffer
Pyocine 5882 M " " H
20^ nutrient broth in saline
217
TABLE 37 Neutralisation titres of aera from groups of mice
that were burned, infected with Ps. aeruginosa







1 Burn, Infect, Topical pyocurie
treatment
0
2 Burn, Infect, System!o pyooine
treatment
1/128
3 Burn, Infeot. No treatment 0
4 Burn, Infect. No infeotion ct
treatment
0
5 Burn, No infection. Topical
pyocine treatment
0





If pyooines are to be useful as therapeutic agents,
they must retain their inhibitory activity in vivo in the
presence of serum and tissue exudate. Higerd, Baechler and
Berk (1967) found that aged normal human or rabbit sera enhanced
the activity of pyoeine C9 fourfold in vitro. The inhibitory
activity of pyocines 1577, 5882 and HI08 in mouse 3erum was
examined. Since the sera from control mice did not inhibit
the growth of Pa. aeruginosa strain P14, the inhibitory-
activity of the test sera was assumed to be due to the injected
pyocine.
The high molecular weight pyocines 1577 and 5882 gave a
similar pattern of results: following intravenous administration
of pyocine, the inhibitory activity of the serum was greatest
in the first sample (i.e. after 0.5 hour) and gradually decreased
over the course of the experiment (2U hours). Intraperitoneal
injection of pyocine resulted in a rise in tte serum inhibitory
titre to a maximum at 3 hours after injeotion, followed by a
decrease during the next 21 hours. Little inhibitory aetivity
could be detected in the sera of mice that had received pyocine
subcutaneously.
Due to difficulties in preparation, pyocine H108 was
administered at a muoh lower titre than pyooines 1577 and 5882
and very little inhibitory activity could be detected in the
sera of the test animals.
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Thus it was concluded that pyocine preparations retain
at least some of their inhibitozy activity in the presence of
the body fluids of the test animal.
The effects of pyocines in the presence of Pa, aeruginosa
in vive were examined in two experimental systemsj by
intraperitoneal administration of bacteria and pyocine, and by
topical application of pyocine to infected burns. Intra¬
peritoneal injection of a suitable dose of Ps, aeruginosa
strain Pit results in rapid death, but mice treated with
pyocine 1577 before they were injected with strain P14 showed
a markedly improved survival rate compared with animals that
did not receive any pyocine or that were treated after they
were infected. It has been shown that pyocine remains aotive
in the blood for some hour3 after intraperitoneal administration
and where it was present in mice when the infeotive dose was
given, the pyocine was apparently capable of reducing the number
of bacteria to a level that could be dealt with by the animals*
defence mechanisms, and most of the mice survived. Similarly,
mice that received bacteria and pyocine simultaneously showed
good survival.
However, the pyocine was unable to prevent the fatal
outcome of Infection when it was given three or six hours after
the infective do6e. The HA- oulture was centrifuged and
resuspended in fresh broth before injection to reduce the carry¬
over of any toxic growth products. Thus the results suggest
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that the lethal products of the bacteria were produced soon
after inoculation and a reduction in bacterial numbers at a
later stage did not prevent death.
Treatment of intraperitoneal infections with the filamentous
pyocine 5882 gave very similar results. Kiee that were
treated with pyocine before they were infected with strain F14
generally survived but mice that were infected first and
treated with pyocine later all died. When the pyocine and
bacteria were given at the same time, five of the six mice
survived. jyocine 1577 used in the experiment load an activity
6
of 1.6 x 10 units per ml whereas pyocine 5882 had an activity
4
of only 5»0 x 10 units per ml, but this difference was not
reflected in the results of the comparative experiments.
Pa. aeruginosa strain P14/P* was isolated from a colony
of 3train P34 that had grown in the presence of pyocine 5882
in vitro. Hov/ever, it appeared that some of the cells in the
infective dose of P14/R were sensitive to the pyocine in vivo.
thus the viability of the infective dose was reduced and some of
the mioe survived. When pyocine 5882 and P14/R were injected
simultaneously all the mice died, compared with only one death
in the group injected with the pyocine and P14 cells simultaneously.
This suggests that the inhibition of P14A cells by pyocine 5882
may be slower than that of P14 cells.
Compared with the protective effect of pyocines 1577 and
5882 on mice infected with strain P14, the results with pyocine
H108 were unfavourable, probably because of the low inhibitory
activity of the pyocine suspension. The infective dose of
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Pb» aeruKinosa strain 114 v&z lethal to all the mice, both in
the presence and absence of pyooine Hl08.
Infections initiated by intraperitoneal inoculation of
Pa. aeruginosa are easy to establish but are poor representatives
of natural pseudomonas infection, whereas the infection of
experimentally-induced burns closely mimics the human counterpart.
The method of "burning mice was based on that described by
Jones, Jackson and Lowbury (1966) and was readily performed.
The only problem was in ensuring that the whole surface of the
brass block was in oontaot with the mouse*s skin. The use
of hairless mice had the advantage that it made depilation
unnecessaiy. The mice did not appear to differ from normal
mice except in their lack of hair.
Jones and his colleagues (1966) reported a mortality
rate of 71% following Ps. aeruginosa infection of mouse burns.
Experiment 1 in this series gave a similar result although the
number of animals involved was small. Burning, without
subsequent infection, produced no deaths in any of these
experiments. The burns that were not infected with Ps. aeruginosa
frequently became contaminated with Grans-positive ccooi, but
these did not appear to have any adverse effects on the mice.
Occasionally Proteus species were also cultured from the
burns. This was probably the result of contamination of the
burn from the faeces of the mouse. Sampling of the faeces
before the start of an experiment revealed a number of lactose
non-fermenting Gram-negative bacilli, including Proteus.
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However, Proteus colonisation of the burns did not seem to
have any deleterious effects on the ndce.
When Ps, aerurf.nosa infects a burn, the bacteria gradually
invade the deeper tissues and death results from septicaemia.
In experiment 2, two routes of pyocine treatment of infected
burns were examined. Topical pyocine treatment was aimed at
reducing the surface infection with Ps, aeruginosa, while
intravenous therapy was designed to oounteract septieaemio
spread of the bacteria. However, the results showed that the
infective dose of Ps, aeruginosa was too small and the mortality
of the infected but untreated mice was very low. In view of
the lack of clear positive controls, it was difficult to draw
any conclusions on the efficacy of pyocine treatment. The
topically-applied pyocine may have reduced the numbers of
Ps, aeruginosa on the burn transiently, but thi3 reduction was
not obvious from the daily cultures. In later experiments,
the frequency of sampling was increased to give a better
picture of changes in the numbers of bacteria on the burn.
Uninfected controls that were treated with pyocine did less
well than uninfected mice that were not treated, as judged by
the daily average weights of the groups. This suggested that
the pyocine treatment alone may have had some adverse effects.
Although the infected mice did not die, their burns remained
colonised by Ps. aeruginosa for some time, but this did not
apparently prevent normal healing of the burn wound.
The technical problems of pyocine therapy centred around
the production of adequate volumes of purified pyocine of high
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activity. A fresh batch of pyocine was prepared for each
experiment and the preparation time was about ten days
(see Section 2). After the final purification stage by
DEAE-cellulose ion-exchange chromatography, the pyocine was
dispersed in a large.volume (o. 80 ml) of buffer and had a low
activity per ml. Ultracentrifugation was used to concentrate
the dilute pyocine suspension and as a result, only small
volumes of purified pyocine were obtained. Dilution of the
concentrate was necessary to provide enough pyocine for the
experiment and consequently the activity per ml of the purified
(stage VI) pyocine suspension used for treatment was rather low
4
(o. 1,2 x 10 units per ml). fyocine suspensions of higher
activity (c. 2.0 x 10^ units per ml) were obtained in larger
volumes at the intermediate step in the purification procedure
(stage IV). These preparations had not been svijected to column
chromatography and thus were contaminated with other protein
material. The therapeutic potential of such pyocine
preparations of lower purity but higher unit activity was
compared with that of the purified pyocine, in experiments
3 and 4. The requirement for pyocine was reduced by examining
topioal treatment only.
The method of applying pyocine to the burn surface i.e.
with a cotton-wool swab soaked in pyooine, was far from
quantitative. It was oonfirmed that the pyocine activity was
not destroyed on the swab, but the volume of pyooine transferred
onto the bum was uncertain. The swab may also have been
22k
responsible for removing organisms from the surface of the burn.
There was no way of preventing this, but the error was common
to all the mice, A sterile swab was used for each treatment
of each mouse to prevent contamination of the stock pyocine
suspension.
The small study in experiment 1 showed that an infective
7
dose of 2,1 x 10 Ps, aeruginosa strain P14 was lethal, but in
further work the doses were found to be too small to cause
death of the positive controls. In order to show that pyocine
treatment could prevent death of infected mice, it was necessary
that the untreated, infected mice (i.e. the positive controls)
should die. To try to achieve this end, the viable count of
the Infective dose of Ps. aeruginosa was raised approximately
twentyfold in experiments 3 and 4.
Experiment 3 showed that the topical treatment of bum
infections with pyocine 1577 did reduce the amount of Ps. aeruginosa
on the burn surface. But this reduction was transient and
within 16 hours, the ps. aeruginosa had returned to its
pre-treatment level. Although the infective dose had been
increased, there was only a 50^ mortality among the positive
controls. Two of the fair infected mice, treated with stage
VI pyocine 1577, died in spite of the temporary reduction of
Ps. aeruginosa on the bum by the pyocine.
Pyocine 5882 was used for treatment in experiment 4, and
was compared with silver nitrate solution which is recommended
for the treatment of human burns (Cason and Lowbury, 1968).
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Superficially the results of this experiment mre favourable
to pyooins therapy. There -was a high mortality rate in all
the infected groups of mice except those treated with
stage VI pyocine 5882, in spite of the low activity of the
pyocine preparation (1,2 x 10^ units per ml). Impression
plates were used to give a aireet image of the surface of the
burn after pyocine treatment. The results showed that there
was a significant reduction in Pa, aeruginosa on the burn
surfaces one hour after treatment with stage IV pyocine 5882
and a slight reduction after treatment with the stage VI
pyocine. Treatment with 0.5*> silver nitrate solution did not
reduce the level of Pa. aeruginosa on the burn. A second
impression of each burn was taken, sterilised and lawned
with Pa. aeruginosa strain P14, to see whether there was any
demonstrable inhibitory activity remaining on the bum one hour
after pyocine treatment. The results suggested that there
was some pyocine activity present on the burns treated with
stage IV pyocine. No inhibitory activity was demonstrable
on any of the other burns.
The results from the impression plates support the idea
that the survival of the infected mice treated with stage VI
pyocine 5882 was fortuitous and may have been due to a lower
level of infection. The numbers of Pa, aeruginosa in the
burns of the surviving mice in each group were estimated by
excising the burned skin, homogenising it and preparing a
viable count. The samples were all taken from mioe that had
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survived until the 8th day of the experiment and the results
showed thai these burn3 were all infected with approximate^
the same number of Is, aeruginosa. This suggested that this
O
level of infection in the bum (c. 2.0 - 7*0 x 10 organisms
per g skin) was not lethal. Quantitative estimation gives a
much more accurate picture of Ps. aeruginosa in the burn and
it would be desirable to follow the changes in numbers of
bacteria during pyocine treatment by this method. It would
however, involve large numbers of mice and thus large volumes
of pyocine, tc obtain meaningful results.
Experiment 5 was designed to clarify the results of the
previous experiment on the efficacy of topical pyocine 5882
treatment on burns infected with Ps. aeruginosa strain P24«
The numbers of mice in each group were increased in an effort
to overcome the variability in the "take-rate" of the
infections. The full preparative procedure for pyooine 5882
was carried through twice to provide an adequate volume of
stage VI pyocine, and treatment was commenced. 24 hours after
infection. Only eight doses of pyooine per mouse were available
and these were spread over 2 days. However, from about
48 hours after infection, Ps. aeruginosa starts to invade
deeper into the burned tissue and thus becomes inaccessible to
topical treatment. The results of the experiment show fairly
conclusively that topical treatment with pyocine 5882 did not
significantly improve the chances of survival of burned mice
infected with Ps. aeruginosa strain P14.
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Cne of the problems associated with the therapeutic U3e
of pyocines is their antigenicity, Pyocines have been shown
to be good antigens when injected with adjuvants into animals,
but it is not known to whet degree they are antigenic when
administered alone. In the course of these experiments on the
therapeutic uses of pyocines in ps, aeruginosa infections, serum
was collected from some groups of mice and tested subsequently
for the presence of antibodies to the pyocine with which the
animals had been treated.
In experiments where the infective dose of rs, aeruginosa
strain P14 and the pyocine were given intraperitoneally, it
was found that in mice that survived, a single injection of
pyocine caused the development of neutralising antibody within
13 days. Control mice that received pyocine only and were not
infected, showed a somewhat lower antibody response than mice
that had also received organisms. It may be that the
Ps, aeruginosa acts in the manner of an adjuvant and increases
the antibody response to the pyocine. Unfortunately, the
neutralising capacity of dilutions of serum greater than 1 in
128 was not examined and the actual neutralisation titre of the
sera may have been much higher. The sera were not tested for
antibodies to the infecting strain P14.
The treatment of ps, aeruginosa burn infections with
pyoaine 1577 resulted in little antibody development, and it
was only in those mice that had reoeived pyocine 1577 intravenously
that pyocine-neutralising antibodies were detected. Topical




Paeudomonas aeruginosa Is often regarded as a saprophyte,
but in the hospital environment it frequently assumes the role
of a dangerous pathogen which takes a particular delight in
attacking debilitated patients. Since the introduction of
broad-spectrum antibiotics, a disturbing increase in the
incidence of Pa, aeruginosa infections has been noted (Finland,
Jones and Barnes, 1959} Asay and Kooh, I960), and has brought
to light the problems associated with the eradication of this
organism. Onoe established, Ps. aeruginosa infections are
difficult to cure because of the organism's natural resistance
to many antimiorobial agents and its ability to develop or acquire
resistance to the few effective agents that are currently available,
e.g. the antibiotics gentamicin and carbenioillin. Even in
surfaoe infections, such as those of burns, where more draatio
antimicrobial therapy oan be used, Ps. aeruginosa infection
remains a serious hazard. Since the organism appears to be
undaunted by our therapeutic efforts, the consideration of an
alternative type of antibiotic treatment seemed reasonable.
The idea of pyocine therapy lias already been broached and the
published reports are favourable (Bird and Grieble, 1969}
Merrikin and Terry, 1972). Thus it seemed feasible to extend
these preliminary studies and examine the therapeutic applications
of pyocines in greater depth.
Ps. aeruginosa is known to be capable of elaborating three
kinds of pyocines which may be differentiated by their molecular
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weight and morphology. Neither Bird and G-rieble (1969) nor
Merrikin and Terry (1972) defined the kind of pyooine they
were dealing with and it is difficult to make a critical
assessment of their results. In this investigation, a
representative of each kind of pyocine was selected; contractile,
filamentous and small, each produced by a different pyocinogenic
strain, but all inhibitory to Pa. aeruginosa strain P14.
This indicator strain was chosen because it was known to be
virulent to mice when applied to experimentally-induced burns
(Jones, Jackson and Lowbury, 196b), A considerable proportion
of the study involved the characterisation of the selected
pyocines and an examination of suitable purification and
concentration techniques. Before therapeutic investigations
were undertaken, in-vitro experiments were carried out to examine
the interactions between the selected pyocines and indicator
strain P14. Some potential problems associated with the
therapeutic use of pyocines were brought to light; it was
difficult to eradicate strain P14 completely by pyocine treatment
and the emergence of pyocine-resistant variants was noted.
An ideal therapeutic agent may be considered as requiring
the following properties:
(a) It should specifically attack the pathogen while
being non-toxic to the host.
(b) It should be stable and active in the presence of
serum and tissue exudate.
(c) It should not encourage the development of resistance.
(d) It should preferably be cheap and easy to use.
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In the light of the results of this investigation, a comparison
may be drawn between the pyocines and an ideal therapeutic agent.
Ityocines are by definition extremely specific in their
inhibitory activity and only attack strains within the genus
that possess suitable receptors. This study was confined to
a single indicator strain and the spectra of activity of the
selected pyooines were not examined. However, it would appear
that a single pyooine preparation would have a very limited
range of aotivity and the sensitivity of an infecting strain to
a number of pyocines would have to be tested before treatment
could commence.
The toxicity of pyocines to animals has not been satisfactorily
established. Homma and Suzuki (1964) found that a cell wall-
associated protein with pyocine activity had some toxic
properties. Bird and Grieble (1969) reported in their
therapeutic stuiies that the administration of pyocine alone to
chick embryos resulted in an 11$ mortality. The nature of
the pyocine that Bird and Grieble used is not clear from their
results (1969) but other workers (Kigerd, Baechler and Berk,
1967; Sovan, 1968) who have studied the contractile pyocines
have found them to be completely non-toxic. Unfortunately,
the results presented here are not conclusive and certain
preparations of the contractile pyocine 5893 were toxio to mice.
Therefore this pyocine was replaced by pyocine 1577 which was
also of the contractile type, but in a purified form had no
adverse effects on mice. The filamentous pyocine 5882 did not
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exhibit any toxio properties, but injection of preparations
of the small pyooine H108 into mice did result in some deaths.
The problems of toxicity associated with pyocines may be due to
impurities, such as enzymes, which are present in the preparations
and with further studies of purification procedures it may be
possible to produce non-toxic products.
However, the problems of antigenicity are not so easily
conquered. A single therapeutia dose of pyocine given
intraperitoneally wa3 sufficient to elicit an antibody response
in mice. This would severely limit systemic pyooine therapy,
and since there are serological relationships between different
pyocinea within the same class (Homma, Goto and Shionoya, 19&7)
treatment with an alternative pyocine would not necessarily solve
the problem. The outlook for topical application of pyooine is
somewhat brighter in this respect since a short course of
treatment did not result in antibody production.
The retention of pyooine activity in the presence of serum
was examined by injecting mice with pyooine by various routes and
examining the serum for inhibitory activity. It was concluded
that the pyooines retained some of their activity for at least
2k hours. The serum inhibitory titre following the intravenous
administration of pyocine fell progressively over this time,
whereas pyooine given intraperitoneally reached its maximum serum
level about three hours after injection and then decreased.
The time-lag presumably reflects the time involved in clearirg
the pyocine from the peritoneal cavity into the bloodstream.
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The way in which this is effected is not understood, but it is
apparently more efficient than the delivery of subcutaneous
pyocine to the blood judging from the low levels of pyocine
activity in the serum following subcutaneous injection.
The small pyoclnes are sensitive to the aotion of proteolytic
enzymes and it might be suggested that they would be inactivated
by such enzymes in the body. However, Braude and Siemienski
(1965) found that colicine activity, which is also sensitive to
proteolytic enzymes, was not destroyed in the serum of nri.ce.
From the levels of inhibitory activity present in mouse serum
after intravenous administration of the small pyocine H108,
it would appear that this pyocine was also unaffected by the
proteolytic enzymes in vivo.
The resistance of Pa, aeruginosa to many antimicrobial
agents is the prime cause for the triumph of this organism in
the hospital environment. Although Patterson (1965) found that
pyocine-resistant mutants were rare, their existence has been
described by several other authors. Kageyama, Ikeda and figami
(1964) suggested that in a sensitive culture, treated with
pyocine, there was a iiigh frequency of mutation to pyocine
resistance. Govan (1968) found that cells that were apparently
resistant to pyocine attack reverted on subsequent re-testing
and stable mutants were difficult to obtain. Tolerant mutants
i.e. cells which are able to absorb small pyocines but are
insensitive to their action, have been reported by Holloway (1971)•
In this investigation, it was found that pyocine-resistant
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variants emerged rapidly in a culture of strain P14 exposed to
pyooine in vitro, and these appeared to be stable on subsequent
testing# However, cultures of strain P14 obtained from infected
animals that had been treated with pyocines did not appear to
have developed resistance during the course of treatment. The
study of pyoclne resistance in vivo was superficial aid. the
rapid emergence of resistant mutants in vitro is foreboding#
The preparation of purified pyooine was a rather lengthy
procedure and the poor "shelf-life" of the purified pyocines
necessitated preparing a fresh batch for each course of treatment.
To date, suitable methods for storing pyocines in their active
state have not been clearly defined, but further research may
solve this problem.
From this review, pyocines emerge with rather dubious
possibilities as therapeutic agents but some of the problems
described may be surmountable by further research. However,
from the results of the therapeutic studies reported here, the
actual value of pyocine therapy is doubtful. Syatemio
administration of pyooine could only prevent the fatal outcome
of infection if it was given before or simultaneously with the
infective dose, and this is a somewhat impractical forn of
treatment. Initially, topical therapy seemed to be a more
likely outlet for pyoolnes, but it was found that the inhibition
of Ps« aeruginosa by the pyocines tested was insufficient to
t
prevent invasion of bacteria from the infected burn and
subsequent septicaemia and death.
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